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Aim and outline 
Peroxisomes are present in nearly all eukaryotic cells and they perform a wide variety of 
metabolic functions. Two major peroxisomal functions include β-oxidation of fatty acids and 
hydrogen peroxide removal however, other many functions exist and they can vary depending 
on the species, cell type and environmental conditions. Peroxisomal functions are determined 
by the peroxisomal matrix and peroxisomal membrane proteins (PMPs) that are present in 
peroxisomes. Therefore, peroxisomal protein homeostasis - protein synthesis, targeting and 
degradation - plays an important role in regulating peroxisome function. Since peroxisomes are 
devoid of protein synthesis machinery, all peroxisomal proteins are encoded by nuclear genes, 
synthesized in the cytosol and post-translationally imported to peroxisomes. While much effort 
has been placed on studying the targeting of PMPs to peroxisomes, little is currently known 
about how and why PMP degradation occurs.  
The aim of this thesis is to shed light on PMP degradation by identifying which PMPs are 
targeted for degradation as well as the factors involved in their degradation. Furthermore, since 
protein degradation can occur for quality control purposes or to regulate organelle functions, 
we aimed to investigate why PMPs are targeted for degradation, in order to understand the 
importance of PMP degradation in peroxisome function. Hence, the research presented in this 
thesis utilizes various approaches to investigate some of the underlying mechanisms and 
cellular functions of PMP degradation in yeast.    
In Chapter 1, we present an overview of various factors that regulate membrane protein 
degradation, focusing on the ubiquitin proteasome system (UPS) and its role in degrading 
membrane proteins from various organelles, including peroxisomes.  
Previous findings reported that the PMPs Pex3p and Pex13p in the yeast H. polymorpha 
and Pex15p in the yeast S. cerevisiae are degraded in a UPS-dependent manner. In Chapter 2, 
we aimed to identify additional PMP substrates of the degradation pathway using S. cerevisiae 
as model organism. In our study, we utilized a tandem fluorescent timer (tFT) consisting of 
sfGFP and mCherry, to provide insights into PMP turnover. We observed that individual PMP-
tFT fusions in cells display varied stability profiles, establishing that a tFT can be used to report 
on the stability of individual PMPs. Furthermore, we show that Pex13-tFT and Pxa1-tFT are 
the two most unstable proteins which are degraded rapidly under peroxisome inducing 
conditions. These PMP-tFT fusions were observed to be well-induced and displayed 
peroxisome localization in cells grown on oleate. This work demonstrates that a tFT is a valid 
and robust approach to examine PMP stability and identify unstable PMPs that have a fast 
turnover.  
We observed that the tFT tag attached to Pxa1p affects the function of Pxa1p, indicating 
that Pxa1-tFT could be degraded for quality control purposes, due to reduced functionality. 
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Because PMPs are involved in peroxisomal biogenesis, any faulty PMPs present in the 
peroxisomal membrane need to be removed in order to maintain peroxisome homeostasis. 
Currently next to nothing in known about PMP quality control. In Chapter 3, we aimed to study 
PMP quality control in the yeast S. cerevisiae using Pxa1p, a peroxisomal fatty acid transporter, 
as a substrate. Using a mutant form of Pxa1p (Pxa1MUT) fused to mGFP, we show that Pxa1MUT-
mGFP targets to peroxisomes and is rapidly degraded by a process that is dependent on 
proteasome. Unlike Pxa1MUT-mGFP, we observed mGFP tagged Pxa1p to be stable, 
establishing a role for quality control in Pxa1MUT-mGFP turnover. By using the tFT approach 
in combination with synthetic genetic array, we show that Ufd4p, a cytosolic E3 ligase, is 
required for Pxa1MUT-mGFP degradation while we also show that inhibiting Pxa1MUT-mGFP 
degradation, by the deletion of UFD4 partially restores Pxa1p function and thereby peroxisomal 
β-oxidation in vivo. These findings establish that faulty PMPs can undergo proteasome-
mediated degradation while also demonstrating that cytosolic proteins involved in general 
protein quality control can impact on peroxisome function.  
The docking complex PMP Pex13p in H. polymorpha was reported to undergo degradation 
by a process that is dependent on Pex2p and Pex4p. Similar to H. polymorpha, our tFT analysis 
show that tFT tagged Pex13p in S. cerevisiae is rapidly degraded (Chapter 2), indicating that 
Pex13p degradation may be a general feature of peroxisomes. In Chapter 4, we aimed to 
examine whether Pex13p degradation is a conserved process across yeast species and identify 
factors that are required for S. cerevisiae Pex13p degradation. Our data reveal that S. cerevisiae 
Pex13p fused to mGFP (Pex13-mGFP) undergoes degradation, likely via a similar mechanism 
to that in H. polymorpha. As in Chapter 3, we utilized a tFT approach to identify which 
additional factors other than peroxisomal proteins are involved in Pex13-mGFP degradation. 
Our data indicate that cytosolic proteins such as Ubc4p, Ufd4p and Ubr2p may play a role in 
Pex13-mGFP turnover. Furthermore, inactivation of the AAA protein Cdc48p, which plays a 
role in extracting membrane proteins from the ER and mitochondria, does not result in 
stabilization of Pex13-mGFP, establishing that Pex13-mGFP degradation probably occurs via 
a different mechanism to that of other organellar membrane proteins. Together, these data 
provide further evidence that Pex13p degradation is a conserved process while also uncovering 
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Proteins perform many functions in the cell. Some proteins provide structural support and 
regulate movement of organelles and cells (Sweeney and Houdusse, 2010). Others function in 
the transport of ions or small molecules across membranes (Wilkens, 2015), transmission of 
extracellular signals to the cell interior (DeWire et al., 2007) while still others catalyse various 
metabolic reactions (Poirier et al., 2006). For the cellular systems and metabolic pathways to 
function efficiently, protein abundance needs to be tightly controlled, through protein synthesis 
and degradation (Eagle et al., 1959; Fonseca et al., 2006). Generally, protein degradation play 
two vital roles in the cell; firstly, to remove redundant proteins that function in regulatory 
processes such as cell cycle progression and transcriptional activation (Lee and Yaffe, 2016) 
and secondly, to remove faulty or damaged proteins that are dysfunctional, a process referred 
to as protein quality control (Sherman and Goldberg, 2001).  
Since proteins are involved in almost every biological process, inefficient degradation of 
abnormal proteins or regulatory proteins could lead to severe consequences. Accumulating 
evidence indicates that reduced or accelerated degradation of proteins represents a prevalent 
pathogenic mechanism underlying a plethora of diseases (Ciechanover and Schwartz, 2004). 
For instance, cystic fibrosis (CF) and rare metabolic disorders including Adrenoleukodystrophy 
(ALD) occur as a result of increased protein degradation. The mutations in cystic fibrosis 
transmembrane conductance regulator (CFTR) result in protein misfolding and rapid 
degradation of CFTR mutants, leading to decreased chloride channel activity and impaired ion 
transport across the epithelial membrane (Du et al., 2005). In most cases, ALD patients harbour 
mutations in the peroxisomal fatty acid transporter Adrenoleukodystrophy protein (ALDP), 
which often result in ALDP degradation. As a result, very-long chain fatty acids are not 
transported to- and metabolized within- the peroxisomes but instead accumulate in the brain 
and other tissues. (Engelen et al., 2014; Morita et al., 2019).  
Neurodegenerative disorders on the other hand can be caused due to reduced protein 
degradation and can be characterized by the accumulation of protein aggregates. These 
include β-amyloid peptide and hyper phosphorylated tau protein aggregates in Alzheimer’s 
disease (Hardy and Selkoe, 2002; Ward et al., 2012), aggregation of α-Synuclein (α-Syn) in 
Parkinson’s disease (Martin et al., 2011; Uversky, 2007) and mutant huntingtin in 
Huntington’s disease (Tsoi et al., 2012; Williams et al., 2008a). The intracellular inclusions 
detected in the brains of patients with neurodegenerative diseases are often ubiquitin-positive 
and contain misfolded disease-specific proteins, indicating that misfolded proteins, although 
ubiquitinated, are not effectively removed by the degradation machinery, proteasome. (Ross 
and Poirier, 2004; Soto, 2003). Moreover, repeated attempts to remove protein aggregates or 
abnormal proteins could saturate the capacity or clog the entire proteasome, hindering its ability 
to degrade other proteins that are critical for regulating cellular activities. Aggregated proteins 
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that are resistant to degradation may also spread from one cell or brain area to another and 
function as seeds to instigate protein misfolding and aggregation in previously unaffected areas 
(Walker and LeVine, 2012). These examples demonstrate that protein degradation plays a vital 
role in cellular health. 
Here we present an overview of membrane protein degradation, with emphasis on 
peroxisomal membrane protein (PMP) degradation. We first describe the functions of protein 
degradation and outline the mechanism of degradation by the ubiquitin proteasome system 
(UPS), the major protein degradation pathway in eukaryotic cells. Next, we discuss the 
challenges associated with removing proteins from membranes. Furthermore, we present the 
current knowledge on membrane protein degradation from other organelles such as the ER and 
mitochondria. We then introduce the topic of peroxisomes, protein targeting into peroxisomes 
and peroxisomal protein degradation. Finally, we discuss the current knowledge on PMP 
degradation, including known and putative PMP substrates of the degradation pathway and we 
also discuss possible roles for peroxisomal and other UPS factors in PMP degradation. 
Keywords: Protein degradation, protein quality control, regulated protein degradation, ubiquitin 
proteasome system, membrane protein removal, peroxisomes, peroxisomal membrane protein 
degradation 
2. Functions of protein degradation 
As mentioned above, proteins can undergo degradation either to remove faulty proteins by 
quality control pathway (2.1) or to regulate cellular activities (discussed in 2.2)  
2.1 Protein quality control: Elimination of faulty proteins 
Faulty proteins can appear in the cell due to mutations in the gene sequence, protein synthesis 
errors, inefficient protein folding, faulty post-translational modifications or damage caused by 
exposure to for example environmental stress (Drummond and Wilke, 2008; Mandelkow and 
Mandelkow, 2012; Radi, 2013; Sitte et al., 2000). Abnormal proteins produced by any of these 
methods are dysfunctional, resulting in loss of protein function. However, build-up of abnormal 
proteins results in a gain-of-toxic function that is unrelated to the protein's function and which 
has become increasingly relevant to human disease (Winklhofer et al., 2008). Generally, 
aberrant proteins tend to expose hydrophobic regions to the cytosol that are normally buried 
within the core of the protein (Gibson and Ellory, 2002). Non-native proteins exposing 
hydrophobic patches can take part in unwanted protein-protein interactions and may ultimately 
culminate in protein aggregation that eliminates the activity of other proteins (Dobson, 2004). 
To minimize potentially harmful effects caused by the build-up of abnormal proteins, cell 
employs protein quality control systems such as molecular chaperones (Hartl et al., 2011; 
Stirling et al., 2003) and protein degradation systems (Fredrickson and Gardner, 2012; He and 
Klionsky, 2009; Hershko and Ciechanover, 1998). Along with protein folding, chaperones also 
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function in refolding misfolded proteins, acting as a first line of defence against the formation 
of protein aggregates (Muchowski and Wacker, 2005). Nevertheless, some aberrant proteins 
undergo rapid degradation due to the inability of chaperones to refold them to their native state.  
2.2 Protein degradation in regulation of cellular activities 
In addition to the role in quality control, protein degradation helps maintain the appropriate 
cellular level of proteins and hence their activities, as well as allowing the rapid downregulation 
of protein levels to occur, to help cells respond to changing conditions (Varshavsky, 2005). 
Effectors of the cell cycle, developmental regulators, homeotic proteins, transcription factors, 
protein kinases and oncogene products can all be targeted for degradation, in order to maintain 
the appropriate protein levels or as response to changing environmental conditions (Bassermann 
et al., 2014; Ee and Lehming, 2012). For instance, the selective and timely degradation of cell-
cycle regulatory proteins, such as cyclins, inhibitors of cyclin-dependent kinase and anaphase 
inhibitors are critical for cell-cycle progression (Bassermann et al., 2014). Cell growth and 
proliferation are further controlled by the degradation of tumour suppressors such as p53 and 
proto-oncogenes including β-catenin (Kitagawa et al., 2009). The rapid degradation of 
numerous transcriptional regulators is involved in controlling various signal transduction 
processes and responses to environmental cues (Conaway et al., 2002). The output of many 
signalling pathways is the transcription of genes that encode proteins necessary for the desired 
cellular response. 
3. Ubiquitin Proteasome System and protein degradation 
The two main pathways involved in the degradation of proteins are the ubiquitin-proteasome 
system (UPS) and autophagy (He and Klionsky, 2009; Hershko and Ciechanover, 1998). While 
UPS is primarily responsible for rapid protein turnover, including the selective removal of 
abnormal and misfolded proteins (Ciechanover et al., 2000), autophagy mostly targets long-
lived proteins and large structures like protein aggregates or organelles (Goldberg, 2003; Seglen 
and Bohley, 1992). The ability of cells to degrade proteins by the UPS was first demonstrated 
more than 40 years ago (Goldberg, 1972). In general, degradation of aberrant or regulatory 
proteins by the UPS involves two major steps 1) ubiquitination of the target protein and 2) 
degradation of the ubiquitinated protein by the proteasome. Ubiquitin (Ub), a highly conserved 
globular protein with 76 amino acids, is covalently attached to the lysine residue of a substrate 
protein (Komander and Rape, 2012; Swatek and Komander, 2016). Conjugation of ubiquitin to 
the substrate involves multiple steps catalysed by three enzymes- an Ub-activating enzyme 
(E1), an Ub-conjugating enzyme (E2) and an Ub ligase (E3) (Figure 1) (Scheffner et al., 1995). 
Ub is first activated by the formation of a thioester bond between the C-terminal Gly76 of the 
Ub molecule and the active site cysteine (Cys) of the E1 (Figure 1) (Schulman and Harper, 
2009). Activated Ub is then passed on from E1 to the active site cysteine residue of the E2. 
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Often, E2 enzymes directly transfer Ub to a target protein, typically with the help of E3s such 
as really interesting new gene (RING) domain containing ligases, also called as RING E3s 
(Figure 1, point 1) (Ozkan et al., 2005). However in some cases, the Ub is first transferred from 
the E2 to the active site of a specific class of E3 (Figure 1, point 2), which possess homologous 
to the E6-AP carboxyl terminus (HECT) domain and these HECT E3s are responsible for 
attaching Ub to the lysine residue of the target protein (Metzger et al., 2012; Petroski et al., 
2006). A third class of E3 ligase, distinct from the RING and HECT classes, are referred to as 
RING-in-between-RING (RBR) E3s (Figure 1, point 3) and they often contain a RING domain, 
followed by an RBR domain and finally a RING-like domain. These RBR E3s recruit an E2, 
which transfers ubiquitin to a cysteine in the RING-like domain before transferring to the 
substrate (Figure 1, point 3) (Wenzel et al., 2011).  
 
 
Figure 1: Schematic overview of the enzyme cascade catalyzing protein ubiquitination and 
degradation. Ubiquitin (Ub) is first activated by a ubiquitin activating enzyme (E1) with ATP hydrolysis. Next, 
the E1 transfers the Ub to a ubiquitin conjugating enzyme (E2), which is eventually transferred to a substrate with 
the aid of a ubiquitin ligase (E3). (1) RING-E3 serve as a bridge to enable Ub to be passed directly from the E2 to 
the substrate while (2) HECT-E3s accept Ub from the E2 onto their own active site before attaching it to a substrate. 
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RBR-E3 ligases (3) bind a Ub conjugated E2 and Ub is transferred from the E2 to the E3, after which Ub is then 
transferred to the substrate. Substrate proteins with single Ub can undergo several rounds of Ub chain elongation. 
Poly-ubiquitinated substrates are then targeted to the proteasome for degradation. 
Cells possess one or two E1s, several E2s (~11 in yeast and ~37 in humans) and multiple 
E3s (~50 E3s in yeast and ~1000/thousand in humans) (Finley et al., 2012; Li et al., 2008; 
Pickart, 2001; Pickart and Eddins, 2004). E3s selectively recognize and mediate the 
ubiquitination of substrate proteins dependent on E1 and E2 enzymes (Pickart, 2001). Several 
lines of evidence show that efficient ubiquitination of certain substrates require additional 
conjugation factors, termed as E4 enzymes. Examples of this class include cullins and E4s such 
as UFD2 and they work in association with E1, E2 and E3 (Hoppe, 2005). 
Proteins can be modified either with a single Ub molecule either at a single site (mono-
ubiquitination) or on multiple sites (multiple mono-ubiquitination) (Pickart and Eddins, 2004). 
Furthermore, because Ub itself possess seven lysine residues, poly-ubiquitin chains can be 
formed by attachment of other Ub molecules to one of these internal lysine residues (Ikeda and 
Dikic, 2008) or to the N-terminal methionine of the previously attached Ub (Kirisako et al., 
2006). The fate of poly-ubiquitinated proteins depends on the lysine chain specific 
ubiquitination (Pickart, 2000). Some poly-ubiquitin chains, particularly the lysine 48 (K48) and 
to a lesser extent (K29), act a potent signals for destruction by the proteasome (Yau and Rape, 
2016), while other poly-ubiquitin linkages (e.g. K6, K11, K27 and K63), as well as mono-
ubiquitination, are known to mediate non-proteolytic cellular process, including DNA repair, 
cell-cycle regulation, signal transduction and protein-protein interactions (Hicke, 2001; 
Husnjak and Dikic, 2012; Komander and Rape, 2012).  
As a rule, a chain of four or more Ub molecules, linked through K48, is required to allow 
protein degradation by the 26S proteasome (Adams, 2003; Tanaka, 2009; Thrower et al., 2000). 
although mono-ubiquitination was also shown to be sufficient for the degradation of certain 
substrates (Braten et al., 2016; Kravtsova-Ivantsiv et al., 2011). While protein degradation by 
the proteasome mostly depends on Ub conjugation, there are a number of proteins that can be 
degraded in a process independent of Ub but still requiring the proteasome (Baugh et al., 2009). 
Several examples of ubiquitin-independent proteasomal degradation include the cyclin 
dependent kinase inhibitor p21Cip1 and Ornithine decarboxylase (ODC), an enzyme involved 
in polyamine biosynthesis (Bercovich et al., 1989; Sheaff et al., 2000).  
Proteasomes have an ancient origin and all eukaryotes, archaea as well as some bacteria 
possess proteasomes of varying complexity (Dahlmann et al., 1989; Gille et al., 2003). In 
eukaryotes, the 26S proteasomes are located mainly in the nucleus and cytosol as free or ER 
attached. Approximately 80% of proteasomes in the yeast Saccharomyces cerevisiae cluster at 
the ER, compared to around 20% in mammalian cells (Enenkel et al., 1998). The 26S 
proteasome is a cylindrical complex comprising of a 20S catalytic core capped at the both ends 
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by a 19S regulatory subunit (Coux et al., 1996). The 19S regulatory particle consist of at least 
19 subunits, including six ATPases, referred to as Rpt proteins, de-ubiquitinating enzymes 
(DUB) and polyubiquitin-binding subunits (Finley, 2009). The 20S particle harbours 28 
subunits arranged in four, seven-membered stacked rings in which proteolysis of the substrate 
protein takes place. Of the four rings, the two inner rings are composed of β subunits (β1- β7) 
and the β1, β5 and β7 subunits contain caspase-like, trypsin-like and chymotrypsin-like 
activities, respectively (Groll et al., 1997). Proteasomes contain a large number of proteins that 
recognize ubiquitinated cargos, including two 19S regulatory subunits (Rpn10p and Rpn13p) 
(Husnjak et al., 2008) and three proteins (Rad23p, Dsk2p and Ddi1p) which temporarily 
associate with the proteasome only during substrate delivery (Elsasser et al., 2004; Funakoshi 
et al., 2002; Kleijnen et al., 2003; Madura, 2004). The latter three proteins interact with the 
proteasome and ubiquitinated cargos through their Ubiquitin-like (UBL) domain and one or 
more Ubiquitin-associated (UBA) domains, respectively (Hartmann-Petersen and Gordon, 
2004; Rao and Sastry, 2002; Wilkinson et al., 2001). Unlike the UBL/UBA proteins, which can 
bind substrates and recruit them to the proteasome for destruction, 19S subunits recognize only 
substrates that are in close proximity to the proteasome (Kleijnen et al., 2000; Madura, 2004). 
Followed by binding to Ub-receptors, substrates are unfolded by the Rpt proteins of the 19S 
subunit in an ATP-dependent manner and the unfolded polypeptide chain is fed into the 
chamber of the 20S particle (Groll et al., 2000; Navon and Goldberg, 2001). During this process, 
the 20S particle and 19S subunit remove the Ub molecules from the substrate, with the help of 
de-ubiquitinating enzymes (DUBs), to recycle the Ub (Guterman and Glickman, 2004; Lee et 
al., 2016; Peth et al., 2013). The substrates passing further through the 20S particle are cleaved 
into small peptides by the β1, β5 and β7 subunits. Association of the 20S subunit with a 19S 
subunit in the cell is a dynamic process and requires ATP-hydrolysis (Glickman and Raveh, 
2005; Lecker et al., 2006). While the 26S proteasome (consisting of 19S and 20S particles) can 
degrade natively folded proteins, mediated by the Ub linkage on the substrate protein (Raynes 
et al., 2016), 20S proteasomal subunits can only degrade unfolded proteins independent of Ub 
attachment and this accounts for 20% of the substrate proteins (Baugh et al., 2009; Ben-Nissan 
and Sharon, 2014; Pickering and Davies, 2012). 
4. The challenges associated with membrane protein degradation 
The list of substrate proteins that undergo UPS-dependent degradation is continually growing 
and we have a detailed mechanistic understanding of how many cytosolic proteins are degraded 
by the proteasome. However, this is generally not the case for the degradation of membrane 
proteins. Since membrane proteins constitute around 30% of the proteome and perform 
essential cellular activities, including transport of molecules across membranes and organelle 
biogenesis (Krogh et al., 2001), timely removal of membrane proteins is critical to maintain 
membrane protein homeostasis and cell vitality (Ng et al., 2012). Considering the complex 
nature of a typical membrane protein that harbours multiple transmembrane domains (TMDs), 
Chapter 1
24
which are embedded in the lipid layer (Fiedler et al., 2010), one of the major challenges in 
membrane protein degradation is to pull the TMDs out of the membrane (Bagola et al., 2011). 
Pathways that perform such functions require a significant input of energy, to extract membrane 
embedded proteins and target them to the proteolytic machinery. Another challenge is to 
specifically recognize the target protein, amongst other membrane proteins, to attach a Ub 
molecule to mark the substrate for degradation via the proteasome. These challenges have also 
made it difficult to understand the mechanism by which membrane proteins are degraded and 
therefore, a detailed understanding of how a given membrane protein is degraded via the UPS 
is an exception rather than a rule.  
How proteins are recognized for degradation by the UPS has been of high interest since 
the discovery of the UPS degradation pathway (Ciechanover et al., 1978). This interest has led 
to the identification and characterization of multiple degradation signals, termed as degrons 
(Varshavsky, 1991). The majority of proteins residing in the cytosol, nucleus and the ER 
possess inherent or hydrophobic degrons that allow their specific recognition and effective 
proteolysis (Ravid and Hochstrasser, 2008). Inherent degrons can be specific amino acid 
sequences permanently present in the proteins and examples of this class include the destruction 
box of cyclins (Barford, 2011) or N- and C-terminal amino acids corresponding to the N-degron 
and the C-degron pathways (Varshavsky, 2019). Acquired degrons, on the other hand, are 
transient elements that are obtained by the post-translational modification of specific amino 
acids within the substrate proteins, such as phosphorylation, oxidation, the ligation of Small 
Ubiquitin-like Modifier (SUMOylation) and hydroxylation (Ella et al., 2019; Ravid and 
Hochstrasser, 2008; Sriramachandran and Dohmen, 2014). For instance, transient 
phosphorylation at serine or tyrosine residues facilitates rapid turnover of proteins such as G1 
cyclins, which are involved in cell-cycle progression (Skowyra et al., 1997; Willems et al., 
1996). A large area of hydrophobic residues that are normally buried in the protein core or 
within interaction surfaces between subunits of protein complexes may also act as an acquired 
degron, when this area becomes exposed because the protein unfolds or fails to fold properly 
or when the protein fails to assemble into a complex (Furth et al., 2011; Scazzari et al., 2015; 
Sung et al., 2016). The exposure of such hydrophobic regions can often result from mutations 
introduced into the protein, through protein translocation errors or mutations in the gene 
encoding for the protein or through protein damage caused by external stress. Therefore, the 
detection of such hydrophobic regions are an essential aspect of the cellular quality control 
systems. For example, San1 (Sir antagonist 1), an Ub ligase involved in nuclear protein quality 
control in yeast binds to hydrophobic domains of misfolded proteins and targets them for UPS-
mediated degradation (Rosenbaum et al., 2011). 
While the above-mentioned examples concern soluble proteins, our knowledge on the 
degradation signals or molecular factors that aid in the recognition of membrane proteins is far 
from complete. Generally, the biosynthesis of membrane proteins involves the integration of 
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the hydrophobic TMD into the lipid bilayer, folding of soluble domains on both sides (cytosol 
and lumen) of the membrane and in the case of multi-spanning proteins, assembly of TMDs 
within the bilayer (Christis et al., 2008; Fiedler et al., 2010). These events pose complex 
challenges to the quality control machinery and thereby necessitate that quality control 
systems be present in distinct compartments (membrane, cytosol and lumen) to monitor the 
folding status of the protein and degrade membrane proteins that are not only incorrectly folded 
but also redundant, damaged or non-functional. In line with this consideration, one could 
speculate that a membrane protein degron would need to be location-specific. For example, 
errors in the cytosolic or luminal domain of a membrane protein may lead to the exposure of 
normally buried residues which could serve as a recognition signal for degradation. This has 
been observed for non-native or mutant form of plasma membrane transporters such as Pma1p 
(Pmal-D378N) and Ste6* (Ste6 with C-terminal truncation) both of which exposes amphipathic 
or hydrophobic helical segment that facilitates recognition by their cognate E3 ligases (Ravid 
et al., 2006). However, a degron for the TMD would need to display different properties. Since 
the proper folding of TMD is achieved through a series of inter- and intra-helical hydrogen 
bonds and salt bridges (Bowie, 2011), misfolding or mutations in the TMD could lead to 
misaligned helices. This would result in the exposure of polar residues, that are normally 
involved in hydrogen bonding, to the hydrophobic environment of the membrane. Detection of 
these such residues could be accomplished by interaction with an E3 ligase, as has been showed 
for the Tul1p ubiquitin ligase, which recognizes misfolded TMD containing proteins in the 
Golgi-complex through interactions via hydrophilic residues in the TMD (Reggiori and Pelham, 
2002).  
As mentioned earlier, not only the recognition step is challenging but also the extraction 
of the TMD containing proteins that are stably anchored in the lipid bilayer presents many 
challenges that need to be overcome. This process requires a significant energy input to transfer 
the membrane-spanning segments from a hydrophobic to a hydrophilic environment and 
facilitate the accompanying unfolding process and solvation of TM helices (Cymer et al., 2015). 
A class of proteins that mediates this type of reaction is the AAA proteins or ATPase Associated 
with cellular Activities, which provide energy by ATP hydrolysis. Such proteins provide the 
mechanical force required to remove a substrate molecule from the membrane (Ogura and 
Wilkinson, 2001). A highly conserved and widely studied AAA protein is p97, also known as 
VCP (mammals), or CDC48 (yeast) is located mainly in the cytosol and functions in unfolding 
protein substrates, disassembling protein–protein complexes and dislocation of proteins from 
various organelle membranes (Jarosch et al., 2002; Ye et al., 2001). Most AAA-ATPases form 
oligomeric complexes with each of the monomers consisting of either one (type I) or two 
(type II) functional ATPase domains (named D1 and D2) accompanied by a regulatory N-
terminal domain. Upon ATP binding and hydrolysis, Walker A (P-loop) and B motifs present 
in the ATPase domains undergo conformational changes that can be propagated to act upon a 
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target substrate, leading to their removal from the membrane. An alternative to ATP dependent 
membrane protein extraction could be clipping of transmembrane segments from cellular 
membranes by intramembrane proteases (Lemberg, 2011). These proteases function by initially 
unwinding the helical structure of a TM segment in the substrate, cleavage the unfolded 
segments and subsequently release of the cleaved products to either side of the membrane 
(Langosch et al., 2015). Although proteases are capable of clearing an entire membrane protein, 
including the TMD, this mode of action has only been observed for membrane proteins with 
one or two TMDs (Langosch et al., 2015). This, together with the observation that such 
proteases have not been identified in the membranes of key organelles such as mitochondria 
and peroxisomes, suggests that AAA-ATPase dependent extraction may well be the major 
mode of membrane protein extraction.  
In the following two sections, we present an overview of UPS-dependent degradation 
pathways that remove membrane proteins from the Endoplasmic Reticulum (ER) and 
mitochondria. We discuss how membrane proteins from these organelles are recognized by the 
degradation machinery. Furthermore, we also outline various modes by which membrane 
proteins are extracted from these organellar membranes, in order to facilitate their degradation 
by the proteasome. 
5. Membrane protein degradation from the ER 
The ER-associated degradation (ERAD) pathway is one of the most well studied degradation 
pathways that targets membrane proteins. Since the ER is the major site for the synthesis and 
assembly of membrane proteins, the ER plays a vital role in membrane protein homeostasis. 
However, this folding process is not infallible, hence the need for a pathway to ensure that 
terminally misfolded or unassembled membrane proteins do not accumulate at the ER but are 
instead degraded (Ng et al., 2012). In addition, ERAD also participates in regulating the levels 
of correctly folded ER membrane proteins such as Pca1p and Hmg2p in response to cellular 
signals (Adle et al., 2007; Adle et al., 2009; Hampton et al., 1996). ERAD begins with the 
recognition of substrate proteins followed by ubiquitination, ATP dependent extraction from 
the ER and proteasomal degradation (Christianson and Ye, 2014). The detection of substrate 
proteins depends principally on an E3 ligase complex, which recognizes degradation signals in 
substrates and stimulates Ub transfer from the E2 to the target protein (Ruggiano et al., 2014). 
In yeast, two membrane embedded E3 ligase complexes exist; HRD and DOA (Figure 2). The 
HRD complex, consisting of the RING E3 ligase Hrd1p and its co-factor Hrd3p, catalyses the 
ubiquitination of several membrane protein substrates, working together with the E2 enzymes 
Ubc7p, Ubc1p and, less frequently, Ubc6p (Figure 2, right) (Bays et al., 2001; Deak and Wolf, 
2001). The DOA complex, on the other hand, ubiquitinates membrane proteins through the 
concerted action of Doa10p (ER embedded RING E3 ligase) and the E2 enzymes Ubc6p and 
Ubc7p (Figure 2, left) (Swanson et al., 2001; Vashist and Ng, 2004). While the yeast ERAD 
The knowns and unknowns of  Peroxisomal membrane protein degradation
27
1
machinery is in itself complex, that of the mammalian machinery is more so. The number of 
mammalian E3 ligases involved in ERAD includes ER embedded synoviolin/HRD1(Kikkert et 
al., 2004) and GP78 (Fang et al., 2001), both of which are orthologous to the yeast Hrd1p 
(Nadav et al., 2003), RNF5/RMA1 (Morito et al., 2008), TEB4 (ortholog of yeast Doa10p) 
(Hassink et al., 2005), TRC8 (Stagg et al., 2009), RFP2 (Lerner et al., 2007) and CHIP (non-
ER protein) (Meacham et al., 2001). These E3s are known to interact with the mammalian 
homolog of yeast E2 enzymes Ubc6p (Ube2j1p and Ube2j2p) and Ubc7p (Ube2g1p and 
Ube2g2p) (Lenk et al., 2002). Ube2g2p is strongly implicated in ERAD, functioning with 
multiple ERAD E3s (Chen et al., 2006; Hassink et al., 2005; Kikkert et al., 2004) while there 
is also evidence supporting roles for ER localized Ube2j1p and Ube2j2p in the degradation of 
ERAD substrates (Elangovan et al., 2017).   
 
Figure 2: Schematic overview of the different steps and branches in ER membrane protein degradation 
by the ERAD pathway in S. cerevisiae. (Left) Chaperones (Ssa1p and Ydj1p) recognize ER membrane proteins 
(Pma1p and Ste6*) with misfolded cytosolic domains (ERAD-C substrates) and mediate the transfer of substrates 
to the E3 ligase Doa10p (1). Doa10p together with E2 enzymes (Ubc6p and Ubc7p) promotes ubiquitination of 
ERAD-C substrates, which are then extracted from the ER membrane by the Cdc48p/Ufd1p/Npi4p complex (2) 
and targeted for degradation by the proteasome (3). (Right) ER membrane proteins (Hmg2p, Sec61-2 and Pdr5*) 
with a misfolded transmembrane domain (ERAD-M) are recognized by the Hrd1p/Hrd3 complex (1). ERAD-M 
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substrates are then ubiquitinated by Ubc7p and Hrd1p/Hrd3p, retro translocated from the ER to the cytosol (2) and 
finally degraded by the proteasome (3). Misfolded domains on the proteins are indicated with a red star. 
 
Much of our knowledge on the ERAD pathway comes from experiments in yeast. 
Membrane proteins with misfolded TMDs (referred to as ERAD-M substrates) are targeted by 
the HRD complex (Sato et al., 2009) while the DOA complex preferentially removes membrane 
proteins with misfolded cytosolic domains (ERAD-C substrates) (Carvalho et al., 2006; Vashist 
and Ng, 2004). ERAD-C substrates are initially recognized by cytosolic chaperones, which 
promote interactions with (and subsequent ubiquitination by) Doa10p (Buck et al., 2007; 
Nakatsukasa et al., 2008). For instance, the degradation of a mutant form of the ATP binding 
cassette transporter Ste6p (Ste6*), the mutated plasma membrane ATPase Pma1p, mammalian 
CFTR expressed in yeast and mammalian apolipoprotein B (apoB) relies on the Hsp70 (Ssa1p), 
Hsp40 (Hlj1p and Ydj1p) and Bip (Kar2p) chaperones. Mutations in these chaperones prevent 
Doa10p dependent ubiquitination and degradation of ERAD substrates (Han et al., 2007; Zhang 
et al., 2001). The simplest view could be that chaperones act as an initial recognition factor by 
binding hydrophobic amino acid clusters in membrane proteins to prevent aggregation 
(Nishikawa et al., 2005) and augment membrane protein access to Doa10p. Contrary to the 
well-explored role of chaperones in substrate recognition, the mechanism by which Doa10p 
recognizes the substrate or chaperone-substrate complex remains unclear. A conserved C-
terminal element (CTE) in Doa10p is involved in the recognition of certain ERAD substrates 
(Zattas et al., 2016) however, no direct interaction between Doa10 CTE and substrate proteins 
was observed so far. Furthermore, the degradation of Ste6* occurred independently of the 
Doa10 CTE (Zattas et al., 2016), suggesting that there might be other sequences in Doa10p that 
are required for the recognition of individual membrane protein substrates.  
Unlike substrates of the DOA pathway, membrane proteins with defective transmembrane 
segments (ERAD-M) appear to be recognized directly by the E3 ligase Hrd1p (Gardner et al., 
2000). Early insight into this mechanism was revealed by studies using Hmg2p, a yeast isozyme 
of the mammalian HMG-CoA reductase (HMGR) and a key enzyme in sterol biosynthesis 
(Hampton and Rine, 1994). Both in yeast and mammals, HMGR degradation by ERAD follows 
a feedback mechanism (Hampton and Garza, 2009; Ravid et al., 2000). For instance, high 
production of sterol pathway products causes reversible misfolding of the Hmg2p 
transmembrane domain (TMD), rendering it more susceptible to degradation by the HRD 
pathway (Gardner and Hampton, 1999; Gardner et al., 2001). The misfolded TMD of Hmg2p 
would expose buried residues which could then be detected by the E3 ligase Hrd1p. 
Interestingly, mutation of the hydrophilic intramembrane residues in Hmg2p or the E3 ligase 
Hrd1p prevents Hmg2p degradation (Sato et al., 2009). These data suggest that the detection of 
misfolded Hgm2p by Hrd1p could occur through inter-TMD interactions. Like Hrd1p, the 
transmembrane segment of other E3 ligases, including yeast Doa10p and mammalian Hrd1p 
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and gp78p (required for mammalian HMGR degradation) possess hydrophilic amino acids 
(Habeck et al., 2015), indicating that the recognition of hydrophilic TMD residues in membrane 
proteins by similar residues within a ligase may be a broadly employed strategy.  
However, a number of Hrd1p substrates, including the thermolabile Sec61-2 protein 
translocon and a mutant form of the ABC transporter Pdr5p appear to be recognized by non-
hydrophilic residues in the TMD of Hrd1p (Sato et al., 2009). Intriguingly, these membrane 
proteins, despite carrying mutations outside the transmembrane segments, such as in the 
cytosolic domain (Sec61-2) or luminal loop (Pdr5*), behave as ERAD-M substrates due to the 
mutations that either precede an unusually short TM segment or remain close to the TM 
segment (Carvalho et al., 2006; Plemper et al., 1998). These mutations could result in the 
destabilization of the TM segment, causing a structural change recognized by Hrd1p (Sato et 
al., 2009). Together, these examples indicate that the Hrd1p TMD specifically recognizes and 
mediates the degradation of ERAD-M substrates.  
Followed by Hrd1p- or Doa10p-mediated substrate recognition and ubiquitination, the 
final steps in the degradation of ERAD substrates includes the extraction and proteasomal 
degradation of ubiquitinated membrane proteins. Generally the extraction of ERAD substrates 
are mediated by the highly conserved and widely studied AAA ATPase known as Cdc48p in 
yeast and p97 in mammals (Ye et al., 2001). Cdc48p/p97 forms heterotrimeric complex with 
cytosolic proteins Ufd1p and Npi4p to extract proteins from the ER membrane for cytosolic 
degradation (Figure 2, step 2) (Meyer et al., 2000; Park et al., 2005; Stolz et al., 2011). Poly-
Ub chains in membrane protein substrates act as a recognition signal for the Cdc48p/p97 
complex. Due to the mechanical force provided by the Cdc48p/p97 complex, certain membrane 
bound proteins can be dislodged entirely from the membrane and released to the cytosol for 
degradation by the proteasome (Figure 2, step 4). This has been observed for substrates 
containing one or more TM segments such as MHC class I heavy chains and unpaired T- Cell 
receptor subunits. Whether the dislocation of these membrane proteins require a protein 
conducting channel formed by Sec61p, Derlin1 or the Hrd1p ligase itself is not known (Plemper 
et al., 1999; Schoebel et al., 2017; Wiertz et al., 1996). Intriguingly, certain membrane proteins 
were observed to be degraded directly at the ER membrane instead of being released in the 
cytosol (Smith et al., 2016). In this report, the authors demonstrated that under conditions of 
proteasome inhibition, the poly-ubiquitinated membrane proteins Hgm2p, Pca1p Ste6* 
remained stable on the ER membrane instead of being released to the cytosol (Smith et al., 
2016). Here, Cdc48p serves to, on the one hand bind poly ubiquitinated proteins on the ER 
membrane and, on the other hand recruit the proteasome to the ER membrane, to mediate the 
extraction and immediate degradation of substrates. Such a mechanism would not only increase 
the efficiency of membrane protein extraction due to the presence of multiple AAA ATPase 
proteasome subunits but would also prevent the aggregation of substrates through the exposure 
of hydrophobic residues to the cytosol. 
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6. Membrane protein degradation from mitochondria 
Similar to ERAD, a pathway exists that targets mitochondrial membrane proteins present at 
both the mitochondrial outer membrane (MOM) and inner membrane (IOM), termed 
mitochondrial associated degradation (MAD). The mechanism of substrate recognition by 
MAD is not well-known. The repertoire of MAD substrates that have been identified to date is 
still limited and currently includes Mfn1p, Mfn2p and Mcl1p in humans and Fzo1p, Mdm34p, 
Msp1p and Tom70p in yeast (Heo et al., 2010; Tanaka et al., 2010). Mitochondria form a highly 
dynamic network in the cell and this network is regulated by opposing fusion and fission events 
(Friedman and Nunnari, 2014; Pernas and Scorrano, 2016). Several key effector proteins of 
mitochondrial fusion (mitofusins; Fzo1p in yeast and Mfn1p and Mfn2p in humans) and fission 
(Fis1p, Mffp and Mdv1p in humans) are located at the OM (Song et al., 2015). With their 
domains exposed at the cytosolic side of the membrane, these proteins are directly accessible 
by the MAD pathway. By selectively removing fusion or fission components, MAD provides a 
highly effective level of regulation (Escobar-Henriques and Langer, 2014). Furthermore, MAD 
likely provides quality control for OM proteins in general as demonstrated by a recent study on 
the MAD-mediated degradation of nitrosylated OM proteins (Benischke et al., 2014). Future 
studies would be needed to provide additional insights into the relationship between different 
mechanisms of OM protein degradation through the UPS. 
Like ERAD, the degradation of membrane proteins by MAD requires component of the 
ubiquitination machinery (E1, E2 and E3 enzymes) for their proteasomal degradation. Several 
components of the ubiquitination machinery have been implicated in MAD, including the E3 
ligases Dma1p, Rsp5p and Mdm30p in yeast and MARCH5/MITOL, MULAN/MAPL and 
Parkin in mammalian cells (Heo et al., 2010; Kim et al., 2013; Wu et al., 2016; Yoo et al., 
2016) . Significantly Parkin, a cytosolic E3 ligase, is recruited to the MOM upon mitochondrial 
stress (Lee et al., 2019). In addition to these E3 ligases, the MAD pathway is potentially 
modulated by de-ubiquitinating enzymes (DUBs) such as Usp30p in mammals and Ubp16p, 
Ubp2p and Ubp6p in yeast (Anton et al., 2013; Cunningham et al., 2015; Kinner and Kolling, 
2003).  
The machinery of the MAD pathway shares some key components with ERAD. For 
instance, substrate-recruiting factors, namely Vms1p (VMS1 in mammals) and Ufd1p/Doa1p 
(UFD1L in mammals) are common to both pathways (Heo et al., 2010; Wu et al., 2016). Vms1p 
and Ufd1p/Doa1p binds Npl4p (NPL4 in mammals) in a mutually exclusive manner. Then, 
either the Vms1p–Npl4p complex or the Ufd1p/Doa1p–Npl4p complex binds to the N terminus 
of Cdc48p (Heo et al., 2010; Tran and Brodsky, 2012). Vms1p is recruited to mitochondria 
mainly under stress conditions, whereas the Doa1p–Cdc48p–Ufd1p–Npl4p complex 
contributes to basal MAD activity. This indicates that different Cdc48-dependent MAD 
pathways exist, with potentially distinct substrate specificities and biological functions. 
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Interestingly, proteasomes were observed to recruit to the surface of stressed mitochondria 
(Nakagawa et al., 2007; Yoshii et al., 2011) and the localization of Pre6p, a component of the 
20S core particle, at the surface of mitochondria further raises the possibility of spatial 
regulation of proteasome assembly (Heinemeyer et al., 1994). 
7. Peroxisomes  
Our understanding of ER and mitochondrial membrane protein degradation is in sharp 
contrast to what is known on peroxisomal membrane protein (PMP) degradation. 
Peroxisomes are cell organelles present in almost all eukaryotic cells and encompass a 
multitude of matrix and membrane proteins that participate in various metabolic 
process/activities, depending on the species and/or cell type (Gabaldon, 2010). The degradation 
of fatty acids through β-oxidation and detoxification of hydrogen peroxide (H2O2) are two 
widely distributed and well-conserved functions but many more exist. These include 
plasmalogen and bile acid synthesis in mammals (Ferdinandusse et al., 2009), methanol 
degradation in yeast (van der Klei et al., 2006), penicillin biosynthesis in fungi (Muller et al., 
1991) and the glyoxylate cycle, biosynthesis of isoprenoids and plant hormones and 
photorespiration in plants (Hayashi and Nishimura, 2003; Li et al., 2005; Mano and Nishimura, 
2005). In humans, a defect in peroxisome biogenesis or deficiency in the activity of a single 
peroxisomal enzyme or transporter protein ultimately leads to serious, often lethal diseases 
(e.g., Zellweger syndrome and ALD) (Braverman et al., 2016; Waterham et al., 2016). The 
existence of many such inherited peroxisomal disorders highlights the significance of 
peroxisomes in human health. 
Apart from the diversity in metabolic functions, peroxisomes show remarkable dynamics 
in morphology, abundance and protein content that vary based on the external cues such as a 
response to a specific nutrient source (Lingard et al., 2009; Ribeiro et al., 2012; Schrader et al., 
2012; Wang et al., 2015). For instance in S. cerevisiae, it is well established that the expression 
of many genes coding for peroxisomal proteins such as metabolic enzymes but also proteins 
required for peroxisome biogenesis are repressed in the presence of glucose and specifically 
induced on fatty acids such as oleic acid, ultimately leading to an increase in peroxisome 
number and size (Gurvitz and Rottensteiner, 2006; Karpichev and Small, 1998; Smith et al., 
2002). Proteins that control peroxisome biogenesis are collectively termed as peroxins and 
encoded by PEX genes (Distel et al., 1996; Smith and Aitchison, 2009). More than 35 peroxins 
have been identified so far and majority of them are peroxisomal membrane proteins (PMPs) 
which fulfil a variety of functions such as matrix and membrane protein import, metabolite and 
ion transport, peroxisome inheritance and organelle membrane tethering (Baerends et al., 2000; 
Schrader and Fahimi, 2008; Smith and Aitchison, 2013). This clearly indicates that PMPs play 
a crucial role in regulating the processes of peroxisome formation and maintenance. It goes 
without saying that PMP homeostasis plays a crucial role in peroxisome function. Below we 
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will briefly discuss how PMPs are imported into peroxisomes, their function in matrix protein 
import and the underlying effects of cells lacking PMPs. 
7.1 PMP import into peroxisomes 
Since peroxisomes are devoid of a protein synthesis machinery, all peroxisomal proteins are 
nuclear encoded, synthesized by poly-free ribosomes in the cytosol (Lazarow and Fujiki, 1985) 
and post-translationally imported into peroxisomes with the help of a peroxisomal targeting 
signal (PTS) sequence (Pieuchot and Jedd, 2012). Upon the induction of peroxisome 
biogenesis, the synthesis and targeting of PMPs was shown to precede that of matrix 
components (Luers et al., 1990; Veenhuis and Goodman, 1990). The trafficking of PMPs to 
peroxisomes depend on mPTS, an arbitrary membrane targeting signal present in the N-terminal 
(Pex3p), C-terminal (Pex15p) or in an internal (PMP47) position within the PMP sequence 
(Baerends et al., 1996; Dyer et al., 1996; Elgersma et al., 1997). Although the mechanisms of 
PMP import are not well understood, three peroxins - Pex3p, Pex19p and Pex16p - have been 
implicated in the targeting and insertion of PMPs into the peroxisomal membrane (Liu et al., 
2016). While Pex3p and Pex19p are present in all organisms, Pex16p has been identified only 
in mammalian cells, Yarrowia lipolytica, Arabidopsis thaliana and Pencillium chrysogenium 
(Kiel et al., 2006; Kim and Mullen, 2013; Opalinski et al., 2012). Generally, PMPs synthesized 
in the cytosol are recognized by the cytosolic chaperone Pex19p, the Pex19p-PMP complex 
then docks at the peroxisomal membrane through the interaction of Pex19p with Pex3p which 
then facilitates the insertion of PMPs in the peroxisome by a yet unknown mechanism. PMPs 
targeted by this way are referred to as Class I PMPs (Imanaka et al., 1996). Alternatively, Class 
II PMPs may traffic via the ER and subsequently insert into the peroxisomes independently of 
Pex19p (Thoms et al., 2012; Yonekawa et al., 2011). Several PMPs including mammalian 
Pex3p (Mayerhofer et al., 2016), Pex2p (RING E3 ligase) and Pex16p in Y. lipolytica, have 
been suggested to target to peroxisomes via the ER (van der Zand et al., 2010), although there 
exists much debate on this topic (Knoops et al., 2014; Otzen et al., 2004; Wroblewska et al., 
2017). The detection of PMPs at the ER was performed in pex3 cells which were assumed to 
completely lack peroxisomes (Baerends et al., 1997). However, recent observations in H. 
polymorpha pex3 and pex19 cells as well as in S. cerevisiae pex3 cells indicates the presence 
of pre-peroxisomal vesicles (PPVs) harbouring a subset of PMPs (including Pex8p, Pex13p, 
Pex14p, Pex15p, Pex17p, Pex25pand Pex22p (Knoops et al., 2014; Otzen et al., 2004; 
Wroblewska et al., 2017). Thus, it is not clear whether these proteins target to peroxisomes via 
the ER or via a different mechanism. 
7.2 Peroxisomal matrix protein import 
Like membrane proteins, the transport of peroxisomal matrix proteins are mediated by specific 
import sequences (Brocard and Hartig, 2006; Lazarow, 2006). However, matrix proteins utilize 
a sorting machinery distinct from that used for PMP import. Proteins destined for the 
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peroxisomal matrix contain a C-terminal (tripeptide) PTS1 sequence (Swinkels et al., 1992) or 
an N-terminal (nonapeptide) PTS2 sequence (Lazarow, 2006; Petriv et al., 2004). After 
synthesis, most matrix proteins containing a PTS1 are recognized by Pex5p (Gatto et al., 2000), 
while PTS2 proteins are recognized by Pex7p (Lazarow, 2006), which functions together with 
the co-receptor proteins Pex18p/Pex21p in S. cerevisiae, Pex20p in H. polymorpha and fungi 
species and the long form of Pex5p (Pex5L) in mammals/higher eukaryotes (Schliebs and 
Kunau, 2006). Recently Pex9p, a new PTS receptor was identified and was shown to import a 
subset of PTS1-containing proteins such as malate synthase 1 and 2 under certain conditions 
(Effelsberg et al., 2016). In addition to the cytosolic PTS receptors mentioned above, matrix 
protein import is mediated by several PMPs (Pex13p, Pex14p and in yeast Pex17p) that 
collectively form the matrix protein import machinery, which is responsible for docking of the 
cargo-bound import receptor at the peroxisomal membrane (Eckert and Erdmann, 2003) and 
translocation of cargo into the peroxisomal lumen by a dynamic translocation pore (Meinecke 
et al., 2010). Generally, receptors are recycled back to the cytosol after cargo release through 
the action of several membrane bound E3 ligases (Pex2p, Pex10p and Pex12p), together with 
an E2 enzyme Pex4p that is bound to the peroxisomal membrane via its interaction with the 
PMP Pex22p (Ali et al., 2018; El Magraoui et al., 2014). Recycling of the receptor involves 
ubiquitylation (Platta et al., 2007) and extraction from the membrane by an AAA-type ATPase 
complex consisting of the proteins Pex1p and Pex6p (Platta et al., 2005). This method of 
recycling resembles, to a certain extent, the degradation of misfolded proteins by the ERAD 
quality control machinery (Schliebs et al., 2010).  
Mutations or absence of any of the PMPs mentioned above can have a significant impact 
on protein import to peroxisomes and the underlying metabolic functions. For instance, loss of 
either one of the docking complex PMPs (Pex13p, Pex14p or Pex17p) abolishes PTS1 and 
PTS2 protein import and renders peroxisomal metabolic pathways inactive (Azevedo and 
Schliebs, 2006; Williams and Distel, 2006). Cells lacking Pex3p, which is involved in early 
peroxisome biogenesis and PMP import, are devoid of functional peroxisomes and 
characterized by the presence of small vesicle like structures (Knoops et al., 2014; Wroblewska 
et al., 2017). Since peroxisome proliferation is controlled by the Pex11p family of proteins, the 
loss of these PMPs results in cells with a reduced number of peroxisomes (Schrader and Fahimi, 
2006a). Furthermore, mutations in the gene encoding for peroxisomal ABC transporter 
(ABCD1) results in protein instability leading to loss of fatty acyl-coA transport to peroxisomes 
and thereby reduced β-oxidation activity (Cartier et al., 1995; Engelen et al., 2014). This clearly 
demonstrates that PMPs play a crucial role in regulating peroxisomal functions but also in 
controlling the processes of peroxisome formation and maintenance. Due to this vital role, there 
must be a tight control between PMP synthesis, import and degradation. While the first two 




8. Membrane protein degradation from peroxisomes 
Since peroxisomes generate large amount of ROS (Schrader and Fahimi, 2006b), a known cause 
of damage to proteins, it is highly likely that PMPs residing in this ROS rich environment are 
potentially vulnerable to oxidative damage (Figure 3, left). Furthermore, because PMPs play 
vital roles in regulating the wide range of peroxisomal functions, it can be imagined that 
targeted down-regulation of certain PMPs may exert control over such functions (Figure 3, 
right). Therefore, investigating the degradation of individual PMPs would allow us to 
understand how PMP homeostasis is regulated, to what extent PMP degradation is involved in 
regulating peroxisome function and what would be the impact of inhibiting PMP degradation 
on peroxisome function. For this reason, a pathway to selectively degrade damaged or 
redundant PMPs, would be an invaluable asset, particularly when the alternative, wholesome 
destruction of peroxisomes by pexophagy (Eberhart and Kovacs, 2018), may not be desirable. 
With this in mind, it is surprising that until relatively recently, PMP degradation has received 
very little attention. In this following section, we shall first sum up the current knowledge on 
the peroxisomal ubiquitination machinery and its role in ubiquitinating peroxisomal proteins. 
Then, we will provide an overview on PMPs which are reported to be degraded and further 
elaborate on the PMPs that are suggested to undergo degradation.  
 
Figure 3: Model depicting possible functions of PMP turnover in quality control and targeted 
degradation. (Left) Reactive oxygen species (ROS) such as hydrogen peroxide produced in the peroxisome 
lumen could cause damage to PMPs resulting in protein misfolding and possibly loss in functionality. 
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Misfolded/unfolded PMPs can then be selectively recognized and ubiquitinated by the ubiquitination machinery 
(E2 and E3), extracted from the peroxisomal membrane and targeted for proteasomal degradation. (Right) Upon a 
signal from an event occurring at the peroxisome, functional PMPs could also undergo Ub-proteasome dependent 
degradation to regulate various peroxisomal process. 
8.1 Insights from PTS receptor recycling and degradation  
The PTS receptors Pex5p and Pex20p family co-receptor proteins (Pex18p and Pex20p) were 
shown to undergo ubiquitination after delivering matrix proteins to peroxisomes (Liu and 
Subramani, 2013; Platta et al., 2008; Purdue and Lazarow, 2001). Depending on the nature of 
ubiquitination, these receptor proteins promote two different outcomes- receptor recycling or 
degradation. For instance, Pex5p and co-receptors Pex18p and Pex20p harbouring single Ub on 
their conserved cysteine residues near the N-termini of these proteins are recycled back to the 
cytosol, allowing the receptors to take part in further rounds of import (Hensel et al., 2011; Kiel 
et al., 2005; Leon and Subramani, 2007; Platta et al., 2007; Williams et al., 2007). Alternatively, 
when receptor proteins are unable to recycle properly either due to a mutation in their conserved 
cysteine residues or lack of recycling machinery components, these peroxisomal proteins were 
shown to undergo poly-ubiquitination on one or more conserved lysine’s (Hensel et al., 2011; 
Kiel et al., 2005; Platta et al., 2007). The available evidence suggests that poly-ubiquitination 
serves a quality control function, priming receptors that are unable to recycle for proteasomal 
degradation (Kiel et al., 2005; Leon et al., 2006; Williams and Distel, 2010). 
 
Figure 4: Model depicting the steps of PTS receptor recycling and degradation in S. cerevisiae. Matrix 
proteins harbouring a PTS1 or PTS2 are recognized by the cytosolic receptors Pex5p and Pex7p/Pex18p/Pex21p 
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respectively. Receptor bound matrix proteins first associate with the docking complex (Pex13p/Pex14p/Pex17p) 
at the peroxisomal membrane (PM), followed by the translocation of the matrix proteins into peroxisome lumen 
(PL). After cargo release, (co) receptor proteins are ubiquitinated by the peroxisomal ubiquitination machinery 
(Pex12p and Pex4p) and recycled by the AAA complex (Pex1p/Pex6p) back to the cytosol. Alternatively, PTS 
receptors are poly-ubiquitinated by E3s (Pex2p/Pex10p) and E2s (Ubc4p/Ubc5p) and targeted for proteasomal 
degradation. 
Peroxisomal receptor ubiquitination requires the typical ubiquitination enzymes- E1, E2 
and E3. Pex4p, the E2 enzyme together with its peroxisomal anchor protein Pex22p promotes 
mono-ubiquitination of Pex5p (in S. cerevisiae and Arabidopsis) (Figure 4) and Pex20p (in 
Pichia pastoris) (El Magraoui et al., 2014; Liu and Subramani, 2013; Williams et al., 2012; 
Williams et al., 2007) whereas the cytosolic protein Ubc4p (but also Ubc5p) in S. 
cerevisiae functions as the E2 enzyme in the poly-ubiquitination of Pex5p and Pex18p (Figure 
4) (El Magraoui et al., 2013; Kiel et al., 2005). In mammals, members of the E2D 
(UbCH5/Ube2D) family of E2s were shown to regulate both the recycling (mono-
ubiquitination) and probably degradation (poly-ubiquitination) of Pex5p (Grou et al., 2008; 
Okumoto et al., 2014). The three PMPs Pex2p, Pex10p and Pex12p also referred as RING 
peroxins that exhibit E3 ligase activity (El Magraoui et al., 2012) facilitate Ub attachment to 
the (co-) receptor proteins. In S. cerevisiae, each E3 ligase is assigned a distinct function for 
either mono-ubiquitination or poly-ubiquitination of Pex5p and Pex18p (Figure 4), whereas 
in P. pastoris, all three E3 ligases are essential for both mono-ubiquitination and poly-
ubiquitination of Pex5p and Pex20p (El Magraoui et al., 2013; Liu and Subramani, 2013). The 
roles of the RING peroxins in ubiquitination of Pex5p were first determined in S. cerevisiae in 
vitro where the authors showed that Pex12p is required for Pex5p mono-ubiquitination (Figure 
4), whereas Pex2p and/or Pex10p is required for Pex5p poly-ubiquitination (Figure 4) (Platta 
et al., 2009; Williams et al., 2008b). In Arabidopsis, the Ub domain-containing proteins DSK2a 
and DSK2b interact with PEX2 and PEX12 and may help shuttle poly-ubiquitinated proteins to 
the proteasome for degradation (Kaur et al., 2013).  
Once the receptor proteins are ubiquitinated by the peroxisomal ubiquitination machinery, 
they are extracted from the peroxisomal membrane in an ATP dependent manner through the 
action of two AAA proteins, Pex1p and Pex6p (Schwerter et al., 2017) which are anchored to 
the peroxisomes by Pex15p in yeast (Figure 4) (Birschmann et al., 2003) or Pex26p in mammals 
(Matsumoto et al., 2003). In S. cerevisiae it is reported that the Pex1p/Pex6p complex facilitates 
the extraction of both mono and poly-ubiquitinated Pex5p (Figure 4) (Platta et al., 2008). 
During the membrane extraction process, the deubiquitinating enzyme Ubp15p in S. cerevisiae 
(Debelyy et al., 2011) and USP9X in mammals (Grou et al., 2012) is required to remove 
ubiquitin from mono-ubiquitinated Pex5p (and likely Pex20p family members), which then 
allows the receptor to take part in another round of import (El Magraoui et al., 2019). Unlike 
the yeast Pex5p, whose levels were stabilized in pex6 mutants, Pex5p levels in human fibroblast 
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and P. pastoris pex6 mutants were observed to be reduced (Chang et al., 1999; Collins et al., 
2000). This would suggest that alternative mechanisms exist to remove poly-ubiquitinated 
proteins from the peroxisomal membrane in humans and P. pastoris and target them for 
degradation. To this end, Law et al., showed that loss of AAA-complex in humans result in the 
accumulation of ubiquitinated Pex5p on the peroxisomal membrane that signals pexophagy, 
thereby suggesting an additional role for AAA proteins in preventing pexophagy, additional to 
its role in receptor recycling (Law et al., 2017).  
Like the PTS1 receptor Pex5p, the PTS2 co-receptor Pex7p was shown to undergo UPS-
mediated degradation in the yeast P. pastoris (Hagstrom et al., 2014) and in humans (Miyauchi-
Nanri et al., 2014). Interestingly, the peroxisomal ubiquitination machinery had no role in 
Pex7p degradation instead, the cytosolic E3 ligase complex CRL4A (Cullin4A-RING Ub E3 
ligase) was required for Pex7p ubiquitination/degradation in humans. In both cases, the authors 
reported that non-functional Pex7p was targeted for degradation, defining these degradation 
events as quality control related. These examples demonstrate that the UPS, particularly the 
peroxisomal ubiquitination machinery, but also non-peroxisomal proteins, function in the 
quality control of receptor proteins by ubiquitinating them and targeting them for proteasomal 
degradation. Furthermore, the PMPs needed for (co) receptor ubiquitination and retro 
translocation resemble ERAD components (Schliebs et al., 2010), suggesting that damaged 
peroxisomal proteins may be retro translocated out of the peroxisome and degraded in the 
cytosol by the 26S proteasome. 
8.2 Lessons from matrix protein degradation  
Three mechanisms of peroxisomal matrix protein quality control has been proposed so far (i) 
degradation of the proteins in the peroxisome lumen by proteases (Aksam et al., 2007; 
Bartoszewska et al., 2012) (ii) degradation of the whole organelles by pexophagy (Eberhart and 
Kovacs, 2018) and (iii) retro-translocation of matrix proteins from peroxisomes followed by 
cytosolic degradation, a process similar to the ERAD pathway and called peroxisome-
associated matrix protein degradation (PexAD) (Lingard et al., 2009). Several studies 
performed in Arabidopsis demonstrate a role for PexAD pathway in the degradation of 
Isocitrate lyase (ICL) and malate synthase (MLS). ICL and MLS are peroxisomal glyoxylate 
cycle enzymes that enable carbon from acetyl-CoA to be utilized in gluconeogenesis, thus 
providing energy for germinating seedlings (reviewed in (Graham, 2008)). A few days after 
germination, when seedlings are able to grow photo-autotrophically, ICL and MLS are 
degraded as they are no longer required (Lingard et al., 2009; Zolman et al., 2005) and 
peroxisomes instead function in the photo respiratory pathway. Here, the removal of obsolete 
matrix proteins such as ICL and MLS by the PexAD pathway (Figure 5, adapted from 
(Williams, 2014)) acts as a mechanism to adapt their protein content to coincide with the 
development progression. The E2 Pex4p and its peroxisomal anchor Pex22p were shown to be 
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required for ICL degradation (Zolman et al., 2005) (Figure 5). In addition, the degradation of 
ICL and MLS was inhibited in cells disrupted for the import receptor Pex5p or the ATPase 
Pex6p (Lingard et al., 2009). Significantly, these enzymes were stabilized in the cytosol in 
the pex5 mutant but localized to the peroxisomes in the pex6. These data indicate that import is 
a pre-requisite for degradation and also that the degradation event does not occur inside 
peroxisomes. Interestingly a study by Farmer at al., showed that the deletion of LON2 in 
autophagy mutants increased the stability of ICL and MLS, suggesting a role for pexophagy as 
well as LON2 in matrix protein turnover (Farmer et al., 2013). The authors suggested that LON2 
could partially disaggregate matrix proteins, to allow their ubiquitin-dependent retro 
translocation out of the organelle. Thus, in the absence of LON2, ubiquitinated matrix proteins 
that are not able to retro translocate efficiently might accumulate, which in turn may trigger 
pexophagy. Alternatively, LON2 could function in recognizing the substrates and targeting 
them to the peroxisomal ubiquitination machinery (Williams, 2014). Either way, future studies 
will be needed to resolve how the degradation of MLS and ICS is achieved. 
                                                                
Figure 5: Model of isocitrate lyase (ICL) and malate synthetase (MLS) degradation by the Peroxisome-
associated matrix protein degradation (PexAD) pathway in Arabidopsis. Influenced by peroxisomal 
metabolism and/or possibly hydrogen peroxide damage (1), Lon protease could facilitate ICL/MLS targeting to 
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the export machinery (2). Next, ICL and MLS ubiquitination is mediated by the peroxisomal E2 Pex4p, probably 
with the aid of the peroxisomal E3 ligases Pex2p, Pex10p and Pex12p (3). Ubiquitinated ICL and MLS is then 
recognized by Pex6p and exported to the cytosol (4), where degradation occurs, most likely through the action of 
the proteasome (5). Defects in the proteins shown in reddish yellow are known to inhibit ICL/MLS degradation 
while the role for other proteins (depicted in grey) on ICL/MLS turnover is currently unknown. 
8.3 What we know about PMP degradation 
As mentioned already, PMP degradation has not been well explored. In the next sections, we 
will present what is currently known on this topic and we will elaborate on both the (suspected) 
mechanisms as well as the functions of these degradation events. 
8.3.1 Pex3p 
One of the first reports on peroxisomal membrane protein (PMP) degradation concerns Pex3p 
in the yeast H. polymorpha (Bellu et al., 2002). Pex3p plays a critical role in peroxisome 
formation by functioning as a docking factor for Pex19p (Fang et al., 2004), the cycling receptor 
that binds and transports newly synthesized PMPs to peroxisomes (Sacksteder et al., 2000). In 
addition to its role in peroxisome biogenesis, Pex3p functions in peroxisome inheritance 
(Munck et al., 2009) and the selective degradation of peroxisomes, a process referred to as 
pexophagy (Eberhart and Kovacs, 2018). Incubating the methylotrophic yeasts H. polymorpha 
and P. pastoris in methanol or the budding yeast S. cerevisiae in oleic acid induces peroxisome 
proliferation, whereas pexophagy is triggered when methanol or oleic acid grown cells are 
shifted to glucose, ethanol or nitrogen-depleted starvation medium (Bellu et al., 2002; Farre et 
al., 2008; Motley et al., 2012; Oku and Sakai, 2016). Under these conditions, peroxisomal 
metabolism is no longer critical for viability and cell growth, resulting in the degradation of 
peroxisomes by the vacuole. This process in H. polymorpha is initiated by the removal of 
Pex3p from peroxisomes by the proteasome system (Bellu et al., 2002; Williams and van der 
Klei, 2013). Interestingly, Pex3p removal was shown to also induce peroxisome degradation 
under peroxisome proliferating conditions (van Zutphen et al., 2011). Since peroxisomes are 
involved in various oxidative reactions such as methanol catabolism which produce ROS, they 
are prone to oxidative damage (Walker et al., 2018). As dysfunction of yeast peroxisomes may 
result in necrotic cell death, timely recognition and constitute turnover of damaged peroxisomes 
is of crucial importance in cell vitality. This demonstrates that Pex3p dependent pexophagy is 
essential for cellular housekeeping as it triggers the removal of damaged or redundant 
peroxisomes. 
The role for the proteasome in Pex3p turnover came from the observation that Pex3p 
degradation in cells shifted from methanol to glucose was inhibited by the treatment of the 
proteasome inhibitor MG132 (Bellu et al., 2002). The involvement of the proteasome further 
suggests a role for ubiquitination in Pex3p turnover. To this end, Pex3p was shown to be 
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ubiquitinated and mutating lysine residues in Pex3p to arginines or deleting the genes encoding 
for peroxisomal RING E3 ligases Pex2p and Pex10p blocked Pex3p degradation and hence 
glucose induced pexophagy (Williams and van der Klei, 2013), indicating a role for these 
proteins in degrading PMPs. However, unlike Pex5p, the AAA ATPase Pex1p was not 
required for Pex3p degradation (Williams and van der Klei, 2013) suggesting that there could 
be other AAA proteins that act to remove Pex3p from peroxisomes. Collectively, these results 
demonstrate that H. polymorpha Pex3p is degraded by a process that is dependent on the 
peroxisomal ubiquitin machinery and the proteasome. Currently, it is unclear if a similar 
requirement of Pex3p removal from peroxisome membrane to initiate pexophagy exists in P. 
pastoris or in S. cerevisiae, where Pex3p is shown to recruit the pexophagy receptor Atg30 
and Atg36 to the peroxisome respectively (Farre et al., 2008; Motley et al., 2012). 
Interestingly, Pex3p ubiquitination and degradation is also observed in mammals and 
pexophagy is initiated only upon Pex3p overexpression (Yamashita et al., 2014). However, 
blocking Pex3p ubiquitination through introduction of mutations in lysine residues of Pex3p 
had no effect on peroxisome degradation (Yamashita et al., 2014) suggesting that unlike yeasts, 
ubiquitination of Pex3p is dispensable for pexophagy in mammals. 
 
8.3.2 Pex13p 
The PMPs Pex13p, Pex14p (and Pex17p in yeast) form a docking complex that functions in 
importing proteins destined for the peroxisomal matrix (Williams and Distel, 2006). Loss of 
either of the PMPs results in the absence of a functional docking complex, leading to a defect 
in matrix protein import. Recently, Pex13p from H. polymorpha was shown to be ubiquitinated 
and degraded by a process that is dependent on the peroxisomal E2 Pex4p and the peroxisomal 
RING E3 ligase Pex2p (Figure 6A) (Chen et al., 2018). Intriguingly, Pex13p degradation was 
only partially inhibited in cells lacking Pex4p, suggesting a role for another E2 enzyme in 
Pex13p turnover. While these proteins affected the degradation of Pex13p, how H. polymorpha 
Pex13p is recognized, extracted from the peroxisomal membrane and targeted for degradation 
is not clear at present (Figure 6A, steps 1 & 3). Furthermore, the reason why Pex13p is degraded 
remains unknown. However, considering its function it is likely that Pex13p turnover might 
play a role in matrix protein import. In this light, an interesting comparison can be drawn from 
the recent studies on Arabidopsis Pex13p, which was shown to be degraded by SP1 (Figure 6B, 
left) (Pan et al., 2016). SP1, a RING-type E3 ligase regulates chloroplast biogenesis by binding 
the components of the TOC protein import complex and targeting them for degradation (Ling 
et al., 2012). In addition to chloroplasts, SP1 associates with the peroxisomal membrane and 
interacts with Pex13p (Pan and Hu, 2018). The authors showed that SP1 affected the stability 
of Pex13p in a manner that is dependent on its catalytic RING domain thus suggesting a role 
for SP1 in Pex13p ubiquitination and degradation (Pan et al., 2016). Furthermore, the deletion 
of SP1 in pex14 cells, which are defective in matrix protein targeting, not only inhibited Pex13p 
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degradation, but also resulted in an increase in peroxisomal β-oxidation activity due to the 
increased import of matrix proteins (Pan et al., 2016). These data strongly suggest that SP1 
negatively regulates peroxisomal matrix protein import by down-regulating import complex 
proteins Pex13p (Figure 6B, right) and possibly Pex14p on the peroxisomal membrane. Like 
Arabidopsis, Pex13p in H. polymorpha could undergo targeted degradation to regulate matrix 
protein import. Alternatively, Pex13p can also be degraded by the peroxisomal ubiquitination 
machinery for quality control purposes, possibly to remove damaged or incorrectly folded 
Pex13p. Since Pex13p degradation has already been reported in plants and the yeast H. 
polymorpha, it would be interesting to investigate if Pex13p turnover is conserved across 




Figure 6: A) A working model for Pex13p degradation in H. polymorpha. Pex13p is recognized for degradation 
by an unknown mechanism (1) and undergoes ubiquitination mediated by the E3 ligase Pex2p and the E2 Pex4p 
(2). Ubiquitinated Pex13p is extracted from the peroxisome in an unknown manner (3) and targeted for 
proteasomal degradation (4). Inhibiting the function of proteins shown in red/yellow blocks Pex13p ubiquitination 
and degradation while proteins denoted in grey are thought to function in Pex13p turnover but their role is currently 
unknown. 
B) Model of Pex13p degradation in Arabidopsis. (Right) Pex13p acts as a docking complex protein that facilitates 
PTS receptor-cargo complex to dock at the peroxisomal membrane followed by the translocation of cargo into 
peroxisome lumen. PTS receptors are then recycled back to the cytosol by a process dependent on the peroxisomal 
ubiquitination machinery (E2 and E3) and Pex1p/Pex6p. (Left) The E3 ligase SP1 present at the peroxisome 
promotes ubiquitination and proteasomal degradation of Pex13p which negatively regulates protein import 
possibly by acting at the docking step and inhibiting the docking of receptor-cargo proteins (indicated by red 
arrow) and the underlying steps in matrix protein import. 
8.3.3 Pex15p 
While the degradation of the PMPs Pex3p and Pex13p likely play a role in regulating 
peroxisomal activities, the degradation of the tail anchored (TA) peroxisomal membrane protein 
Pex15p by the AAA-ATPase Msp1 serves as a first example of PMP quality control in this 
yeast. The PMP Pex15p, which anchors the AAA proteins (Pex1p and Pex6p) to the 
peroxisomes, is involved in the recycling of matrix proteins receptor back to the cytosol 
(Birschmann et al., 2003). Msp1p on the other hand, consists of an N-terminal transmembrane 
(TM) anchor followed by a C-terminal cytoplasmic ATPase domain and is localized mainly in 
the mitochondrial outer membrane (OMM) but also partially in the peroxisomal membrane 
(Nakai et al., 1993; Okreglak and Walter, 2014). Several studies have shown that Msp1p is 
involved in removing incorrectly targeted TA proteins such as the PMP Pex15p lacking the 
peroxisomal targeting signal of the C-terminal 30 residues (Pex15Δ30) that is mislocalized to 
mitochondria (Figure 7A) (Okreglak and Walter, 2014; Weir et al., 2017; Wohlever et al., 
2017). Like other AAA-ATPases, Msp1p was proposed to be involved in the extraction of 
mistargeted Pex15Δ30 from the OMM and target them for degradation in the cytosol. However 
a recent study showed that Pex15Δ30 is first recognized by Msp1p in the outer mitochondrial 
membrane (Figure 7A, steps 1 & 2), then targeted to the ER (Figure 7A, step 3) and 
ubiquitinated by Doa10p (ER embedded E3 ligase) and its co-factors (Ubc6p and Ubc7p) 
(Matsumoto et al., 2019) (Figure 7A, step 4). Subsequently, the Cdc48-Ufd1-Npl4 complex 
mediates the extraction of ubiquitinated Pex15Δ30 present at the ER membrane for proteasomal 
degradation in the cytosol (Figure 7A, steps 5 & 6). It is not clear why only Cdc48p and not 
Msp1p can extract Pex15Δ30 and target it for degradation. One possible explanation could be 
that substrate extraction and unfolding by Cdc48p may be closely coupled with proteasomal 
processing (Bodnar and Rapoport, 2017). In contrast to Msp1p-mediated clearance of Pex15p 
that relies on the ER-associated degradation (ERAD) system, a study by Dederer et al., showed 
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that Msp1p and Doa10p acts in parallel to degrade Pex15Δ30 (Dederer et al., 2019). Here, 
Doa10p was suggested to play a major role in Pex15Δ30 degradation while Msp1p deals only 
with a fraction of Pex15Δ30 that is mistargeted to mitochondria. Because the authors followed 
the steady protein levels and not the rate of Pex15Δ30 turnover, it is plausible that in cells 
lacking Msp1p or Doa10p, Pex15Δ30 degradation is inhibited to a similar extent, suggesting 
that Msp1p and Doa10p act in the same pathway as proposed by (Matsumoto et al., 2019). 
Nevertheless, it is clear that Pex15Δ30 degradation is mediated by the ubiquitin proteasome 
system (UPS) which involves Msp1p, Doa10p and Cdc48p complex. Most importantly, these 
examples demonstrate that PMP quality control pathways exists in yeast and acts to remove 
mislocalized or redundant PMPs. Similar to the yeast Msp1p, its human homolog ATAD1 also 
localizes to both mitochondria and peroxisomes and has been shown to remove mislocalized 
TA proteins such as Pex26p (Chen et al., 2014). 
Intriguingly Msp1p localized to the peroxisomal membrane functions in degrading 
peroxisomal Pex15p when present in excess of its interacting partner Pex3p (Weir et al., 2017) 
(Figure 7B). Although the exact mechanism and additional factors involved in Pex15p 
degradation remain unknown, the authors suggested that Pex3p binding to Pex15p rapidly 
converts Pex15p from a Msp1p-susceptible to a Msp1p-resistant form and protects it from 
degradation by Msp1p (Figure 7B). Together, a role for Msp1p/ATAD1 in TA membrane 
protein (Pex15p or Pex26p) quality control is clearly known. Considering that Msp1p 
recognizes the substrate TA membrane proteins such as Pex15p via their exposed hydrophobic 
core residues that are normally buried inside (Li et al., 2019), it is possible that Msp1p might 




     
Figure 7: A) Model of Msp1p-mediated clearance of the mitochondrially mistargeted Pex15p mutant (Pex15Δ30). 
The Pex15p mutant is first recognized by Msp1p, which mediates the extraction from the mitochondrial membrane 
and targets the mistargeted Pex15p to the ER. Within the ER membrane, Pex15p is ubiquitinated by a process 
dependent on Doa10p and Ubc6p/Ubc7p, extracted by the Cdc48p complex and released into cytosol for 
proteasomal degradation.  
B) Model of Msp1p-mediated degradation of peroxisomal Pex15p. Following insertion into peroxisomes, nascent 
Pex15p can be recognized by Msp1p however, this requires either Pex15p and/or Msp1p to be present above their 
usual levels. The interaction of Pex3p with Pex15p promotes maturation of nascent Pex15p and blocks recognition 
and degradation by Msp1p (indicated by red line). 
 
 




Like yeast, the role for quality control in humans has been suggested for the PMP 
Adrenoleukodystrophy (ALD) protein (ALDP). The involvement of peroxisomes in metabolic 
pathways such as fatty acid β-oxidation (Wanders and Waterham, 2006) necessitate the 
transport of metabolites in and out of peroxisomes. Peroxisomes possess specialized transport 
systems such as ATP-binding cassette (ABC) transporters (Theodoulou et al., 2006), which are 
mainly involved in trafficking various compounds across membranes, ranging from ions to 
peptides. ABC transporters are found either as complete or half transporters which can homo- 
or hetero dimerize to form an active transporter (Liu et al., 1999). In mammals, four half-ABC 
transporter superfamily members belonging to the subclass D have been identified in the 
peroxisomal membrane and they include ALDP, an ALD-related protein (ALDRP) , a 70-kDa 
PMP (PMP70) and the PMP70-related protein (PMP70R) (Baker et al., 2015; Theodoulou et 
al., 2006; Wanders et al., 2007). Of these transporters, ALDP has been studied extensively due 
to its role in ALD, a human disorder caused by the mutations in the ALDP encoding gene 
ABCD1 (Kemp et al., 2011; Mosser et al., 1993). ALDP is suggested to be involved in the 
import of CoA esters of very-long-chain fatty acyl-coA (VLCFA) into the peroxisome (van 
Roermund et al., 2008), in a similar fashion as performed by their yeast homologs Pxa1p/Pxa2p 
in S. cerevisiae (Hettema et al., 1996; Shani et al., 1996). To date, more than 340 non-recurrent 
missense mutations of the ABCD1 gene have been identified 
(https://adrenoleukodystrophy.info/). In these missense mutations, approximately 70% of the 
ABCD1/ALDP proteins are either not detected or reduced in amount in ALD fibroblasts (Kemp 
et al., 2001; Takahashi et al., 2007). As a result of this lack of ALDP, patients suffering from 
ALD fail to oxidize VLCFAs, leading to the accumulation of fatty acids in plasma and tissues 
(Engelen et al., 2014). Until now neither the mechanism of instability nor the proteases 
responsible for degradation of the mutant proteins have not been fully characterized. Recently, 
Takahashi et al., reported that the degradation of mutant ALDP protein was partially inhibited 
by treatment with MG132, suggesting that these ALDP mutants are degraded via the 
proteasome (Takahashi et al., 2007), Interestingly, a subset of unstable ALDP mutant proteins 
in patient cells became stable under low-temperature culture conditions and exhibited proper 
peroxisomal localization (Morita et al., 2019) while under these conditions patient cells 
displayed increased residual β-oxidation activity (Zhang et al., 2011). Some of the ALDP 
mutants which were rapidly degraded in vivo still possessed ATP hydrolysis activity in vitro 
(Roerig et al., 2001), indicating that mutant forms of ALDP retain a certain degree of 
functionality.  
8.4 Potential PMP substrates of the UPS/PMP degradation pathway  
Several reports in the literature strongly suggest that in addition to the PMPs discussed above, 




The budding yeast S. cerevisiae undergoes asymmetrical division, where a portion of its 
organelles, including peroxisomes, are delivered to the bud while the remaining organelles are 
retained in the mother cell (Fagarasanu and Rachubinski, 2007). Inp1p and Inp2p have 
important but opposite roles during peroxisome partition (Fagarasanu et al., 2010). While Inp1p 
associates with Pex3p and functions in tethering peroxisomes to the cortical ER in the mother 
cell (Knoblach et al., 2013), Inp2p acts as an adaptor that mediates peroxisome recruitment by 
the myosin Myo2p for transport to the daughter cells. A fine balance between Inp1p and Inp2p 
is therefore required to ensure the correct partitioning of peroxisomes between mother and 
daughter cells. Fagarasanu et al., showed that the levels of Inp2p fluctuate during the cell cycle 
(Fagarasanu et al., 2006). Similar to Inp2p, Inp1p levels also varied during the cell cycle 
(Fagarasanu et al., 2005), which could suggest that both Inp1p and Inp2p undergo degradation. 
Nevertheless, little is known about the cellular abundance of Inp1p or Inp2p and their role in 
peroxisome inheritance (Fagarasanu et al., 2005). 
Inp2p levels were observed to be maximal during peroxisome inheritance and decreased 
later in the cell cycle when around half of the peroxisomes have been delivered to the bud 
(Fagarasanu et al., 2006). This could indicate that Inp2p undergoes degradation at later stages 
in peroxisome inheritance and could possibly function in terminating peroxisome motility. 
Evidence for Inp2p degradation comes from data on myo2 mutants that are defective in binding 
and transporting peroxisomes, producing buds devoid of peroxisomes. Unlike wild-type cells 
which exhibit fluctuation in the levels of Inp2, an overall increase in Inp2p levels was observed 
at all stages of cell cycle in myo2 mutants (Fagarasanu et al., 2009). The higher levels of Inp2p 
was not due to increased synthesis but rather reflected a result of reduced degradation. Since 
Inp2p can only be detected on bud-localized peroxisomes in wild-type cells (Fagarasanu et al., 
2006) it is possible that Inp2p undergoes degradation in the bud. However based on this data, 
together with the data on myo2 mutants where Inp2p is predominantly localized to mother cells 
(Fagarasanu et al., 2009), Knoblauch et al., proposed that the Inp2p degradation machinery 
could be present in both the bud and the mother cell, the activation of which would cause the 
release of transferred peroxisomes in bud and prevent additional recruitment of peroxisomes 
from the mother cell.  
The degradation of Inp2p to terminate peroxisome movement to daughter cells agrees with 
current models for the inheritance of other organelles, such as yeast vacuoles. Vac17p, the 
vacuole-specific receptor for Myo2p, undergoes degradation following ubiquitination mediated 
by a novel E3-ubiquitin ligase Dma1p and its paralogue Dma2p (Tang et al., 2003; Yau et al., 
2014), to release the vacuole in the bud. Interestingly, Dma1p and Dma2p are also required for 
peroxisome movements in yeast (Yau et al., 2014). Furthermore a PEST motif, a protein domain 
consisting mainly of the amino acids proline (P), glutamic acid (E), serine (S) and threonine (T) 
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that mediates Vac17p degradation (Tang et al., 2003) is also present in Inp2. Whether PEST 
sequences, the proteasome and ubiquitination machinery proteins such as E3- ligase Dma1p 
and Dma2p play a role in Inp2p turnover would be interesting to investigate.  
8.4.2 Pex14p 
In addition to the docking protein Pex13p, which was shown to be ubiquitinated and degraded 
by the UPS, ubiquitinated peptides of Pex14p have been detected in S. cerevisiae and human 
cells (Kim et al., 2011; Mayor et al., 2007; Pan et al., 2016). Pex14p, a Pex13p interacting 
partner and docking complex protein (Azevedo and Schliebs, 2006; Urquhart et al., 2000), 
serves as a first site of contact for peroxisomal receptor proteins at the peroxisomal. In H. 
polymorpha, the levels of non-phosphorylated form of Pex14p were reduced in the cells deleted 
for PMP20 (Bener Aksam et al., 2008) while the phosphorylated form of Pex14p remained 
unaffected in this mutant. PMP20 is a peroxiredoxin involved in the degradation of H202 and 
the absence of Pmp20p results in enhanced oxidative stress in cells (Aksam et al., 2008). Such 
an increase in oxidative stress could result in damage to PMPs such as Pex14p, possibly by 
post-translation modifications, that could lead to protein misfolding and target them for 
degradation. Interestingly, Pex14p levels appear increased in cells lacking one of the 
peroxisomal E3 ligases Pex2p, Pex10p or Pex12p or the E2 enzyme Pex4p (Chen et al., 2018; 
Koek et al., 2007; van der Klei et al., 1998). The increased stability of Pex14p in these mutants 
may indicate that Pex14p degradation is inhibited. This also suggests that like pmp20 mutants, 
Pex14p in wild-type cells might be damaged or incorrectly folded and thereby be targeted for 
quality control purposes. It is highly likely that the presence of damaged or redundant PMPs, 
when not removed from peroxisomes, could result in aggregation of misfolded PMPs. Whether 
UPS play a role in the reduced levels of non-phosphorylated Pex14p needs to be determined. 
9. Perspectives 
The metabolic functions of peroxisomes are largely determined by protein content – which 
matrix and peroxisomal membrane proteins (PMPs) reside in peroxisomes. PMPs regulate 
most aspects of peroxisome biology and for the peroxisomes to function effectively, PMPs 
homeostasis is essential - this includes the regulation of PMP targeting as well as PMP quality 
control processes and degradation. We currently have a good idea which proteins are involved 
in PMP targeting. However, we do not understand how PMPs are inserted into the membrane. 
Likewise, our knowledge on PMP degradation is very limited.  
To date only four PMPs- Pex3p (yeast), Pex13p (yeast and plants), Pex15p (yeast) and 
ALDP (humans) have been observed to undergo degradation by the proteasome (Chen et al., 
2018; Morita et al., 2019; Pan et al., 2016; Williams and van der Klei, 2013). Significantly, the 
role for ubiquitin in Pex3p, Pex13p and Pex15p turnover has been established however, the 
ubiquitination machinery (i.e) E2s and E3s involved in ALDP degradation have not been 
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identified yet. The abundance of Inp2p in cells has been suggested to regulate peroxisome 
inheritance (Fagarasanu et al., 2009) and the data on Pex14p suggests that they are prone to 
oxidative damage (Aksam et al., 2008). The question remains whether these PMPs undergo 
UPS dependent degradation and if there are other potential PMP substrates that might be 
targeted for degradation (Figure 8). Furthermore, it is essential to investigate the function 
behind the turnover of individual PMPs, including whether the PMP degradation event serves 
a particular purpose, such as with Pex3p or whether the PMP degradation event is for quality 
control purposes, as observed for Pex15p. 
 
Figure 8: Schematic overview of future research areas that could provide detailed insights into PMP 
degradation. (1) Which of the PMPs are targeted for degradation? and (2) how PMP substrates are specifically 
recognized from other PMPs present at the peroxisomes, (3) which mechanisms are involved in PMP 
ubiquitination and (4) extraction of ubiquitinated PMPs from the peroxisomes are currently not well-known and 
requires further investigation.  
While our knowledge on the involvement of peroxisomal ubiquitin machinery in PMP 
degradation is increasing, how PMPs are recognized and extracted from peroxisomal membrane 
to facilitate degradation by the proteasome is unknown (Figure 8). To this end, the role for 
Pex1p/Pex6p in PMP degradation is unclear at the moment and these proteins were observed to 
be dispensable for Pex3p turnover (Williams and van der Klei, 2013), suggesting a role for 
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other AAA proteins in PMP extraction. Whether peroxisomes, like ER and Mitochondria, 
require the activity of Cdc48p would be interesting to investigate. Alternatively Msp1p, which 
functions in degrading Pex15p (Matsumoto et al., 2019), may also function in the degradation 
of other PMPs. Currently, we do not have direct evidence to show PMPs are first released in 
the cytosol in an ATP dependent manner before being degraded by the proteasome. This raises 
the possibility that proteasomes could transiently localize to the peroxisomes and degrade 
PMPs, a characteristic similar to what had been observed for ER and Mitochondria, particularly 
for degrading membrane proteins with multiple TMDs. 
The involvement of the E2 Pex4p and RING E3 peroxins (Pex2p and Pex10p) indicates a 
role for peroxisomal ubiquitination machinery in PMP degradation (Chen et al., 2018; Williams 
and van der Klei, 2013) but there is also evidence that support a role for non-peroxisomal 
proteins in peroxisomal protein degradation, such as the E2 enzyme Ubc4p, involved in Pex5p 
degradation (Kiel et al., 2005) and the cytosolic E3 ligase complex CRL4A, that participates in 
Pex7p degradation (Miyauchi-Nanri et al., 2014). Furthermore, the observation that Pex13p is 
only partially inhibited in pex4 cells could suggest that there are other E2 enzymes involved in 
Pex13p turnover. One obvious candidate would be Ubc4p as its role in Pex5p degradation has 
already been demonstrated. Interestingly the E3 ligase Dma1p (and its paralogue Dma2p), 
involved in Vac17p degradation, regulates peroxisome movements (Yau et al., 2014). 
Furthermore, the cytosolic E3 ligase Ubr2p has been implicated in peroxisome biogenesis 
(Lockshon et al., 2007; Saleem et al., 2010). It would be interesting to investigate whether these 
E3 ligases are involved in PMP degradation while future work that focusses on identifying non-
peroxisomal factors that might regulate the degradation of PMPs will surely provide new 
insights into how PMP degradation is connected to general cellular degradation pathways, 
including which UPS components are shared amongst the different degradation pathways. 
Therefore, studying PMP degradation would not only help us to understand whether PMPs are 
degraded through conserved degradation pathways but it will also help us understand how 
PMPs are regulated and to what extent PMP turnover controls peroxisomal functions. 
Furthermore, it would also provide valuable insights into role of PMP quality control in human 
health and diseases.  
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Protein homeostasis is the balance between protein synthesis and degradation. Changes in 
protein homeostasis have a severe impact on cell health and can lead to severe human diseases 
such as Parkinson’s disease. Despite the significance of peroxisomes in human health, very 
little is known about the degradation of peroxisomal membrane proteins (PMPs). Therefore, we 
were interested in developing a technique that can be used to investigate the stability of PMPs 
in S. cerevisiae cells in vivo. A tandem fluorescent protein timer (tFT) is a powerful tool for 
assessing protein degradation in living cells. A tFT is a fusion of two different fluorescent 
proteins with distinct fluorophore maturation kinetics. When coupled to a protein of interest, 
the stability of the protein of interest can be determined from the ratio of fluorescent intensities 
of the two fluorescent domains. In this chapter, we have validated the tFT approach for 
investigating the degradation of PMPs in S. cerevisiae. Our data demonstrates that tFT tagging 
does not appear to affect the induction or peroxisomal localization of the tFT-tagged PMPs we 
tested, two major characteristics of PMPs that are crucial for peroxisome biogenesis. 
Furthermore, we show that the tFT approach has the potential to report on the stability of PMPs 
as well as to identify unstable PMPs that undergo rapid degradation. In addition, we present 
evidence, which demonstrates that our tFT approach can provide insights into the reasons why 
PMP degradation occurs.  
 
















Cellular proteins are being continually synthesized and degraded. Alterations to this 
equilibrium, for instance due to reduced or increased degradation, often results in changes to 
cellular protein abundance, which can dramatically impact on cell health. As an example, 
disturbances in the degradation of cell cycle control proteins such as the p53 tumour 
suppressor plays a vital role in many forms of human cancers (Nakayama and Nakayama, 
2006). Also, accumulation of damaged or misfolded mitochondrial and Endoplasmic 
reticulum (ER) proteins in the cell are linked to neurodegenerative disorders such as 
Alzheimer's, Parkinson's and Huntington's diseases (Heo and Rutter, 2011; Matus et al., 
2011; Morimoto, 2008). The impaired degradation of ER or mitochondrial proteins, resulting 
in protein aggregation, often disturbs the normal physiology of the corresponding organelles, 
leading to dysfunctional mitochondria or ER, which can dramatically affect cell health. 
These examples demonstrate that correct regulation of protein degradation plays a vital role 
not only in regulating protein homeostasis and the underlying protein function but also in 
cell health.  
Peroxisomes are organelles found in virtually all eukaryotic cells, encompassing a 
multitude of proteins that are involved in various metabolic processes, depending on the species 
and/or cell type (Gabaldon, 2010). Common functions of peroxisomes include fatty acid β-
oxidation, lipid biosynthesis and de-toxification of hydrogen peroxide but many more exist 
(Hiltunen et al., 2003; Islinger et al., 2012; Smith and Aitchison, 2013). The significance of 
peroxisomes in humans is demonstrated by the fact that deficiencies in peroxisomes often lead 
to lethal human diseases such as Adrenoleukodystrophy or Zellweger syndrome (Waterham et 
al., 2016). Despite the importance of peroxisomes in human health, little is known about 
peroxisomal protein homeostasis. 
Depending on conditions, peroxisomes can undergo dynamic changes not only in size, 
shape and number but also in protein composition (Lingard et al., 2009; Ribeiro et al., 2012; 
Schrader et al., 2012; Wang et al., 2015). More than 30 proteins, collectively termed as peroxins 
and encoded by PEX genes, are involved in the biogenesis of peroxisomes (Distel et al., 1996; 
Smith and Aitchison, 2009). The majority of these peroxins are peroxisomal membrane proteins 
(PMPs), which are involved in various aspects of peroxisome biogenesis, including peroxisome 
formation, division of peroxisomes and peroxisomal matrix and membrane protein import 
(Baerends et al., 2000a; Schrader and Fahimi, 2008; Smith and Aitchison, 2013). Because PMPs 
play a vital role in regulating peroxisome biogenesis and function, there must be a tight control 
of PMP levels, through the translation and degradation of PMPs. The expression of PEX genes 
encoding for PMPs is regulated and depends, for example, on the nature of nutrients available 
to the cell. For the yeast Saccharomyces cerevisiae, it is well known that the expression of genes 
encoding for PMPs involved in fatty acid β-oxidation is low when cells grow on glucose but is 
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highly induced when fatty acids such as oleate are provided as sole carbon source (Gurvitz and 
Rottensteiner, 2006; Karpichev and Small, 1998; Smith et al., 2002). However, a subset of 
genes coding for PMPs that are essential for peroxisome formation and maintenance are 
expressed under peroxisome repressing conditions and their expression is only moderately 
enhanced on oleate (Rottensteiner et al., 2003a). These examples demonstrate that PMP 
regulation occurs at the level of transcription and that it can be specific for individual PMPs.  
While the transcription dependent regulation of PMPs has been the subject of many studies, 
the stability or the degradation of PMPs is less well studied. Recently, the PMPs Pex3p and 
Pex13p from the yeast Hansenula polymorpha were shown to be removed from peroxisomes 
and subsequently degraded by the Ubiquitin Proteasome System (UPS). While Pex3p removal 
was shown to initiate pexophagy (Bellu et al., 2002; Williams and van der Klei, 2013), the 
degradation of Pex13p was suggested to have a role in matrix protein import (Chen et al., 2018). 
Furthermore, the levels of Inp1p and Inp2p, proteins involved in peroxisome inheritance in 
yeast, were shown to fluctuate during the cell cycle in a pattern that parallels the dynamics of 
peroxisomes (Fagarasanu et al., 2006; Fagarasanu et al., 2005), suggesting that the turnover of 
these proteins could act as a signalling mechanism during peroxisome inheritance. However, 
the degradation of Inp1p and Inp2p has not been investigated further. Peroxisomes also generate 
large amounts of reactive oxygen species (ROS) such as hydrogen peroxide (Schrader and 
Fahimi, 2006). Therefore, it is highly likely that PMPs residing in this ROS rich environment 
are vulnerable to oxidative damage yet little is known about the degradation of damaged PMPs. 
Hence, our knowledge on PMP degradation is far from complete but it is highly likely that, in 
addition to Pex3p and Pex13p, other PMPs are targeted for degradation because they are non-
functional, damaged or because their degradation regulates a peroxisomal process (Williams, 
2014). Therefore, investigating the degradation of individual PMPs would allow us to 
understand how PMPs are regulated, to what extent PMP degradation is involved in regulating 
peroxisome function and what would be the impact of an imbalance in PMP homeostasis on 
peroxisome function. 
As a first step towards investigating PMP degradation, it is mandatory to know globally 
which PMPs undergo degradation. An array of methodologies exist that would allow PMP 
degradation to be followed in cell cultures. Pulse-chase analysis, a classical method involving 
the radioactive labelling of a protein for a short period of time (pulse) and the decay in 
radioactivity measured over time (chase) can be used to infer protein half-life (Schimke and 
Doyle, 1970). Radiolabelling, combined with mass spectrometry, allows the turnover of a large 
number of proteins to be analysed in parallel (Pratt et al., 2002). Protein stability can also be 
assayed by blocking protein synthesis using cycloheximide, after which the levels of the protein 
of interest present are determined by immunoblotting (Belle et al., 2006). However, both these 
methods are less suitable for monitoring protein turnover in living cells, a feature important for 
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a systems level understanding of protein function. To measure the rate of protein turnover in 
living cells, several different techniques exist, two of which are discussed here.  
The first method employs a photo-switchable fluorescent protein. Here, the protein of 
interest is tagged with a fluorescent protein, which can either acquire (photo-activation), change 
(photo-conversion) or lose (photo-bleaching) fluorescence by illuminating the protein 
population with a high-intensity laser light (Geva-Zatorsky et al., 2012; Lippincott-Schwartz et 
al., 2003; Zhang et al., 2007). Followed by irradiation, the decrease in fluorescence signal is 
monitored over time and the measured signal intensities are fitted to an appropriate model, thus 
yielding turnover or half-life estimates of protein fusions.  
The second approach employs a single fluorescent protein that acts as a timer (Terskikh et 
al., 2000). In this method, a fluorescent protein (which is fused to a protein of interest) changes 
colour over time as it undergoes maturation. The process by which a fluorescent protein 
acquires its chromophore is termed as maturation and the time needed to form the chromophore 
is called maturation time (Iizuka et al., 2011). The ratio of fluorescence intensities of the second 
and first fluorescent state (i.e. the second and first colour that the fluorescent protein adopts) 
provides a measure of protein age and thereby reports on the stability of the tagged protein. 
However, photo-switchable fluorescent proteins and single fluorescent timer have several short 
comings, including the photo toxic effect caused by high laser light, the low brightness of 
certain fluorophores or their tendency to form oligomers, which can influence the behaviour of 
tagged proteins (Dobrucki et al., 2007; Subach et al., 2009; Terskikh et al., 2000; Tsuboi et al., 
2010).  
A recently described approach, involving the use of a tandem fluorescence timer (tFT), can 
overcome some of these limitations (Khmelinskii et al., 2012). The tFT technique employs two 
monomeric bright fluorescent proteins with different maturation kinetics: a fast maturing green 
(e.g. GFP) and a slow maturing red (e.g. mCherry) fluorescent protein. The intensity ratio 
between the slow and fast maturing fluorescent domains (mCherry/GFP) reports on the stability 
of a protein fused to tFT (Khmelinskii et al., 2012). Because a tFT consists of a fast maturing 
fluorescent domain it enables us to identify unstable fusion proteins with a rapid turnover while 
at the same time display the potential to track most stable or long-lived proteins by the use of 
red fluorescence.  
In this chapter, we have validated the suitability of the tFT approach to investigate PMP 
turnover. Our data demonstrates that tFT analysis is a valid and robust approach to examine 







Tagging peroxisomal membrane proteins (PMPs) with a tandem fluorescent timer (tFT) 
The tandem fluorescent timer (tFT) approach has been previously used to investigate protein 
turnover in living cells of different organisms, including S. cerevisiae and Zebrafish (Barry et 
al., 2016; Dona et al., 2013; Khmelinskii et al., 2012). We wanted to determine the suitability 
of the tFT approach in investigating the turnover of PMPs in vivo in S. cerevisiae. The tFT tag 
is composed of super folded green fluorescent protein (sfGFP), which is a rapidly folding and 
fast maturing fluorescent protein with a half-life of around 6 mins (Khmelinskii et al., 2012; 
Khmelinskii et al., 2016; Pedelacq et al., 2006) and mCherry, which matures with a half-time 
of around 40 mins (Khmelinskii et al., 2012; Merzlyak et al., 2007). The ratio of mCherry to 
sfGFP intensities (mCherry/sfGFP) provides a measure of the age of the tFT fusion protein and 
thereby its stability (Khmelinskii et al., 2012). We fused a tFT tag to different PMPs at their C-
terminus and expressed PMP-tFT fusions under the control of their endogenous promoter 
(Figure 1A and 1C). Shortly after the synthesis of the PMP-tFT fusion, tFT tagged PMP 
molecules will mostly display green fluorescence (Figure 1A, step 1) and gradually display red 
fluorescence over time (Figure 1A, step 2). PMP-tFT fusions undergoing fast turnover will 
mostly be degraded prior to mCherry maturation, resulting in a pool of newly synthesized PMP-
tFT molecules exhibiting low red fluorescence (Figure 1B, left). The mCherry/sfGFP ratio 
would therefore be lower and fusion proteins are said to be unstable. By contrast, the intensity 
of mCherry and the ratio would be higher for stable PMP-tFT fusions with a slow turnover 
(Figure 1B, right).  
By using the tFT approach, we assessed the stability of PMPs and identified unstable PMPs 
in S. cerevisiae. For this, we fused a tFT tag to 15 PMPs, in order to examine the stability of 
individual PMP-tFT protein fusions. PMPs selected for tFT tagging, which are involved in 
various peroxisomal functions, include Pex3p (involved in PMP import) and Pex13p, Pex14p 
and Pex17p (all are members of the docking complex required for peroxisomal matrix protein 
import) (Brown and Baker, 2003; Subramani et al., 2000). In addition, we also selected Pex11p, 
Pex25p and Pex27p (three PMPs involved in peroxisome fission) and Inp1p and Inp2p (both 
required for peroxisome inheritance) (Fagarasanu et al., 2010; Schrader et al., 2012). The 
peroxisomal E3 ligase complex consisting of Pex2p, Pex10p and Pex12p (required for recycling 
and degradation of peroxisomal matrix protein receptor Pex5p) and peroxisomal E2 anchor- 
Pex22p (involved in Pex5p recycling) were also selected for tFT tagging (El Magraoui et al., 
2014; Platta et al., 2009; Williams et al., 2008). Finally, we fused a tFT tag to the fatty acid 
transporters Pxa1p and Ant1p, which are involved in transporting long and medium chain fatty 
acids to peroxisomes, respectively (Baker et al., 2015; van Roermund et al., 2012).  
Compared to conventional gene tagging, which involves the introduction of a tag and 
marker sequence together into the desired chromosomal loci (Wach et al., 1997), we used an 
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efficient endonuclease-driven approach for tFT tagging of PMPs (Khmelinskii et al., 2011). 
This method involves the use of I-SceI meganuclease to remove all the auxiliary sequences 
including the marker coding sequences, that are reported to affect endogenous gene expression 
by changing mRNA abundance, stability or localization (Lind and Norbeck, 2009). By using 
this tagging approach, we seamlessly fused a tFT tag to the PMPs of interest by homologous 
recombination (Figure 1C). I-SceI targets a rare 18-base pair sequence absent from the genome 
of S. cerevisiae (Colleaux et al., 1986). In this tagging approach, the tFT module consists of full 
length mCherry coding sequence followed by a I-SceI site, selection marker (URA3 gene), 
second I-SceI site and a portion of mCherry (mCherry∆N) and full length sfGFP coding sequence 
(Figure 1C). Here, mCherry∆N (mCherry sequence lacking last 91 amino acids) is used for 
homologous recombination (see below- Figure 1C step 3). First, the tagging module is 
amplified in a PCR reaction with short overhangs homologous to C-terminus of the PMP locus 
and integrated in to the genome of S. cerevisiae which expresses I-SceI under a galactose 
inducible promoter (GAL1) (Figure 1C, step 1). The positive clones are selected using URA 
marker and correct integration of tFT module is checked by colony PCR. Followed by correct 
module integration, cells expressing PMP-tFT fusions are grown on galactose containing 
medium to induce the expression of I- SceI, resulting in the excision of heterologous terminator 
sequences and URA marker (Figure 1C step 2). The double stranded break can then be repaired 
by homologous recombination between the mCherry and mCherryΔN sequences (Figure 1C step 
3). This effectively removes all the auxiliary sequences from the integrated module, leaving a 
single copy of the tFT tagged PMP in the genome. Cell expressing tFT fusions will exhibit 






Figure 1: Tagging peroxisomal membrane proteins (PMPs) with a tandem fluorescent timer (tFT) 
A) A PMP is fused to a tandem fluorescent timer (tFT) tag, which consists of two fluorescent domains with distinct 
fluorophore maturation rates. Super folded GFP (sfGFP) matures approximately with a half-time of ~6 mins 
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(indicated by 1) whereas, mCherry matures with a half-time of ~40 mins (indicated by 2). The ratio of the 
mCherry/sfGFP fluorescent signals reports on the stability of a tFT tagged PMP (PMP-tFT) fusion protein.  
B) For PMP-tFT fusions with fast turnover, peroxisomes contain large fraction of PMPs displaying higher green 
fluorescence compared to mCherry, resulting in low mCherry/sfGFP ratio. For PMP-tFT fusions with slow 
turnover, tFT tagged PMPs in peroxisomes exhibit high green and red fluorescence, leading to higher 
mCherry/sfGFP ratio. tFT tagged PMPs with low and high mCherry/sfGFP ratio are therefore categorized as 
unstable and stable proteins respectively.  
C) The seamless gene tagging approach was used to construct PMP-tFT strains. Strains also expressed the I-SceI 
meganuclease under a galactose inducible promoter. First, a module for the C-terminal tagging of a PMP with 
a mCherry-sfGFP tFT is integrated into the genome locus of the PMP of interest. Subsequent I-SceI expression 
leads to the excision of heterologous terminator (term- indicated in red) and the URA3 selection marker. 
Followed by this, the repair of the double strand break occurs by homologous recombination between the 
mCherry and mCherryΔN sequences. In the final strains, the tFT fusions (PMP-tFT) are expressed under the 
control of their endogenous promoter and terminator sequences. 
D) Table indicating which PMPs were tagged with a tFT in our study.  
The stability of tFT tagged proteins vary, ranging from unstable to highly stable 
Following seamless tFT tagging of 15 individual PMPs, we assessed the stability of each PMP-
tFT fusion in vivo under two different conditions: peroxisome repressing (glucose – Figure 2A) 
and peroxisome inducing conditions (oleate medium containing 0.1% glucose – Figure 2B). 
Since most PMPs tested here play a crucial role in peroxisome biogenesis, any effect due to tFT 
tagging of PMPs could affect peroxisome function resulting in reduced growth on oleate. 
Therefore, 0.1% glucose was added to our oleate medium (hereafter referred to as oleate-plus 
medium) to facilitate proper growth (see materials and methods for details). In S cerevisiae, 
peroxisomes are the sole compartment for β-oxidation of fatty acids such as oleate. Growth on 
oleate induces the expression of several genes encoding for peroxisomal proteins (including 
PMPs) involved in fatty acid oxidation and it also stimulates the import of matrix enzymes into 
peroxisomes required for fatty acid oxidation (Gurvitz and Rottensteiner, 2006). This oleate 
dependent induction is accompanied by a proliferation of peroxisomes (Veenhuis et al., 1987). 
By contrast, growth on fermentable carbon sources such as glucose represses the expression of 
genes encoding for proteins (including PMPs) involved in β-oxidation and therefore 
peroxisomes are few in numbers. Since a subset of PMPs are present only in low levels on 
glucose conditions (Karpichev and Small, 1998), it would be interesting to know whether PMP 
levels under these conditions are regulated by degradation. Therefore, we examined the stability 
of PMPs involved in different peroxisomal functions (Figure 1D) under peroxisome repressing 
and peroxisome inducing conditions. We used yMaM344, a strain expressing truncated non-
fluorescent mCherry∆N protein (Khmelinskii et al., 2014) as negative control. The fluorescence 
intensities of mCherry and sfGFP were measured every day for four days, from whole colonies 
of cells expressing PMP-tFT fusions and were corrected for auto fluorescence using intensity 
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values of the negative control strain (see materials and methods). The normalized mCherry and 
sfGFP values were then used to calculate mCherry/sfGFP ratios in cells expressing individual 
PMP-tFT fusions (see materials and methods for further details). The ratios obtained depict the 
relative stability of PMP-tFT fusions and are displayed in a heat map (Figure 2), colour coded 
from dark green (mCherry/sfGFP of 0) to red (mCherry/sfGFP of 2). We categorized PMP-tFT 
fusions with mCherry/sfGFP ratios lower than 1.0 as unstable proteins. 
We observed that individual PMP-tFT fusion proteins display different stability profiles 
(Figure 2A and 2B). Under peroxisome repressing conditions Pex2-tFT, Pex13-tFT, Pxa1-tFT, 
Ant1-tFT and Inp2-tFT displayed low mCherry/sfGFP ratios, ranging from 0.5 to 0.9 on 
indicated days (Figure 2A). On the other hand, Pex11-tFT appeared to be the most stable tFT 
fusion, with the highest ratio ranging between 1.5 and 1.8. The remaining PMP-tFT fusions 
were categorized as stable proteins as they exhibited ratios ranging from 1.0 to 1.5 (Figure 2A). 
Similarly, under peroxisome inducing conditions (Figure 2B), Pex2-tFT, Pxa1-tFT, Pex13-tFT 
and Inp1-tFT were observed to have low mCherry/sfGFP ratios (<1.0), indicating that these 
four proteins are unstable fusion proteins and could undergo degradation in cells grown on 
oleate containing medium. Again, Pex11-tFT appeared to be the most stable tFT fusion with 
ratios ranging between 1.7 and 2.0 on indicated days. The remaining ten of the fifteen PMP-
tFT fusions are categorized as stable proteins as they displayed ratios between 1.0 and 1.7.  
Furthermore, we observed that most PMP-tFT fusions in cells grown on oleate-plus plates 
displayed lower ratios on day three and four compared to days one and two (Figure 2B). S 
cerevisiae cells grown on oleate-plus liquid medium reach stationary phase after approximately 
24 hrs (Kawalek et al., 2016) compared to growth on oleate liquid medium, where the cells 
require around 64 hrs (~2.5 days) to reach stationary phase (Al-Saryi et al., 2017). While it is 
challenging to determine the growth phase of cells growing on plates, we suspect that cells 
expressing PMP-tFT fusions would be in the later stages of growth after three or four days on 
oleate-plus plates. At this stage, most of the oleate will have been utilized and there will be little 
oleate available to induce the oleate response element (ORE) involved in the upregulation of a 
subset of PMPs (Gurvitz and Rottensteiner, 2006). This may result in reduced tFT fusion protein 
expression and thereby a reduced ratio at later time points (Figure 2B- day 3 and day 4). 
Furthermore, the mCherry/sfGFP ratio in Inp2-tFT cells grown on oleate-plus medium was very 
low (< 0.3) and the ratio on days one and four was observed to be negative (Figure 2B, indicated 
in grey). The mCherry intensity values of Inp2-tFT were similar or slightly lower compared to 
background (WT) fluorescence, resulting in negative mCherry/sfGFP ratio. This suggests that 
Inp2-tFT levels in oleate-plus medium are below the detection limit of the fluorescence-based 
plate reader.  
Based on our tFT approach, we concluded that Pxa1-tFT and Pex13-tFT are unstable 
proteins, suggesting that they could possibly undergo degradation. The peroxisomal fatty acid 
transporter Pxa1p is a homologue of the human protein ALDP (Adrenoleukodystrophy protein) 
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(Shani et al., 1995) and mutations in ALDP leads to severe disease called ALD 
(Adrenoleukodystrophy) (Engelen et al., 2014; Mosser et al., 1993). Many ALD causing ALDP 
mutants are targeted for degradation yet the mechanisms underlying ALDP instability are 
unknown (Morita et al., 2018). Hence, studying how Pxa1p degradation is facilitated could 
provide new insights on ALDP mutant degradation in ALD. Furthermore, the degradation of 
Pex13p and UPS proteins involved in Pex13 degradation has already been reported in H. 
polymorpha (Chen et al., 2018), making it interesting to investigate the instability of tFT tagged 
S. cerevisiae Pex13p further.  
 
Figure 2: The stability of tFT tagged PMPs under peroxisome inducing and repressing conditions. 
Heat map representing the stability of PMP-tFT fusions in A) Glucose (peroxisome repressing medium) and B) 
Oleate-plus medium (peroxisome inducing medium). mCherry and sfGFP fluorescence was measured from whole 
colonies of cells expressing PMP-tFT fusions at the indicated time points (days 1-4). The fluorescent intensities 
obtained on days 1, 2, 3 and 4 from each strain were used to calculate mCherry/sfGFP ratios. mCherry/sfGFP 
ratios representing the stability of PMP-tFT fusions are colour coded from green (unstable) to red (highly-stable). 
Grey indicates a negative mCherry/sfGFP ratio (see text for details). 
Pex13-tFT is functional while tFT tagged Pxa1p exhibits reduced functionality  
Next, we wanted to validate our tFT setup and for this, we selected two unstable PMP-tFT 
fusions- Pex13-tFT and Pxa1-tFT fusion proteins identified from our stability analysis (Figure 
2). We examined whether tFT tagging to Pxa1p and Pex13p affects the functionality of these 
proteins. Because PMP-tFT fusions were constructed with a seamless gene tagging approach, 
PMP-tFT fusions are the only copy of the PMP present in the cell. Therefore, the functionality 
of PMP-tFT fusions can be easily assessed. Since Pex13p is involved in the import of 
peroxisomal matrix enzymes required for the β-oxidation of fatty acids (Hiltunen et al., 2003), 
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the loss of Pex13p leads to a block in matrix protein import and thereby contributes to loss of 
functional peroxisomes (Elgersma et al., 1996; Erdmann and Blobel, 1996). We reasoned that 
if tFT tagging to Pex13p affects its functionality, cells would be unable to utilize oleate for 
growth. Unlike pex13 cells, which display a growth defect on media containing oleate as sole 
carbon source (unlike oleate-plus media, which contains glucose), the growth of cells 
expressing Pex13-tFT was similar to WT (Figure 3A), establishing that Pex13-tFT is functional. 
Compared to Pex13p, loss of Pxa1p function does not lead to a growth defect in cells 
because its function (oleate transport to peroxisomes for β-oxidation) can be taken over by the 
fatty acyl-CoA synthetase Faa2p (Hettema et al., 1996). Therefore, in order to assess the 
functionality of Pxa1p alone, we performed growth experiments with cells lacking Faa2p. As 
expected pxa1faa2 cells were unable to grow on oleate (Figure 3B). Interestingly, faa2 cells 
expressing Pxa1-tFT (faa2.Pxa1-tFT) displayed poorer growth on oleate compared to WT cells 
(Figure 3B). In order to examine the extent to which growth of faa2.Pxa1-tFT cells are affected, 
we also assessed the growth of this strain on oleate liquid medium (Figure 3C). faa2.Pxa1-tFT 
cells grew better compared to pxa1faa2 or pex4 cells. However, the growth of faa2.Pxa1-tFT 
was slower compared to WT cells, suggesting that Pxa1-tFT retains only a certain degree of 
functionality (Figure 3C). Overall, our growth assays suggest that Pex13-tFT is functional while 
also indicating that Pxa1-tFT is reduced in functionality.  




Figure 3: Growth of cells expressing Pex13-tFT and Pxa1-tFT on oleate medium. A) Ten-fold serial 
dilutions of WT and Pex13-tFT cells, together with pex13 and pex4 cells were spotted on oleate plates and grown 
at 30º C for 7 days. pex13 and pex4 cells act as negative control. B) Spot assay to test the growth of tFT tagged 
Pxa1p in faa2 cells. Ten-fold serial dilutions of WT and faa2cells producing Pxa1-tFT (faa2.Pxa1-tFT) together 
with pxa1faa2 and pex4 cells were spotted on oleate plates and grown at 30º C for 9 days. pxa1faa2 and pex4 cells 
acts as negative control. C) The functionality of Pxa1-tFT was also tested by checking the growth of WT and faa2. 
Pxa1-tFT cells on oleate medium (0, 6, 14, 18, 24, 30, 38, 48, 60 and 74 hours). The growth of pxa1 faa2 and pex4 
cells acts as control. Values represent the mean ± SD of two independent experiments. 
PMP-tFT fusions are induced under peroxisome inducing conditions 
Following on from our functionality analysis, we next assessed whether the tFT tagged PMPs 
are induced under peroxisome inducing conditions. For this, we checked Pxa1-tFT and Pex13-
tFT levels after shifting the cells from peroxisome repressing (glucose) to peroxisome inducing 
conditions (oleate-plus medium). Pxa1-tFT levels were observed to be very low in cells grown 
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on glucose (Figure 4A- 0h) while the levels were upregulated in oleate-plus medium with only 
a minor decrease in protein levels after 24 hours of growth (Figure 4A- 8h, 16h and 24h). This 
is in line with previous studies where they reported that genes coding for peroxisomal β-
oxidation proteins such as Pxa1p are repressed by glucose but are induced several fold in the 
presence of fatty acid containing medium such as oleate (Gurvitz and Rottensteiner, 2006; 
Karpichev et al., 2008; Karpichev and Small, 1998; Rottensteiner et al., 2002). Hence, it is 
difficult to draw conclusions from the data on Pxa1-tFT stability gained from cells grown on 
glucose medium because of the low levels of Pxa1-tFT present under these conditions. By 
contrast, Pxa1-tFT levels are well induced and easily detectable on oleate-plus medium (Figure 
4A), demonstrating that Pxa1 turnover can be studied effectively under this condition using tFT 
approach.  
Pex13-tFT on the other hand was expressed in cells grown on glucose and oleate-plus 
medium (Figure 4B). The levels were higher at 8 hours of growth on oleate containing media, 
after which Pex13-tFT levels started to decrease (Figure 4B- 16h and 24h). This pattern of 
Pex13-tFT induction in glucose and oleate-plus medium was similar to Pex13-mGFP levels in 
WT cells, as previously reported (Wroblewska et al., 2017), suggesting that tFT tagging does 
not affect the induction of Pex13p. In addition to Pxa1-tFT and Pex13-tFT, we also followed 
Pex11-tFT levels, since this PMP was observed to be the most stable fusion protein. Compared 
to Pxa1-tFT and Pex13-tFT, Pex11-tFT levels remained stable over time and the levels were 
slightly higher in oleate-plus medium compared to the levels in glucose (Figure 4C). Similar to 
Pex13-tFT, the induction of tFT tagged Pex11p is comparable with previous reports 
(Wroblewska et al., 2017), indicating that our PMP-tFT fusions behave as expected. 
In addition to full-length PMP-tFT fusions (PMP-mCherry-sfGFP), an immunoreactive 
band at ~45 kDa was present in all the samples (Figure 4A, 4B and 4C, represented by *) while 
a band at ~33 kDa was also observed with samples containing Pex11-tFT and Pex13-tFT 
(Figure 4B and 4C, represented by **). Previously, Khmelinskii et al., reported that the 45 kDa 
band denotes a shorter mCherry-sfGFP product (Khmelinskii et al., 2016). This product is 
caused by the hydrolysis of the mature mCherry fluorophore during TCA lysate preparation, 
which leads to breakdown of the mCherry polypeptide. Furthermore, the immunoreactive band 
at ~ 33 kDa was shown to be produced by incomplete proteasomal degradation of tFT fusions 
and these fragments appeared to be relatively stable in the cell (Khmelinskii et al., 2016). The 
presence of additional bands in our western blot analysis (Figure 4 * and **) is in line with the 
previous data, indicating that PMP-tFT fusions behave in a way similar to other tFT fusion 
proteins. Overall, our data demonstrates that PMP-tFT fusions are well induced and their pattern 
of induction is as expected.  
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Figure 4: The induction of PMP-tFT fusions in cells growing on oleate-plus medium. Representative 
western blot of Pxa1-tFT (A), Pex13-tFT (B) and Pex11-tFT (C) levels in glucose grown cells (peroxisome 
repressing) shifted to oleate-plus medium (peroxisome inducing). Samples were collected from glucose (0 h) and 
oleate grown cells at indicated time points. Cells were lysed and samples were subjected to SDS-PAGE and 
immunoblotting with antibodies against mGFP, Pyruvate Carboxylase 1 (Pyc) or Glucose 6 Phosphate 
Dehydrogenase (G6PD). Pyc and G6PD acts as loading control. *denotes a mCherry-sfGFP product obtained from 
mCherry hydrolysis during TCA lysate preparation and ** denotes a tFT fragment produced due to incomplete 
proteasomal processing (see text for details). TCA samples were run on 7.5% SDS PAGE gel (A) and 12.5% SDS 
PAGE gel (B, C). 
PMP-tFT fusions display spot like structures, suggesting peroxisomal localization 
Next, we examined if cells expressing PMP-mCherry-sfGFP (PMP-tFT) fusions exhibit spot-
like or punctate structures, which is a characteristic feature of PMP localization on the 
peroxisomal membrane (Mattiazzi Usaj et al., 2015; Mix et al., 2018; Nyathi et al., 2010; 
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Palmieri et al., 2001). For this, we used fluorescence microscopy (FM) analysis to image Pxa1-
tFT, Pex13-tFT and Pex11-tFT cells grown on glucose and oleate-plus medium. Together with 
the strains expressing PMP-tFT fusions, we used a WT strain lacking fluorescent markers, as 
control.  
As expected, WT cells did not exhibit any spot-like structures in either the GFP or mCherry 
channel (Figure 5A) while several GFP and mCherry positive fluorescent spots were observed 
in Pxa1-tFT and Pex13-tFT cells grown on oleate-plus medium (Figure 5B and 5C – 8h and 
16h), suggesting that these PMP-tFT fusions are localized to peroxisomes. Pxa1-tFT cells on 
the other hand exhibited only one or two faint spot-like structures on glucose (Figure 5B- 0h). 
This data validates our western blot analysis, where tFT tagged Pxa1p displayed low levels in 
glucose (Figure 4A- 0h). Furthermore, the reduction in the number of GFP and mCherry spots 
observed in Pex13-tFT cells at later time points in oleate-plus medium (Figure 5C- 16h), again 
confirms the western blotting data on Pex13-tFT levels (Figure 4B- 16h). Compared to Pxa1-
tFT and Pex13-tFT cells which exhibited many fluorescent spots, fewer spot-like structures 
were observed with Pex11-tFT cells grown on oleate-plus medium and these structures were 
larger than in the other PMP-tFT containing strains tested (Figure 5D). This result is in contrast 
to the previous data on Pex11-mGFP localization, where several spot- like structures were 
observed in Pex11-mGFP cells grown on oleate (Mattiazzi Usaj et al., 2015). Since Pex11p is 
involved in peroxisome fission (Marshall et al., 1995) and deletion of PEX11 results in a 
reduced number of peroxisomes that are larger than in WT cells (Rottensteiner et al., 2003b), 
we suspect that fusing the tFT tag to the C-terminus of Pex11p disturbs Pex11p function.  
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Figure 5: PMP-tFT fusions display spot like structures in cells, suggesting correct peroxisomal 
localization. Fluorescence microscopy analysis of cells expressing Pxa1-tFT (B), Pex13-tFT (C) or Pex11-tFT 
(D) grown in glucose (0 h) and oleate-plus medium (8 and 16 h). WT strain lacking fluorescent markers was used 
as a control (A). Images were processed using Image J with optimal settings. sfGFP (200, 700) and mCherry (200, 
400) settings were used to process images of WT and Pxa1-tFT. For Pex13-tFT: sfGFP (200, 800) and mCherry 
(200, 400) and for Pex11-tFT: sfGFP (200, 8000) and mCherry (200, 5000) settings were used. Scale bar represents 
3µm. 
The unstable PMP-tFT fusions have a fast turnover 
Since Pex13-tFT and Pxa1-tFT are observed to be unstable, based on our tFT analysis (Figure 
2B), it is strongly suggestive that these PMPs undergo protein degradation. Hence, our next 
step was to validate our tFT analysis using biochemical approaches to examine the degradation 
of Pex13-tFT and Pxa1-tFT. To achieve this, we performed chase analysis with the protein 
synthesis inhibitor cycloheximide (CHX), assessing the turnover of Pex13-tFT and Pxa1-tFT 
in cells grown on oleate-plus medium for ~12 hrs (O.D 1.5). We also followed Pex11-tFT 
turnover, since this Pex11-tFT displayed the highest mCherry/sfGFP ratio in our tFT analysis 
and was therefore expected to be stable compared to the other PMP-tFT fusions. As a control, 
Pxa1-tFT, Pex13-tFT and Pex11-tFT cells grown on oleate-plus medium for ~12 hrs were 
treated with DMSO (Figure 6A, 6B and 6C – Ctrl). Equal volume of samples from control and 
CHX treated cells were collected at indicated time points (0, 30, 60 and 120 mins) and used for 
western blotting (see materials and methods). We observed that Pxa1-tFT is rapidly degraded 
in CHX treated cells (Figure 6A- CHX) compared to Ctrl cells (Figure 6A- Ctrl). Pex13-tFT on 
the other hand was observed to be degraded in cells treated with DMSO (Figure 6B- Ctrl) or 
CHX (Figure 6B- CHX), with the degradation being faster in CHX treatment. Similar pattern 
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of degradation was observed with Pex11-tFT (Figure 6C- Ctrl and CHX). The reduction of 
Pex13-tFT and Pex11-tFT levels observed with Ctrl cells grown on oleate-plus medium (for 
12h- 14h) can partly be explained by our previous western blot results, where tFT tagged 
Pex13p and Pex11p displayed lower levels at 16h (Figure 4B- 16h compared to 8h), suggesting 
that there could either be more degradation or reduced Pex13-tFT synthesis in Ctrl cells grown 
oleate-plus medium between 12h and 14h (Figure 6B- Ctrl). The increase in Pxa1-tFT levels 
observed with Ctrl cells after 120 mins (~ 14hrs in oleate-plus medium) again confirms our 
western blotting results, where Pxa1-tFT levels were observed to increase between 8h and 16h 
of growth in oleate-plus medium (Figure 4A 8h and 16h). 
We quantified the protein levels in CHX treated cells and observed that both Pxa1-tFT and 
Pex13-tFT undergo rapid protein degradation (Figure 6A and 6B) whereas Pex11-tFT turnover 
is much slower (Figure 6C). Pxa1-tFT and Pex13-tFT displayed a half-life of around 15 mins 
and 30 mins respectively, compared to Pex11-tFT, which exhibited a half-life of around 60 
mins (Figure 6D). Similar to our western blot analysis displayed in Figure 4, two 
immunoreactive bands at ~45 kDa and ~33 kDa were observed with CHX chase analysis of 
Pxa1-tFT, Pex13-tFT and Pex11-tFT (Figure 6A, 6B and 6C). The band at ~33 kDa, produced 
due to the incomplete proteasomal degradation of tFT fusions, is highly visible in the samples 
containing Pxa1-tFT (Figure 6A- indicated by **) and Pex13-tFT (Figure 6B- indicated by **) 
compared to Pex11-tFT (Figure 6C- indicated by **). This strongly suggests a role for 
proteasome in the degradation of Pxa1-tFT and Pex13-tFT. 





Figure 6: Pxal-tFT and Pex13-tFT are rapidly degraded. Cycloheximide (CHX) chase analysis 
conducted with cells expressing Pxa1-tFT (A), Pex13-tFT (B) and Pex11-tFT (C). Cells expressing PMP-tFT 
fusions were grown on oleate-plus medium to an OD of 1.5 and cells were treated with DMSO (Ctrl) or CHX. 
Equal volume of samples (6 OD) were collected at indicated time points (0, 30, 60 and 120 mins) for western 
blotting with antibodies against mGFP and Pyc. *denotes a shorter, mCherry-sfGFP product resulting from 
mCherry hydrolysis during TCA lysate preparation and ** denotes a fast migrating tFT fragment produced by 
incomplete proteasomal processing (Khmelinskii et al., 2016). D) Quantification of Pxa1-tFT, Pex13-tFT and 
Pex11-tFT levels after CHX addition. Protein levels were normalized to Pyc at the corresponding time point and 
to the protein levels at time point 0 or T0 (set to 1). Values represent the mean ± SD of three independent 
experiments. 
Discussion 
Imbalances in protein homeostasis, caused by either excessive or reduced protein degradation, 
often leads to severe disease (Heo and Rutter, 2011; Matus et al., 2011). Therefore, knowledge 
on which proteins are degraded, as well as the function of their degradation, is essential to 
Chapter 2
88
understand how protein degradation is linked to cellular health. Several methods can be used to 
study the degradation of proteins. Of these methods, the tandem fluorescent timer (tFT) 
approach has been successfully used to investigate protein turnover in S. cerevisiae cells in vivo 
(Khmelinskii et al., 2012). Here, we have validated the tFT approach to study the stability of a 
number of PMPs, involved in different peroxisomal functions. We have utilized a tFT 
consisting of sfGFP and mCherry and used the mCherry/sfGFP ratio to gain insight into the 
stability of PMPs under different conditions. Using this approach, we observed that individual 
PMP-tFT fusions in cells displayed varied stability profiles, ranging from unstable to highly 
stable, establishing that a tFT can be used to report on the stability of individual PMPs (Figure 
2).  
Due to the size and the fold of the tFT tag, it is very possible that tagging a protein with a 
tFT affects the stability and/or behaviour of the protein. In line with this, Kowalski et al., 2018 
showed that mitochondrial proteins fused to a tFT become mislocalized to the cytosol and are 
subsequently degraded (Kowalski et al., 2018). Furthermore, this same study demonstrated that 
the tFT tagged mitochondrial protein COX12 was impaired in function. We noticed comparable 
behaviour with tFT tagged Pxa1p, one of the PMP-tFT fusions used in our analysis. Pxa1p plays 
a role in transporting fatty acids into peroxisomes, where they undergo β-oxidation. 
Interestingly, wild-type Pxa1p is reported to be stable with a half-life of ~9 hrs (Shani and Valle, 
1996), while we observed that tFT tagged Pxa1p is unstable and rapidly degraded with a half-
life of ~15 mins (Figure 6). Furthermore, we observed that faa2 cells expressing Pxa1-tFT 
displayed reduced growth on oleate, suggesting that tFT tagged Pxa1p is impaired in function 
(Figure 5). This strongly suggests that fusion of a large tFT tag to Pxa1p affects the stability 
and function of Pxa1p, indicating that Pxa1-tFT could be degraded for quality control purposes, 
due to reduced functionality. Because PMPs are involved in peroxisomal biogenesis, any faulty 
PMPs present in the peroxisomal membrane need to be removed in order to maintain 
peroxisome homeostasis. However, little is known about PMP quality control. Our tFT 
approach therefore provides an interesting way in which the stability and degradation of PMPs 
that are prone to become faulty or non-functional can be identified and studied. In addition, the 
tFT approach can be used to identify factors involved in the degradation of faulty PMPs and 
gain insights into the mechanism of PMP quality control (see chapter 3 of this thesis). 
While a tFT can be used to identify unstable PMPs, that are degraded for quality control 
purposes, the tFT approach has also the potential to unveil PMPs that can undergo degradation 
for purposes other than quality control. An example is Pex13-tFT, which retained its 
functionality yet is rapidly degraded, indicating a role for targeted degradation of Pex13-tFT 
(Figure 5). In line with this, the degradation of Pex13p observed in H. polymorpha was 
suggested to have a role in matrix protein import (Chen et al., 2018). The authors also 
demonstrated that Pex2p- a peroxisomal RING E3 protein is involved in the degradation of H. 
polymorpha Pex13p. Here, we used the tFT approach to show that S. cerevisiae Pex13p is 
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degraded like H. polymorpha Pex13p. This approach can be used further to investigate whether 
Pex2p has a role in S. cerevisiae Pex13p degradation and also identify which other factors may 
be involved in the degradation of Pex13p (see chapter 4 of this thesis). 
In this report, we have shown that the tFT approach can be used to investigate PMP 
stability and degradation in live S. cerevisiae cells. However, there are some points that need to 
be taken into consideration when employing the tFT approach. Our western blot analysis 
demonstrates that, similar to other tFT fusions (Khmelinskii et al., 2016), certain PMP-tFT 
fusions exhibit two prominent immunoreactive bands at ~45 kDa (produced from mCherry 
hydrolysis during TCA processing) and ~33 kDa. The 33 kDa band, which is reported to be 
produced by incomplete proteasomal degradation of tFT fusions (Khmelinskii et al., 2016), is 
highly visible with unstable protein fusions (Pxa1-tFT and Pex13-tFT) compared to Pex11-tFT, 
a stable fusion protein (Figure 6). This in itself could be used as readout to identify PMP-tFTs 
processed by the proteasome. Furthermore, fusion of a tFT tag to PMPs may result in 
destabilization of the PMPs, as was observed with our Pxa1-tFT fusion. While the tFT approach 
could be used to destabilize PMPs or identify PMPs that are prone to become faulty, this might 
not be always be desirable and should be taken into consideration when using the tFT approach 
to investigate protein turnover. 
In summary, the tFT approach is a valid and robust method that can be used to investigate 
PMP stability or turnover in vivo. As an added advantage, the tFT approach can be used in 
combination with Synthetic Genetic Array (SGA) technique to identify factors involved in the 
degradation of unstable PMP-tFT fusions identified from our analysis (Khmelinskii et al., 
2014). By crossing unstable PMP-tFT fusions with a deletion library consisting of mutants 
inhibited in autophagy or the ubiquitin proteasome system (UPS), mutants that increase the 
stability of tFT fusions are the potential candidates involved in the degradation of the unstable 
PMP-tFT fusions, providing insights into the underlying mechanism and factors involved in 
PMP degradation. Such approaches have been used in chapters 3 and 4 of this thesis. 
 
Materials and Methods 
Yeast strains and plasmid  
Saccharomyces cerevisiae strains and plasmids used in this study are listed in Table 1 and 2 
respectively. The primers used in this study are mentioned in Table 3. Gene fragments, used for 
C-terminal tagging (gene integrations) or gene deletions, were amplified in a PCR reaction 
using Phusion DNA polymerase (Thermo Fisher Scientific). All gene integrations were 
confirmed by colony PCR using Phire Hot Start II DNA polymerase (Thermo Fisher Scientific). 
Gene deletions were checked by colony PCR as well as southern blotting analysis of 
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chromosomal DNA, using the ECL Direct Nucleic Acid Labelling and Detection system 
(Thermo Fisher Scientific), according to the protocol provided by the manufacturer. 
Preparation of S. cerevisiae competent cells and transformations were performed as 
described previously (Knop et al., 1999). Cells were grown overnight at 30°C in 10 mL YPD 
medium. The OD600 of the overnight culture was measured and cells were diluted to 0.15 OD 
in 50 mL YPD medium. After growth at 30°C to an OD of 0.9, cells were pelleted by 
centrifugation at 5000 rpm for 5 min, washed with sterile water twice and with 1M sorbitol 
once. Cells were then resuspended in 300 μL of 1 M Sorbitol, stored at -80℃ or used directly 
for performing transformations. For each transformation - 50 μL of competent cells, 12-15 μL 
of PCR product, 40 μL pre-boiled salmon sperm DNA (boiled at 100℃ for 10 min and 
immediately cooled on ice-water) and 300 μL Li-AC solution mix (800 μL mL 50% PEG-3350, 
100 μL 100 mM Tris-HCl pH7.5 with 10 mM EDTA and 100 μL 1M Lithium acetate) were 
mixed together and incubated at 30℃ for at least 30 mins. Followed by this 40 μL DMSO was 
added, heat shock was performed at 42℃ for at least 15 mins and cells were immediately placed 
on ice for 1 mins. Cells were then collected by brief centrifugation, washed with 1mL YPD and 
finally resuspended in 4 mL YPD. After 2-3 hrs of incubation at 30℃, cells were pelleted down 
and plated on YPD plates containing appropriate antibiotics or on YND plates containing 
required amino acids. Plates were incubated at 30℃ for 2 to 3 days.  
Construction of S. cerevisiae Pxa1-tFT  
 In order to fuse tFT tag to the C-terminus of PXA1, first the tFT tagging module along with 
~50bp flanking regions homologous to C-terminus of PXA1 was amplified in a PCR reaction 
using plasmid pMaM168 as a template and primers Int-Pxa1-Fwd and Int-Pxa1-Rev. The tFT 
tagging cassette consists of full-length mCherry sequence, selection marker (URA3 gene), two 
I-SceI cut sequences, mCherryΔN (sequences coding for mCherry lacking last 91 amino acids) 
and full-length sfGFP sequences (Fig 1C). The amplified PCR product was then transformed 
into the wild-type strain (yMaM330) that expresses I-SceI coding sequences under the control 
of GAL1 promoter (Table 1). Cells were then plated on YND plates containing 30 mg/L leucine, 
20mg/L histidine and 20mg/L methionine and incubated at 30℃ for minimum of 3 days. Correct 
integration of tFT module or the positive transformants of Pxa1-tFT were checked by colony 
PCR using primers IPxa1-cPCR-Fwd and IPxa1-cPCR-Rev 
Construction of S. cerevisiae faa2.Pxa1-tFT and pxa1 faa2 
Saccharomyces cerevisiae faa2.Pxa1-tFT strain was constructed by replacing Faa2 region in 
Pxa1-tFT strain with geneticin resistance gene. The deletion of faa2 was performed as follows: 
First, a PCR fragment containing kanMX sequences (coding for geneticin marker) and ~50bp 
of the FAA2 flanking regions were amplified from the plasmid pFA6a-kanMX using the primers 
Del-KFaa2-Fwd and Del-KFaa2-Rev. The resulting PCR cassette or FAA2 deletion cassette 
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was transformed into Pxa1-tFT strain, cells were plated on YPD plates containing 150 μg/ml 
Geneticin (Invitrogen) and incubated at 30°C for 2-3 days. Positive transformants of faa2.Pxa1-
tFT, grown on YPD selective plates, were selected and checked by colony PCR using primers 
DKFaa2-cPCR-Fwd and DKFaa2-cPCR -Rev. The obtained positive transformants were 
further checked by southern blotting to confirm FAA2 deletion in Pxa1-tFT. 
For the construction of pxa1 faa2 strain, first PXA1 was deleted in yMaM330 (wild-type) 
strain to create pxa1 strain. Followed by this, FAA2 was replaced by URA3 gene in pxa1 strain 
to create pxa1 faa2 double deletion strain. To construct pxa1 strain, a PXA1 deletion cassette 
containing hygromycin (hphMX) resistance gene along with 45- 50bp homologous sequences 
in the PXA1 region were amplified from the plasmid pHIPH-Pex14 mKate2 using the primers 
Del-Pxa1-Fwd and Del-Pxa1-Rev. The obtained PXA1 deletion cassette was transformed into 
yMaM330 and cells were plated on YPD plates containing 300 μg/ml Hygromycin (Invitrogen). 
Hygromycin resistant transformants were selected and checked by colony PCR using primers 
DPxa1-cPCR-Fwd and DPxa1-cPCR-Rev. The deletion of PXA1 in yMaM330 was further 
confirmed by southern blotting. With the newly obtained pxa1 strain, FAA2 deletion cassette 
was amplified from pMaM168 using the primers Del-UFaa2-Fwd and Del-UFaa2-Rev. The 
cassette containing URA3 resistance gene and ~50bp FAA2 flanking regions was transformed 
into pxa1 and cells were plated on YND plates containing 30 mg/L leucine, 20mg/L histidine 
and 20mg/L methionine. The positive transformants of FAA2 deletion in pxa1 were checked by 
colony PCR using primers DUFaa2-cPCR-Fwd and DUFaa2-cPCR -Rev. In addition to colony 
PCR, the obtained positive transformants were further checked by southern blotting to confirm 
FAA2 deletion in pxa1. 
Culture conditions 
Yeast cells were cultured overnight at 30°C on YM2 medium (6.7 g/L yeast nitrogen base 
without amino acids (YNB, Difco), 1% Caesin hydrolysate (Sigma-Aldrich), 60 mg/L uracil, 
60 mg/L tryptophan) containing 2% glucose. Cells were then diluted to OD600 of 0.1 in YM2 
medium plus 0.3% glucose and grown for 7-9 hrs. To induce peroxisome proliferation, cells 
grown on YM2 medium plus 0.3% glucose were transferred to YNO-glucose or oleate-plus 
medium (6.7 g/L YNB, 1% casein hydrolysate, 60 mg/L uracil, 60 mg/L tryptophan, 0.5% 
tween, 0.1% oleate and 0.1% glucose). In oleate-plus medium cells were grown to an OD of 
1.5, after which cells were harvested for TCA lysate preparation, fluorescence microscopy or 
cycloheximide (CHX) chase experiment. For CHX chase analysis, cells were treated with 
cycloheximide (CHX, Sigma-Aldrich), a protein synthesis inhibitor, to a final concentration of 





Preparation of yeast TCA lysates 
TCA lysates were prepared using cells grown on oleate-plus medium to OD of 1.5. Cell extracts 
of TCA-treated cells were prepared for SDS-PAGE as described previously (Baerends et al., 
2000b). SDS-PAGE and western blotting were performed by established methods. Equal 
amounts of protein were loaded per lane and blots were probed with antibodies against mGFP 
(Santa Cruz Biotech, sc-9996), pyruvate carboxylase 1 (Pyc) and glucose 6 phosphate 
dehydrogenase (G6PD). Secondary goat anti-rabbit (Thermo Fisher Scientific, 31460) antibody 
conjugated to alkaline phosphatase or goat anti-mouse (Thermo Fisher Scientific, 31430) 
antibody conjugated to horseradish peroxidase were used for detection. Pyc and G6PD was 
used as a loading control.  
Quantification of Western blots 
Western blots were scanned using a densitometer (Bio-Rad, GS-710) and protein levels were 
quantified using Image J software (https://imagej.nih.gov/ij/). For CHX chase experiments, the 
intensity of each band measured was normalized by dividing by the intensity of the 
corresponding Pyc band (loading control). The normalized values at time point 0 was set to 1.0 
and values obtained after CHX addition at indicated time points are displayed as a fraction of 0 
values. Standard deviations were calculated using Excel. The data presented are derived from 
three independent experiments.  
Seamless marker excision and stability analysis of PMP-tFT fusions in vivo 
Tandem fluorescent protein timers (tFT): mCherry and sfGFP were endogenously tagged to 
PMPs listed in Fig 1D as described (Khmelinskii et al., 2011). Cells expressing PMP-tFT 
fusions were grown to saturation (24 h at 30°C) in SC medium (6.7 g/L YNB, 2g/L amino acid 
dropout mix (-URA)) plus 2% glucose. After 24h of growth on SC plus 2% glucose, cells were 
then spotted on glucose plates (SC medium containing 2% glucose and 2% agar) using a RoToR 
pinning robot (Singer Instruments) and incubated for 24 h at 30°C. For seamless URA3 marker 
excision, colonies were then pinned onto galactose plates (SC medium containing 2% galactose, 
2% Raffinose and 2% agar) to induce expression of I-SceI and grown for 24 h at 30°C. 
Subsequent pinning onto glucose plates (i.e. SC medium lacking uracil) was used to assess the 
efficiency of marker excision. Pinning from galactose plates onto 5-FOA plates (SC medium 
plus 2% glucose and 1g/L 5-fluoroorotic acid (5-FOA) was used to remove cells that had not 
lost the ScURA3 marker (Figure 2A–C). Followed by this cells were pinned on to glucose plates 
(6.7 g/L YNB, 2g/L amino acid dropout mix (-LEU), 2 % glucose and 2% agar) and oleate-plus 
plates (6.7 g/L YNB, 2g/L amino acid dropout mix (-LEU), 0.5% tween, 0.1% oleate, 0.1% 
glucose and 2% agar). Using Infinite M1000 Pro plate reader equipped with automatic plate 
loading stackers (Tecan) and custom temperature control chambers, mCherry intensity (587/10 
nm excitation, 610/10 nm emission) and sfGFP intensity (488/10nm excitation, 510/10 nm 
Investigating peroxisomal membrane protein turnover with tandem fluorescent timer
93
2
emission) were measured from colonies grown on glucose and oleate-plus plates. First set of 
measurements were taken after 24h (1 day) of growth and measurements were taken every 24h 
until 96h (4 days). 
Whole colony fluorescence intensities (mCherry and sfGFP), obtained from PMP-tFT 
fusions in cells were corrected for auto fluorescence by subtracting the intensity measurements 
obtained with the control strain, yMaM344 (expressing non-fluorescent protein). The values 
obtained were then corrected for median effects by dividing the median of fluorescence 
intensities (mCherry and sfGFP) obtained after auto fluorescence correction from PMP-tFT 
fusions in cells. The corrected values of mCherry divided by the sfGFP values yielded a ratio, 
representing the stability of PMP-tFT fusions in cells. The heat map generated using the ratios 
are presented in Fig 2. 
Fluorescence microscopy 
All images were captured at room temperature using an inverted microscope (Axio Scope A1, 
100×1.30 NA Plan-Neofluar objective, Carl Zeiss), Micro-Manager software and a digital 
camera (CoolSNAP HQ2; Photometrics). For wide field microscopy, GFP fluorescence was 
visualized with a 470/440-nm band pass excitation filter, a 495-nm dichromatic mirror, and 
525/50-nm band pass emission filter. mCherry fluorescence was visualized with a 587/25-nm 
band pass excitation filter, a 605-nm dichromatic mirror, and 647/70-nm band pass emission 
filter. 
For localization analysis, cells were grown on oleate-plus medium to an OD600 of 1.5 and 
images were captured. The acquired images were processed using Image J software 
(https://imagej.nih.gov/ij/) with optimal settings. sfGFP (200, 700) and mCherry (200, 400) 
settings were used to process images of WT and Pxa1-tFT. For Pex13-tFT: sfGFP (200, 800) 
and mCherry (200, 400) and for Pex11-tFT: sfGFP (200, 8000) and mCherry (200, 5000) 
settings were used. Scale bar represents 3µm. For figure preparation, Adobe Photoshop CS6 
and Adobe Illustrator CC 2018 was used. 
Spot assay 
Yeast strains were grown overnight at 30 °C on YM2 medium containing 2% glucose and 
shifted to YM2 medium plus 0.3% glucose. After 6h of growth in YM2 plus 0.3% glucose, cells 
were diluted to 0.1 OD and ten-fold serial dilutions were made up to 0.0001 OD. From every 
dilution, 3 μL yeast cells were spotted onto oleate plates containing 6.7 g/L YNB, 1 g/L SCSM–
LEU dropout mix (Hopkins mixture, FOR MEDIUM), 180 mg/L leucine, 0.1% oleate, 0.05% 
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TABLE 1- Saccharomyces cerevisiae strains used in this study 
 
Strain Description [ genotype] Reference 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 (Khmelinskii et al., 2014) (Knop lab) 
BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Reference 
yMaM330 [Wild type- 
WT] 
MATalpha his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
can1Δ:: STE2pr-spHIS5 lyp1Δ::STE3pr-
LEU2  
leu2Δ::GAL1pr-I-SCEI-natNT2                               
(Khmelinskii et al., 
2014) (Knop lab) 




(Khmelinskii et al., 
2014) (Knop lab) 
Pex2-tFT yMaM330, PEX2::mCherry-sfGFP [URA3] Knop lab 
Pex3-tFT yMaM330, PEX3::mCherry-sfGFP [URA3] Knop lab 
Pex10-tFT yMaM330, PEX10::mCherry-sfGFP [URA3] Knop lab 
Pex11-tFT yMaM330, PEX11::mCherry-sfGFP [URA3] Knop lab 
Pex12-tFT yMaM330, PEX12::mCherry-sfGFP [URA3] Knop lab 
Pex13-tFT yMaM330, PEX13::mCherry-sfGFP [URA3] Knop lab 
Pex14-tFT yMaM330, PEX14::mCherry-sfGFP [URA3] Knop lab 
Pex17-tFT yMaM330, PEX17::mCherry-sfGFP [URA3] Knop lab 
Pex22-tFT yMaM330, PEX22::mCherry-sfGFP [URA3] Knop lab 
Pex25-tFT yMaM330, PEX25::mCherry-sfGFP [URA3] Knop lab 
Pex27-tFT yMaM330, PEX27::mCherry-sfGFP [URA3] Knop lab 
Ant1-tFT yMaM330, ANT1::mCherry-sfGFP [URA3] Knop lab 
Pxa1-tFT yMaM330, PXA1::mCherry-sfGFP [URA3] This study 
Inp1-tFT yMaM330, INP1::mCherry-sfGFP [URA3] Knop lab 
Inp2-tFT yMaM330, INP2::mCherry-sfGFP [URA3] Knop lab 
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faa2.Pxa1-tFT faa2 deletion in PXA1-tFT, faa2::kanMX This study 
pxa1 pxa1 deletion, yMaM330, pxa1::hphMX This study 
pxa1faa2 faa2 deletion in pxa1, faa2::URA3 This study 
pex4 pex4 deletion strain, BY4741, pex4::kanMX Knop lab 
pex13 pex13 deletion strain, BY4742, pex13::kanMX Euroscarf 
 
TABLE 2- Plasmids used in this study 
 
Plasmid Description Use Reference 
pMaM168 





1. C-terminal tFT 
tagging ; PXA1-tFT 
integration into 
yMaM330 
Gene disruption (faa2) 
by URA3 marker 
(Khmelinskii et 







pFA6a plasmid containing 
geneticin (kanMX6) resistance 
gene; kanMX, AmpR 
2. Gene disruption 
(faa2) by kanMX6 
marker 
(Khmelinskii et 





pHIPH containing mKate2 and 
C-terminal of PEX14 ; hphMX, 
AmpR 
Gene disruption 
(pxa1) by hphMX 
marker 
(Chen et al., 
2018)  
 
TABLE 3- Oligonucleotides (primers) used in this study 
 






To amplify a fragment of 3211 bp from 
pMaM168, PCR fragment contains tFT 
module and ~50bp flanking regions 
homologous in the C-terminus of the Pxa1 






To amplify a fragment of 3211 bp from 
pMaM168, PCR fragment contains tFT 
module and ~50bp flanking regions 
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homologous in the C-terminus of the Pxa1 
region; used to construct Pxa1-tFT strain 
IPxa1-cPCR-Fwd AGATGCCATTGCCGATTGGA 
Colony PCR- forward primer, to check 
positive transformants of Pxa1-tFT 
(expected size- 803 bp) 
IPxa1-cPCR-Rev AGATGAACTCGCCGTCCTGC 
Colony PCR- reverse primer, to check 







To amplify a fragment of 1607 bp from 
pFa6A-kanMX, PCR fragment contains 
kanMX resistance gene and ~50 bp 
flanking FAA2 region; used to construct 
faa2 (deletion) strain 
 
Del-KFaa2-Rev 





To amplify a fragment of 1607 bp from 
pFa6A-kanMX, PCR fragment contains 
kanMX resistance gene and ~50 bp 
flanking FAA2 region; used to construct 
faa2 (deletion) strain 
 
DKFaa2-cPCR-Fwd CAGAACATCCTCCGGACCGT 
Colony PCR- forward primer, to check 
positive transformants of faa2 (expected 
size- 790 bp) 
 
DKFaa2-cPCR-Rev AGAAACAACTCTGGCGCATCG 
Colony PCR- forward primer, to check 
positive transformants of faa2 (expected 







To amplify 1851 bp fragment from pHIPH-
Pex14mKate2, PCR fragment contains 45-
50 bp homologous sequence in Pxa1 region 
and Hygromycin resistance gene; used to 







To amplify 1851 bp fragment from pHIPH-
Pex14mKate2, PCR fragment contains 45-
50 bp homologous sequence in Pxa1 region 
and Hygromycin resistance gene; used to 
construct pxa1 strain  
 




Colony PCR- forward primer, to check 
positive transformants of pxa1(expected 
size- 790 bp) 
 
DPxa1-cPCR-Rev ACCTCCTTTGGCCTTCAATC 
Colony PCR- forward primer, to check 
positive transformants of pxa1(expected 







To amplify 1232 bp fragment from 
pMaM168, PCR fragment contains URA3 
sequence and ~50 bp homologous 
sequence in Faa2 region; used to delete 
FAA2 in pxa1 strain  
 
Del-UFaa2-Rev 





To amplify 1232 bp fragment from 
pMaM168, PCR fragment contains URA3 
sequence and ~50 bp homologous 
sequence in Faa2 region; used to delete 
FAA2 in pxa1 strain  
 
DUFaa2-cPCR-Fwd CAGAACATCCTCCGGACCGT 
Colony PCR- forward primer, to check 
positive transformants of FAA2 deletion in 
pxa1 (expected size- 477 bp) 
 
DUFaa2-cPCR-Rev TAGGATGAGTAGCAGCACG 
Colony PCR- forward primer, to check 
positive transformants of FAA2 deletion in 
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Peroxisomes are eukaryotic organelles that function in numerous metabolic pathways and defects in 
peroxisome function can cause serious developmental brain disorders such as adrenoleukodystrophy 
(ALD). Peroxisomal membrane proteins (PMPs) play a crucial role in regulating peroxisome function. 
Therefore, PMP homeostasis is vital for peroxisome function. Recently, we established that certain 
PMPs are degraded by the Ubiquitin Proteasome System (UPS) yet little is known about how faulty/non-
functional PMPs are targeted for degradation via quality control. Here we have investigated the 
degradation of Pxa1p, a fatty acid transporter in the yeast Saccharomyces cerevisiae. Pxa1p is a 
homologue of the human protein ALDP and mutations in ALDP result in the severe disorder ALD. By 
introducing two corresponding ALDP mutations into Pxa1 (Pxa1MUT), fused to mGFP, we show that 
Pxa1MUT-mGFP is rapidly degraded from peroxisomes in a proteasome-dependent manner, while wild 
type Pxa1-mGFP remains relatively stable. Furthermore, we identify a role for the ubiquitin ligase Ufd4p 
in Pxa1MUT-mGFP degradation. Finally, we establish that inhibiting Pxa1MUT-mGFP degradation results 
in a partial rescue of Pxa1p activity in cells. Together, our data demonstrate that faulty PMPs can 
undergo proteasome-dependent quality control. Furthermore, our observations may provide new 
insights into the role of ALDP degradation in ALD. 
 
 




















Peroxisomes are eukaryotic organelles that encompass a protein-rich matrix bound by a single 
membrane. Their morphology, abundance and function depends on species and developmental 
stage (Gabaldon, 2010). Some well-known peroxisomal functions include fatty acid oxidation 
and hydrogen peroxide detoxification, but many more exist (Smith and Aitchison, 2013). Their 
importance in human health is underlined by the severe diseases such as adrenoleukodystrophy 
(ALD) caused by defects in peroxisome function (Kemp et al., 2016).  
Peroxisome function is largely determined by peroxisomal protein content. Most 
peroxisomal membrane proteins (PMPs) are synthesized in the cytosol and targeted directly to 
peroxisomes (Nuttall et al., 2011) although a subset of PMPs may be delivered to peroxisomes 
via the endoplasmic reticulum (Mayerhofer, 2016). PMPs regulate many aspects of peroxisome 
biology, including peroxisomal protein import (Fang et al., 2004), peroxisome numbers 
(Williams et al., 2015) and small molecule transport into peroxisomes (van Roermund et al., 
2012). For peroxisome function, PMP homeostasis is vital; this includes the regulation of 
targeting but also protein quality control processes and protein degradation. Recently, we 
demonstrated that the PMPs Pex3p and Pex13p in the yeast Hansenula polymorpha are actively 
down-regulated (Chen et al., 2018; Williams and van der Klei, 2013). Pex3p degradation 
initiates selective autophagy of peroxisomes while Pex13p degradation is linked to peroxisomal 
matrix protein import. Both Pex3p and Pex13p are degraded by the Ubiquitin Proteasome 
System (UPS) (Bett, 2016). In this system, ubiquitin (Ub) is activated by a ubiquitin-activating 
enzyme (E1), then transferred to the active site cysteine of an ubiquitin-conjugating enzyme 
(E2) and finally, Ub is attached to the substrate with the aid of an ubiquitin ligase (E3) (Metzger 
and Weissman, 2010; Schulman and Harper, 2009; Ye and Rape, 2009). Three classes of E3s 
exist. HECT E3 ligases accept Ub onto an active site cysteine and then transfer Ub to a substrate 
(Metzger et al., 2012; Weber et al., 2019), whereas RING E3 ligases act as bridge between E2 
and substrate, allowing Ub transfer to occur (Deshaies and Joazeiro, 2009; Metzger et al., 2014). 
The third class of E3 ligase, known as RING-in-between-RING (RBR) E3s, contain a RING 
domain, followed by an RBR domain and finally a RING-like domain (Wenzel et al., 2011). 
These RBR E3s, like HECT E3s, accept Ub from an E2 onto a cysteine in the RING-like domain 
before transferring it to the substrate (Dove et al., 2016). 
The examples of Pex3p and Pex13p demonstrate that targeted down-regulation of PMPs 
does occur. However, because peroxisomes are involved in various oxidative metabolic 
reactions, they can generate large amounts of reactive oxygen species (ROS) such as hydrogen 
peroxide (Schrader and Fahimi, 2006). Because ROS are toxic compounds which cause damage 
to biomolecules (Costa et al., 2007), it is highly likely that PMPs residing in the ROS rich 
environment of the peroxisome undergo oxidative damage. Therefore, PMP quality control is 
likely to play a vital role in peroxisome biology yet to date little is known on how misfolded, 
non-functional or faulty PMPs are targeted for degradation via quality control. Here we have 
investigated PMP quality control in the yeast Saccharomyces cerevisiae using Pxa1p as 
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substrate. Pxa1p is a half-ABC transporter, containing six transmembrane helices and a 
nucleotide-binding domain (NBD). The hetero-dimerization of Pxa1p with Pxa2p, another half-
ABC transporter, is required for transporting acyl-CoA such as Oleoyl-CoA into peroxisomes 
(Hettema et al., 1996; Shani et al., 1996). Pxa1p is the homologue of human 
adrenoleukodystrophy protein (ALDP) (Shani et al., 1995). Mutations in ALDP cause ALD 
(Engelen et al., 2014) and many ALDP mutants are rapidly degraded, likely by the proteasome 
(Morita et al., 2019) . This has led to the suggestion that blocking ALDP degradation might 
constitute a feasible therapeutic approach to treat ALD (Morita et al., 2019; Zhang et al., 2011). 
However, to date little is known about the mechanisms underlying ALDP instability or 
degradation. 
Using a mutant form of Pxa1p (Pxa1MUT) that mimics ALD-causing ALDP mutations, 
fused to mGFP, we show that Pxa1MUT-mGFP is rapidly degraded from peroxisomes. 
Furthermore, we show that Pxa1MUT-mGFP degradation is dependent on the proteasome while 
our data also demonstrate a role for the E3 ligase Ufd4p in Pxa1MUT-mGFP degradation. Finally, 
we show that inhibiting Pxa1MUT-GFP degradation partially restores Pxa1p function in vivo. 
Taken together, our study demonstrates that faulty PMPs can undergo proteasome-mediated 
degradation. Furthermore, our observations on Pxa1MUT-mGFP degradation may provide new 
insights into the role of ALDP stability in ALD. 
 
Results  
Pxa1MUT-mGFP undergoes proteasome-mediated degradation from peroxisomes 
Unlike wild-type (WT) ALDP, many mutant versions of ALDP are unstable and are rapidly 
degraded (Takahashi et al., 2007; Yamada et al., 1997), suggesting that quality control of faulty 
peroxisomal fatty acid transporters occurs. To investigate this in S. cerevisiae, we chose to study 
the degradation of the yeast ALDP homologue Pxa1p. For this, we selected two ALD causing 
mutations in ALDP, a commonly occurring glycine to serine substitution at position 512 
(p.Gly512Ser) together with a lysine to arginine substitution at position 513 (p.Lys513Arg), 
both present in the walker A motif of the NBD (www.adrenoleukodystrophy.info). The 
p.Gly512Ser mutation causes reduced protein stability in vivo (Feigenbaum et al., 1996) 
although importantly, it does not abolish ATP-hydrolysis activity in vitro (Roerig et al., 2001). 
The p.Lys513Arg mutation also causes protein instability in vivo 
(www.adrenoleukodystrophy.info). The corresponding ALDP mutations (p.Gly650Ser and 
p.Lys651Arg) were both introduced into yeast PXA1. We chose to introduce two mutations to 
maximize the destabilizing effect to Pxa1p. The Gly650Ser/Lys651Arg mutant form of Pxa1p 
is referred to as Pxa1MUT. We choose to fuse Pxa1MUT to mGFP (Pxa1MUT-mGFP), which 
allowed us to follow Pxa1MUT using both biochemical and microscopy based techniques. 
Furthermore, the DNA encoding for Pxa1MUT-mGFP was integrated into the genome of the S. 
cerevisiae strains used and therefore represents the only copy of PXA1 in the cells.  
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Since Pxa1p functions in transporting fatty acyl-CoA, such as Oleoyl-CoA, into 
peroxisomes for β-oxidation (Hettema et al., 1996; Shani et al., 1996), we performed all our 
experiments using cells grown on oleate containing media, to better understand the turnover of 
Pxa1MUT-mGFP under conditions when the protein is required. For this purpose, S. cerevisiae 
cells were pre-cultivated on glucose medium and shifted to oleate medium, to induce the 
expression of the proteins required for peroxisomal β-oxidation (Gurvitz and Rottensteiner, 
2006; Karpichev and Small, 1998; Smith et al., 2002). However, because we performed 
experiments using deletion mutants that are unable to utilize oleate as carbon source (see 
below), we used oleate medium containing 0.1% glucose throughout the study, to allow results 
to be comparable. Therefore unless otherwise stated, oleate medium always contained 0.1% 
glucose.  
First, we investigated whether Pxa1MUT-mGFP is properly targeted to peroxisomes. For 
this, we used fluorescence microscopy to examine the localization of Pxa1MUT-mGFP in cells 
grown on oleate. Pex3-mKate2 (Figure 1A) or DsRed-SKL (Figure S1A) was used as a marker 
for peroxisomes. As control, we used cells producing an mGFP-tagged version of WT Pxa1p 
(Pxa1-mGFP). We observed that mGFP spots co-localized with mKate2 spots in strains 
expressing Pxa1-mGFP (Figure 1A, row 4) or Pxa1MUT-mGFP (Figure 1A, row 6) while line 
profile data indicate a strong correlation between the normalized fluorescent intensity of mGFP 
and mKate2 (Figure 1A, row 4 and row 6, right), indicating that both Pxa1-fusions correctly 
target to peroxisomes. Likewise, mGFP spots co-localized with DsRed spots in cells expressing 
Pxa1MUT-mGFP and DsRed-SKL (Figure S1A), confirming that Pxa1MUT-mGFP correctly 
targets to peroxisomes. We also observed larger, more diffuse spots in both mGFP and mKate2 
channels (Figure 1A, red arrows). However, these were also seen in WT cells lacking 
fluorescent markers (Figure 1A, row 1) and likely represent auto-fluorescence.  
The mGFP signal in cells expressing Pxa1MUT-mGFP was lower and fewer GFP spots 
were visible compared to those expressing Pxa1-mGFP (Figure 1A, row 6), which is consistent 
with the reduced protein levels of Pxa1MUT-mGFP compared to those of Pxa1-mGFP (Figure 
1B, 1C and S1C). Lower protein levels could suggest either reduction in protein production or 
reduced protein stability. To examine the stability of Pxa1MUT-mGFP we performed chase 
analysis using the protein synthesis inhibitor cycloheximide (CHX). For this purpose, cells were 
pre-cultivated on glucose, transferred to oleate containing media (peroxisome inducing 
conditions) and grown for 11 hrs until an OD600 of ~1.5. After 11 hrs of growth in oleate 
containing media, cells were treated with either CHX or DMSO (control), cells were grown 
further for 6 hrs (Pxa1-mGFP) or 2hrs (Pxa1MUT-mGFP) on inducing medium and samples were 








Figure 1: Pxa1MUT-mGFP targets to peroxisomes but displays reduced protein levels 
A. Pxa1-mGFP and Pxa1MUT-mGFP localization in cells co-expressing Pex3-mKate2 (row 4 and 6). Cells pre-
cultivated on glucose were grown on oleate/glucose media to an OD600 of 1.5 and fluorescence images were 
taken. Here, a WT strain lacking fluorescent markers (row 1) together with WT strains expressing only Pex3-
mKate2 (row 2), Pxa1-mGFP (row 3) or Pxa1MUT-mGFP (row 5) act as controls. Blue arrows- GFP spots, 
yellow arrows- mKate2 spots and red arrows- background fluorescence. The line profiles (taken from the spots 
indicated with blue or yellow lines in images of WT.Pxa1-mGFP + Pex3-mKate2 and Pxa1MUT-mGFP + Pex3-
mKate2 cells) indicate normalized fluorescent intensity along a line drawn through the peroxisomes (dotted 
yellow line). Scale bar: 3 μm.  
B. Cells expressing Pxa1-mGFP or Pxa1MUT-mGFP were grown on oleate/glucose media to an OD600 of 1.5, lysed 
and samples were subjected to SDS-PAGE and immunoblotting with antibodies against mGFP and Pyc.  
C. Bar chart displaying Pxa1-mGFP and Pxa1MUT-mGFP levels, normalized to the loading control Pyc. Protein 
levels in Pxa1-mGFP cells were set to 1. Values represent the mean ± SD of three independent experiments. 
Here, asterisks represent statistically significant decrease in Pxa1MUT-mGFP levels compared to Pxa1-mGFP 
levels. For quantification, blots in Figure S1C were used.  
We observed an increase in Pxa1-mGFP and Pxa1MUT-mGFP levels in DMSO-treated 
cells over time (Figure 2A, DMSO), consistent with the observation that Pxa1-mGFP levels 
continue to increase until ~36 hrs after transfer of cells to induction medium (Figure S1D). 
Significantly, Pxa1MUT-mGFP was rapidly degraded and displayed a significantly shorter half-
life (~15 mins) compared to Pxa1-mGFP (~360 mins or 6 hrs) (Figure 2A, CHX and S1E) in 
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Figure 2: Pxa1MUT-mGFP is rapidly degraded from peroxisomes 
A. Cycloheximide (CHX) chase analysis on cells expressing Pxa1-mGFP and Pxa1MUT-mGFP. (Left) Cells pre-
cultivated on glucose media were grown on oleate/glucose media (inducing condition) to an OD600 of 1.5. After 
treatment with DMSO (Ctrl) or CHX, cells were grown further on inducing medium and samples were collected 
at the indicated time points for immunoblotting with antibodies against mGFP and Pyc. (Right) Quantification 
of Pxa1-mGFP and Pxa1MUT-mGFP levels after CHX addition. Protein levels were normalized to Pyc at the 
corresponding time point and to the protein levels at time point 0 (set to 1). Values represent the mean ± SD of 
three independent experiments. For quantification, blots in Figure S1E were used.  
B. Co-localization analysis of Pxa1-mGFP (Left) and Pxa1MUT-mGFP (Right) with the peroxisomal marker Pex3-
mKate2 after CHX treatment. Cells expressing Pxa1-mGFP or Pxa1MUT-mGFP together with Pex3-mKate2 
were grown on oleate/glucose media to an OD600 of 1.5 and treated with CHX. Fluorescence images were taken 
from cells grown on oleate/glucose media at the indicated time points (mins) after CHX addition. Blue arrows- 
GFP spots, yellow arrows- mKate2 spots and red arrows- background fluorescence. Scale bar: 3 μm. Line 
profiles were generated as described in Figure 1.  
C. Box plot quantification of mGFP and mKate2 fluorescence intensity at the peroxisomal membrane in WT cells 
producing Pex3-mKate2 and Pxa1-mGFP (Left) or Pxa1MUT-mGFP (Right) after CHX treatment. Fluorescence 
intensities were measured in cells (n=40) using ImageJ as described in the materials and methods section. The 
box represents intensity values from the 25th  percentile to the 75th  percentile. The orange area represents 
intensity values from the 25th  -50th  percentile and the grey area represents intensity values from the 50th -75th  
percentile. Whiskers indicate maximum and minimum values. 
D. Average ratio ± SD per cell (n = 40) of mGFP to mKate intensities in WT cells producing Pex3-mKate2 and 
Pxa1-mGFP (Left) or Pxa1MUT-mGFP (Right). Numbers above the columns (Left) depict the p-value. Asterisks 
(Right) denote significance between ratios at different time points, ** P <0.01- statistically significant (Right) 
and P> 0.05- not significant (Left). 
Next, we sought to determine whether Pxa1MUT-mGFP degradation occurs after 
targeting to peroxisomes. For this, we imaged CHX treated WT cells co-expressing Pex3-
mKate2 and Pxa1-mGFP or Pxa1MUT-mGFP. We observed that the number of mGFP positive 
spots reduced over time in cells expressing Pxa1MUT-mGFP (Figure 2B, right panel) while cells 
expressing Pxa1-mGFP displayed many more mGFP positive spots after 120 mins of CHX 
treatment (Figure 2B, left panel). The number of mKate2 spots remained stable after CHX 
treatment in both strains (Figure 2B). These observations suggest that Pxa1MUT-mGFP is 
degraded from peroxisomes. To validate this further, we quantified mGFP and mKate2 
fluorescence intensities on peroxisomes in our fluorescent images. We observed that, as 
expected, the mKate2 intensity remained stable over time in the two strains (Figure 2C). 
Likewise, the mGFP intensity on peroxisomes in CHX-treated Pxa1-mGFP cells remained 
stable (Figure 2C, left panel) but decreased rapidly in Pxa1MUT-mGFP cells treated with CHX 
(Figure 2C, right panel). In addition, the mGFP/mKate2 ratio in CHX treated Pxa1MUT-mGFP 
cells decreased rapidly over time but remained stable in Pxa1-mGFP cells after CHX addition 
(Figure 2D). The rate of the decrease in mGFP intensity in Pxa1MUT-mGFP cells treated with 
CHX appears different from that obtained using western blotting (Figure 2A), likely due to the 
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high background observed in the mGFP channel (Figure 1A, row 1 and 2). Together, these data 
strongly suggest that Pxa1MUT-mGFP is rapidly degraded from peroxisomes.  
Since ALDP mutants are thought to be degraded via the proteasome (Takahashi et al., 
2007), we first examined whether the proteasome has a role in Pxa1MUT-mGFP degradation, 
through the use of a mixture of the proteasome inhibitors MG132 and Bortezomib (Figure 3A 
and S1F). We assessed Pxa1MUT-mGFP turnover in cells lacking Pdr5p (the major drug efflux 
transporter (Golin et al., 2007)), to enhance the uptake of inhibitors (Dederer et al., 2019; 
Fleming et al., 2002). In addition, we examined Pxa1MUT-mGFP degradation in cells lacking 
Atg12p (Figure 3B and S1G), which is involved in autophagy (Hanada et al., 2007). From our 
CHX chase analysis, we observed that Pxa1MUT-mGFP degradation is inhibited in pdr5 cells 
after the addition of proteasome inhibitors (Figure 3A, CHX+ MG132+Bortezomib) compared 
to non-treated cells (Figure 3A, CHX). These data, together with the observation that the 
deletion of ATG12 had no effect on Pxa1MUT-mGFP turnover (Figure 3B and S1G) 
demonstrates that the proteasome is involved in Pxa1MUT-mGFP degradation. Next, we checked 
whether ubiquitination has a role in Pxa1MUT-mGFP degradation by expressing a mutant form 
of ubiquitin (UbK48R) in Pxa1MUT-mGFP cells, to inhibit poly-ubiquitin chain formation on the 
substrate and subsequent degradation by the proteasome (Thrower et al., 2000). We observed 
that Pxa1MUT-mGFP turnover is reduced in cells expressing UbK48R, compared to Ub expressing 
cells (Figure 3C and S1G). However, we were unable to detect ubiquitinated Pxa1MUT-mGFP 
(Figure 3D). Possibly ubiquitinated Pxa1MUT-mGFP is below the level of detection because of 
the high speed by which Pxa1MUT-mGFP is degraded. In summary, these data demonstrate that 





Figure 3: Inhibiting the proteasome but not autophagy disturbs Pxa1MUT-mGFP degradation  
A. Graph representing Pxa1MUT-mGFP levels in pdr5 cells under proteasome inhibitor (PI) conditions. pdr5 cells 
expressing Pxa1MUT-mGFP pre-cultivated on glucose were grown on oleate/glucose media for 10 h. After 
incubation with DMSO or proteasome inhibitors (MG132 and Bortezomib) for 90 mins, CHX was added to 
DMSO (represented as CHX) and PI treated cells (denoted as CHX+MG132+Bortezomib. TCA samples for 
western blotting were collected from cells grown on oleate/glucose media at the indicated time points after 
treatment with inhibitors. Protein levels were normalized to Pyc at the corresponding time point and to the 
protein levels at time point 0 (set to 1). Values represent the mean ± SD of three independent experiments. For 
quantification, blots in Figure S1F were used.  
B. Pxa1MUT-mGFP levels in WT and atg12 cells after CHX treatment. Cells pre-cultivated on glucose were grown 
on oleate/glucose media to an OD600 of 1.5 and treated with CHX. TCA samples were collected from cells 
grown on oleate/glucose at the indicated time points after CHX treatment and probed with western blotting. 
Protein levels were normalized to Pyc at the corresponding time point and to the protein levels at time point 0 
(set to 1). For quantification, blots in Figure S1G were used.  
C. Quantification of Pxa1MUT-mGFP levels in WT cells and cells expressing Myc-tagged ubiquitin (Ub) or 
ubiquitin mutant (UbK48R) after treatment with CHX. The experiment and quantification of levels were 
performed as mentioned in Figure 3B. Values represent the mean ± SD of three independent experiments. For 
quantification, blots in Figure S1G were used. 
D. Immunoprecipitation performed using anti-GFP antibodies on lysates from pdr5 cells, pdr5.Pxa1MUT-mGFP 
cells, pdr5.Pxa1MUT-mGFP/MycUb cells and pdr5.MycUb cells. Cells were pre-cultivated on glucose, 
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transferred to oleate/glucose media for 10 hrs and incubated with proteasome inhibitors (MG132 and 
Bortezomib) for 90 mins. Pxa1MUT-mGFP was immunoprecipitated under native conditions using GFP-trap 
magnetic beads. Load and elute fractions were subjected to immunoblotting with antibodies against the Myc-
tag (to detect Myc-ubiquitin) or the GFP-tag (to detect Pxa1MUT-mGFP). 
 
Identifying components required for Pxa1-tFT degradation 
To gain the first insights into mechanisms of Pxa1MUT-mGFP quality control, we set out to 
identify components required for Pxa1MUT-mGFP degradation using a tandem fluorescent 
protein timer (tFT). A tFT is a fusion of two fluorescent proteins; the slow maturing mCherry 
and the rapid maturing sfGFP (Figure 4A). When tagged to a protein of interest, the 
mCherry/sfGFP ratio provides information on protein stability. tFT fusions undergoing fast 
turnover are degraded prior to mCherry maturation, resulting in a low mCherry/sfGFP ratio, 
whereas the mCherry/sfGFP ratio increases for proteins with slower turnover (Khmelinskii et 
al., 2012). Similar to Pxa1MUT-mGFP, Pxa1-tFT levels in cells were much lower compared to 
Pxa1-mGFP levels (Figure 4B) while Pxa1-tFT was rapidly degraded in cells treated with CHX 
(Figure 4C and S1H). The turnover of tFT-tagged Pex11p, a stable PMP (Chen et al., 2018), 
was slower in comparison (Figure 4C and S1H). Furthermore, the GFP immunoreactive band 
at around 33kDa observed with samples containing Pxa1-tFT (Figure 4B and S1H, marked **) 
is derived from incomplete tFT processing by the proteasome (Khmelinskii et al., 2016), 
suggesting a role for the proteasome in Pxa1-tFT turnover. From these data, we conclude that, 
similar to Pxa1MUT-mGFP, Pxa1-tFT undergoes proteasome-mediated degradation and for this 




Figure 4: Identifying factors involved in Pxa1MUT-tFT degradation by tandem fluorescent timer  
A. Schematic representation of the Pxa1-tandem fluorescent timer (tFT) fusion. Pxa1p is fused to two fluorescent 
proteins with different maturation kinetics: rapidly maturing sfGFP and slow maturing mCherry. The 
fluorescent intensity ratio of mCherry to sfGFP provides information of Pxa1p stability. 
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B. WT cells together with cells expressing Pxa1-mGFP, Pxa1-tFT or Pxa1MUT-mGFP were initially grown on 
glucose, shifted to oleate/glucose media and grown until an OD600 of 1.5. After lysis, samples were probed by 
immunoblotting with antibodies against mGFP and Pyc. *denotes a shorter, mCherry-sfGFP product resulting 
from mCherry hydrolysis during TCA treatment (Gross et al., 2000; Khmelinskii et al., 2016) and ** denotes 
a tFT fragment produced by incomplete proteasomal processing (Khmelinskii et al., 2016). 
C. The stability of tFT tagged Pxa1p and Pex11p was assayed using CHX chase analysis. Cells pre-cultivated on 
glucose were grown on oleate/glucose media an OD600- 1.5. After treatment with CHX, cells were further grown 
on oleate/glucose media and samples collected at the indicated points were subjected for western blotting. 
Protein levels obtained at each time point were normalized to Pyc at the corresponding time point and to the 
protein levels at time point 0 (set to 1). Values represent the mean ± SD of three independent experiments. For 
quantification, blots in Figure S1H were used. 
D. Screen for components involved in Pxa1-tFT stability. WT and mutant cells expressing Pxa1-tFT were grown 
on oleate/glucose plates and fluorescent intensities were measured. The resulting mCherry/sfGFP ratio on the 
indicated days (1-3) were used to calculate the Z-score (see materials and methods). Z-score colour coded from 
blue (decrease) to red (increase), represents changes in Pxa1-tFT stability. Mutant strains with Z-score >1.0 
(indicated by *) on two of the three days tested were defined as potentially interesting.   
E. Western blot analysis of Pxa1-tFT levels in WT, atg12, pex2 and pex4 cells grown on oleate/glucose media to 
an OD600 of 1.5. After lysis, samples were probed by immunoblotting with antibodies against mGFP and Pyc. 
*denotes a shorter, mCherry-sfGFP product resulting from mCherry hydrolysis during TCA lysate preparation 
(Khmelinskii et al., 2016). The apparent discrepancy between the molecular weight of Pxa1-tFT in this panel 
and in Figure 4B is because samples here were run onto a 7.5% acrylamide SDS-PAGE gel while samples in 
4B were loaded onto a 10% acrylamide SDS-PAGE gel, resulting in a different run profile. 
Next, we investigated the stability of Pxa1-tFT in a library of 132 strains that lack a 
protein involved in protein degradation or which contained a mutant version of a protein 
involved in protein degradation (in case the deletion was lethal) using a synthetic genetic array 
(Schuldiner et al., 2005; Tong and Boone, 2006). This library represents a large fraction of the 
factors known to have a role in the degradation of proteins in yeast (see Table S2 for details on 
which strains were included in the library). The effect of the mutations on the stability of Pxa1-
tFT was examined using mCherry/sfGFP intensity ratios obtained from whole colonies after 
one, two and three days of growth on oleate/glucose plates. These mCherry/sfGFP ratios were 
used to calculate a heat map of Z-scores (Figure 4D), which depicts the stability of Pxa1-tFT in 
each strain. A strain displaying similar Pxa1-tFT stability as in WT cells would have a Z-score 
of 0 while strains with enhanced stability would exhibit a Z-score >0 (see materials and 
methods). Mutant strains that displayed an increase in Z-score >1.0 on two of the three days 
tested were considered as potential candidates that increased Pxa1-tFT stability. Pxa1-tFT 
stability was increased in cells lacking functional proteasomes (pre2, pre6, rpn10, rpt6-25 and 
ubp6 cells) but not in cells lacking Atg12p (Figure 4D), confirming a role for the proteasome 
in Pxa1-tFT stability. These results demonstrate that our tFT analysis is a valid way to identify 
factors potentially involved in Pxa1MUT-mGFP degradation.  
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Pxa1-tFT stability was increased in strains deleted for genes coding for the peroxisomal 
E2 Pex4p or one of the three peroxisomal E3 ligases Pex2p, Pex10p and Pex12p (Agne et al., 
2003) (Figure 4D). Consistent with this, Pxa1-tFT protein levels were enhanced in pex2 and 
pex4 cells (Figure 4E), thereby confirming our tFT data. Roles for these proteins in PMP 
ubiquitination/degradation have already been reported (Chen et al., 2018; Sargent et al., 2016; 
Williams and van der Klei, 2013), suggesting that common mechanisms may govern PMP 
ubiquitination and degradation. However, Pxa1-tFT stability was also enhanced in cells lacking 
a number of de-ubiquitinating enzymes (DUBs), which could suggest a role for these DUBs in 
the deubiquitination of Pxa1MUT-mGFP prior to proteasomal degradation. In addition, cells 
lacking the E3s Nam7p, Dma2p, Tul1p and Ufd4p, the E3 co-factor proteins Ela1p and Skp2p 
and the ubiquitin-binding protein Dsk2p (Supplementary Table S2), factors not previously 
associated with peroxisomes, also displayed enhanced Pxa1-tFT stability. Overall, our tFT 
analysis identified factors potentially involved in the degradation of faulty Pxa1p. 
 
Components involved in Pxa1-tFT stability play a role in Pxa1MUT-mGFP degradation 
Previously we demonstrated that the peroxisomal ubiquitination machinery is required for the 
degradation of the PMPs Pex3p and Pex13p (Chen et al., 2018; Williams and van der Klei, 
2013). Because deletion of PEX4, PEX2, PEX10 or PEX12 results in Pxa1-tFT stabilization 
(Figure 4D and 4E), we were interested to investigate whether they also had a role in Pxa1MUT-
mGFP degradation. Indeed, Pxa1MUT-mGFP levels were enhanced in cells deleted for PEX2 or 
PEX4 (Figure 5A and S2A) while Pxa1MUT-mGFP turnover was also inhibited in these cells 
(Figure 5B and S2B), validating our tFT data as well as indicating a role for these peroxisomal 
proteins in Pxa1MUT-mGFP degradation. Furthermore, Pxa1MUT-mGFP localised to 
peroxisomes in these strains (Figure 5C), indicating that stabilisation did not arise from 
mistargeting to other cell compartments. However, because cells deleted for PEX2 or PEX4 
also lack functional peroxisomes (Burkhart et al., 2014), we investigated the impact of 
peroxisome function alone on Pxa1MUT-mGFP turnover by assessing the stability and turnover 
of Pxa1MUT-mGFP in pex5 cells, which also lack functional peroxisomes (Van der Leij et al., 
1993). Our data demonstrate that Pxa1MUT-mGFP degradation was inhibited in pex5 cells 
(Figure 5A, B and S2B), suggesting that Pxa1MUT-mGFP degradation may be linked to 
peroxisome function. Again, Pxa1MUT-mGFP targeting was not impaired in pex5 cells (Figure 
5C). We observed that Pex3-mKate2 levels are comparable in WT, pex2, pex4 and pex5 cells 
(Figure S2C), suggesting that the effect of these deletion strains is not general for all PMPs. 
Nevertheless, these data indicate that studying Pxa1MUT-mGFP turnover in strains deficient in 
peroxisome function could be challenging because any effects may potentially be indirect.  
Therefore, we turned to investigate the role of candidates identified in our tFT analysis 
not previously associated with peroxisome function, including Ufd4p, Nam7p, Ela1p, Dsk2p, 
Skp2p, Tul1p and Dma2p. Interestingly, we observed that Pxa1MUT-mGFP levels were 
significantly higher in cells lacking Ufd4p (Figure 6A and S2A). Deletion of ELA1, DSK2, 
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SKP2, TUL1 or DMA2 did not impact significantly on Pxa1MUT-mGFP levels (Figure 6A and 
S2A) and were not investigated further. Furthermore, Pxa1MUT-mGFP levels were significantly 
lower in the NAM7 deletion strain compared to the WT (Figure 6A and S2A). However, because 
we were specifically interested in UPS mutants that increased the stability of Pxa1MUT-mGFP, 
the role of NAM7 in Pxa1MUT-mGFP stability was not investigated further. 
Significantly, we observed that ufd4 cells retain the ability to grow on media containing 
oleate as sole carbon source (Figure 6B), indicating that they contain functional peroxisomes 
and hence that Pxa1MUT-mGFP stabilization in this strain does not stem from a deficiency in 
peroxisome function. Since Ufd4p is a cytosolic E3 ligase that regulates the degradation of 
faulty proteins (Theodoraki et al., 2012), but it has not been linked to peroxisome function, we 
chose to investigate the role of Ufd4p in Pxa1MUT-mGFP degradation further. We performed 
CHX chase analysis and observed that Pxa1MUT-mGFP degradation is inhibited in ufd4 cells 
compared to WT cells (Figure 6C and S2B). Furthermore, using fluorescence microscopy in 
combination with CHX chase assays, we investigated the localization and turnover of Pxa1MUT-
mGFP in ufd4 cells. As can be seen in Figure 6D (t=0, left panel), mGFP spots co-localize with 
mKate2 spots in ufd4 cells. In addition, line profile data indicate strong correlation between the 
normalized fluorescent intensity of mGFP and mKate2, demonstrating that Pxa1MUT-mGFP is 
indeed localised to peroxisomes in ufd4 cells (Figure 6D). The peroxisomal localisation of 
Pxa1MUT-mGFP in ufd4 cells was confirmed using DsRed-SKL as a peroxisomal marker 
(Figure S1A). Significantly, cells deleted for UFD4 display increased numbers of mGFP spots 
after 120 mins of CHX treatment, compared to the WT strain (Figure 6D, right panel; t=120 
mins). Furthermore, mGFP spots in ufd4 cells co-localize with mKate2 spots after 120 mins of 
CHX treatment (Figure 6D, left panel), demonstrating that Pxa1MUT-mGFP accumulates on 
peroxisomes in these cells. Together, these data establish that the E3 ligase Ufd4p is involved 





Figure 5: Pxa1MUT-mGFP degradation is inhibited in peroxisome deficient strains  
A. Bar chart displaying Pxa1MUT-mGFP levels in WT, pex2 and pex4 strains (Left) and WT, atg12 and pex5 strains 
(Right). Cells pre-cultivated on glucose were grown on oleate/glucose to an OD600 of ~1.5 and TCA samples 
were collected for western blotting. For quantification of Pxa1MUT-mGFP levels, blots in Figure S2A were 
used. Pxa1MUT-mGFP levels in WT were set to 1, values represent the mean ± SD of three independent 
experiments. Asterisks represent statistically significant increase of Pxa1MUT-mGFP levels in mutant strains 
compared to in WT cells. ** P <0.01- statistically significant and P> 0.05- not significant (NS). 
B. CHX chase of Pxa1MUT-mGFP in WT, pex2 and pex4 strains (Top) and WT, atg12 and pex5 strains (Bottom). 
Cells were grown on oleate/glucose media to an OD600 of 1.5, treated with CHX and samples were collected 
from oleate/glucose grown cells at the indicated time points after CHX treatment. Protein levels were 
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normalized to Pyc at the corresponding time point and to the protein levels at time point 0 (set to 1). Values 
represent the mean ± SD of three independent experiments. For quantification, blots in Figure S2B were used.  
C. Co-localization analysis of Pxa1MUT-mGFP with the peroxisomal marker Pex3-mKate2 in WT, pex2, pex4 and 
pex5 cells. The WT strain lacking fluorescent markers was used as control. Fluorescence images were taken 
from cells grown on oleate/glucose media to an OD600 of 1.5. Blue arrows- GFP spots, yellow arrows- mKate2 
spots and red arrows- background fluorescence. Scale bar: 3 μm 
 
 
Figure 6: Ufd4, a cytosolic E3 ligase is involved in Pxa1MUT-mGFP degradation   
A. Pxa1MUT-mGFP levels in WT, ufd4, nam7, ela1, dsk2, skp1, tul1 or dma2 cells. TCA samples for western 
blotting were collected from cells pre-cultivated on glucose and grown on oleate/glucose to an OD600 of ~1.5. 
For quantification of Pxa1MUT-mGFP levels, blots in Figure S2A were used. Pxa1MUT-mGFP levels in WT were 
set to 1, values represent the mean ± SD of three independent experiments. Numbers above the columns depict 
the p-value. 
B. Ten-fold serial dilutions of WT and pex4 cells together with WT and ufd4 cells producing Pxa1MUT- mGFP 
were spotted on oleate plates and grown at 30º C for 7 days.  
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C. CHX chase of Pxa1MUT-mGFP in WT and ufd4 strains. Cells were pre-cultivated on glucose, grown on 
oleate/glucose to an OD600 1.5, treated with CHX and samples were collected from oleate/glucose grown cells 
at the indicated time points after CHX addition. Protein levels were normalized to Pyc at the corresponding 
time point and to the protein levels at time point 0 (set to 1). Values represent the mean ± SD of three 
independent experiments. For quantification, blots in Figure S2B were used. 
Co-localization analysis of Pxa1MUT-mGFP with the peroxisomal marker Pex3-mKate2 in ufd4 (Top panel) or WT 
(Bottom panel, taken from Figure 2A, for comparison) cells, after CHX treatment. Cells were grown as indicated 
in Figure 6C and images were taken from cells grown on oleate/glucose media at the indicated time points (mins) 
after CHX treatment. Blue arrows- GFP spots, yellow arrows- mKate2 spots and red arrows- background 
fluorescence, Scale bar: 3 μm. Line profiles were generated as described in Figure 1. The circular structures visible 
in GFP images of ufd4.Pxa1MUT-mGFP cells (top panel) expressing Pxa1MUT-mGFP can also be seen in images of 
WT.Pxa1MUT-mGFP cells (Figure S1B, top lane) and likely represent large peroxisomes. 
 
Inhibiting Pxa1MUT-mGFP degradation enhances peroxisomal β-oxidation 
Around 70% of the mutant forms of ALDP are unstable and are degraded (Kemp et al., 2001; 
Takahashi et al., 2007). However, many of these mutants retain a certain level of functionality 
(Roerig et al., 2001). This has led to the hypothesis that blocking ALDP degradation could 
enhance ALDP activity in cells and be beneficial for ALD patients (Morita et al., 2019; Yamada 
et al., 1997; Zhang et al., 2011). Our data clearly indicate that Pxa1MUT-mGFP builds up at 
peroxisomes when its degradation is inhibited in ufd4 cells. Hence, we reasoned that we could 
use our experimental setup as proof of principle and measured the capacity of WT and ufd4 
cells expressing Pxa1-mGFP or Pxa1MUT-mGFP to perform β-oxidation (Figure 7A). Pxa1MUT-
mGFP in WT cells displayed reduced activity in comparison to Pxa1-mGFP (Figure 7A) 
although higher than pxa1 cells, indicating that importantly, Pxa1MUT-mGFP retains a degree 
of functionality. Significantly, ufd4 cells expressing Pxa1MUT-mGFP exhibited an increase in 
β-oxidation activity of around 15% compared to the activity of WT.Pxa1MUT-mGFP cells 
(Figure 7A). We also observed that β-oxidation appeared enhanced in ufd4 cells expressing 
Pxa1-mGFP compared to WT cells, although statistical analysis suggested that this increase 
was not significant (Figure 7A). To investigate further, we determined the levels of Pxa1-mGFP 
in WT and ufd4 cells expressing Pxa1-mGFP (Figure 7B), observing that these levels were 
indeed increased in ufd4 cells. Significantly, Pex14p levels were not affected by ufd4 deletion 
(Figure 7B), indicating that the effect is likely to be specific for Pxa1-mGFP. 
Overall, our results provide proof of principle that blocking Pxa1MUT-mGFP degradation 
can partially restore Pxa1MUT-mGFP function in cells, supporting the view that inhibiting ALDP 
degradation may be a promising therapeutic avenue to explore to target ALD.  




Figure 7: Inhibiting Pxa1MUT-mGFP degradation enhances β-oxidation activity in vivo.  
A. Bar chart displaying β-oxidation activity in WT and ufd4 cells expressing Pxa1-mGFP or Pxa1MUT-mGFP. β-
oxidation activity was measured in cells grown overnight on oleate/glucose media. β-oxidation in pxa1 and 
fox1 cells acts as control. The activity in WT.Pxa1-mGFP cells was taken as a reference [100%]. Values 
represent the mean ± SD of four independent experiments. Numbers above the columns depict the p-value 
calculated to determine whether changes to β–oxidation activity in the different strains, are significant. 
B. Bar chart displaying Pxa1-mGFP and Pxa1MUT-mGFP levels in WT and ufd4 cells. Pex14p levels in WT and 
ufd4 cells acts as a control. Cells pre-cultivated on glucose were grown on oleate/glucose to an OD600 of 1.5, 
cells were lysed and samples were probed by immunoblotting. For quantification, blots in Figure S2C were 
used. Pxa1-mGFP levels in WT.Pxa1-mGFP cells were set to 1. Similarly, Pex14 levels in WT.Pxa1-mGFP 
cells were used as a reference and set to 1. Values represent the mean ± SD of three independent experiments. 
Numbers above the columns depict the p-value calculated to determine whether changes to Pxa1/Pxa1MUT-
mGFP or Pex14p levels in the different strains, when compared to the corresponding WT strain, are significant. 
 
Discussion 
Here we have demonstrated that a faulty version of the peroxisomal fatty acid transporter Pxa1p 
is targeted for proteasome-dependent degradation. Pxa1MUT-mGFP, our chosen substrate, is 
rapidly degraded from peroxisomes. An important question remains how Pxa1MUT-mGFP is 
recognized for degradation? The mutations introduced into Pxa1p (Gly650Ser/Lys651Arg) are 
present in the conserved walker A motif of the NBD (Walker et al., 1982). Mutation of either 
these conserved lysine or glycine residues compromises both the ATP hydrolysis and substrate 
translocation activity of ABC transporters (Byeon et al., 1995; Schneider et al., 1994; Zoghbi 
and Altenberg, 2014), including ALDP (Roerig et al., 2001). Hence, the substitutions we 
introduced into Pxa1MUT-mGFP likely reduce ATP hydrolysis and hence transport activity, 
which in turn could allow Pxa1MUT-mGFP to be recognized for degradation. However, Pxa1p 
forms a heterodimer with Pxa2p and deletion of PXA2 decreases the stability of Pxa1p (Shani 
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and Valle, 1996), indicating that Pxa2p binding is required for Pxa1p stability. Therefore, it is 
equally possible that the substitutions in Pxa1MUT-mGFP inhibit binding to Pxa2p, which in 
turn allows Pxa1MUT-mGFP to be recognized for degradation. Interestingly, Byeon et al. 
reported that mutating the walker A lysine in muscle adenylate kinase results in a 
conformational change in the NBD (Byeon et al., 1995) while recent work on the bacterial 
transporter MJ0796 demonstrated that walker A lysine mutations impact on both ATP 
hydrolysis and homo-dimerization (Zoghbi and Altenberg, 2014). Hence, we speculate that the 
introduced mutations in Pxa1MUT-mGFP result in a conformational change in Pxa1p, which 
could allow the protein to be recognized for degradation. Identifying which factors are involved 
in the recognition of faulty peroxisomal fatty acid transporters will provide valuable insights 
into the mechanisms underlying their degradation.  
Our data show that the addition of proteasome inhibitors significantly reduce Pxa1MUT-
mGFP turnover, demonstrating a role for the proteasome in Pxa1MUT-mGFP degradation 
(Figure 3A). While the data on the ubiquitin mutant (UbK48) suggests that ubiquitination is 
involved in Pxa1MUT-mGFP degradation (Figure 3C), our attempts to detect ubiquitinated forms 
of Pxa1MUT-mGFP proved unsuccessful (Figure 3D). Notably, ubiquitinated forms of ALDP 
carrying the R617H or H667D mutations could also not be detected (Takahashi et al., 2007), 
even though these mutants were likely degraded by the proteasome. There could be two possible 
explanations for his: Pxa1MUT-mGFP is ubiquitinated but that the ubiquitinated form of 
Pxa1MUT-mGFP is below the limit of detection, or that the ubiquitination of another protein 
could facilitate the degradation of Pxa1MUT-mGFP. The latter mode of degradation has been 
proposed for several substrates of the proteasome. Dang et al., reported that instead of A3G, its 
binding partner viral infectivity factor (Vif) undergoes poly-ubiquitination and this could be 
critical for A3G proteasomal degradation (Dang et al., 2008), proposing that poly-ubiquitinated 
Vif might act as an adaptor protein to bring A3G to the proteasome for degradation (Prakash et 
al., 2009). Another protein that may be degraded via a similar mechanism is the retinoblastoma 
tumour suppressor protein (Rb) (Gonzalez et al., 2001). Rb is thought to be targeted for 
proteasomal degradation by the ubiquitination of its binding partner, human papillomavirus 
protein E7 (Berezutskaya and Bagchi, 1997; Gonzalez et al., 2001). Pxa2p forms a heterodimer 
with Pxa1p (Hettema et al., 1996; Shani et al., 1996), but we do not suspect that Pxa2p 
ubiquitination is required for Pxa1MUT-mGFP degradation because loss of Pxa2p does not 
inhibit Pxa1p degradation but instead decreases the stability of Pxa1p (Shani and Valle, 1996). 
Clearly further work is required to investigate how ubiquitin contributes to the proteasome-
mediated degradation of Pxa1MUT-mGFP. 
Based on the results of our tFT screening, several proteins not previously associated 
with peroxisomal function were identified that could play a role in Pxa1-tFT stability (Figure 
4C). Of these, only loss of Ufd4p, a cytosolic E3 ligase involved in the degradation of faulty 
proteins (Theodoraki et al., 2012), significantly increased the stability of Pxa1MUT-mGFP 
(Figure 6A), indicating that Ufd4p is involved in Pxa1MUT-mGFP degradation. Although future 
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work needs to investigate the mechanisms by which Ufd4p controls Pxa1MUT-mGFP 
degradation, we consider it significant that a cytosolic E3 ligase could regulate the turnover of 
a faulty PMP because this indicates that general cellular quality control pathways can facilitate 
the degradation of faulty PMPs. While the data we present here concern the degradation of a 
mutant form of Pxa1p, we consider it unlikely that the sole purpose of PMP quality control is 
the degradation of mutant PMPs; we consider it more likely that damaged PMPs undergo 
quality control. As previously mentioned, the ROS rich environment of the peroxisome could 
result in the oxidative damage of proteins, which could suggest that damaged Pxa1p undergoes 
PMP quality control. In line with this, although Pxa1-mGFP is much more stable than Pxa1MUT-
mGFP in our CHX experiments, degradation of Pxa1-mGFP does occur (Figure 2A) while 
Pxa1-mGFP levels are higher in ufd4 cells compared to WT cells (Figure 7B). Therefore, it is 
plausible that Pxa1MUT-mGFP is targeted for degradation via quality control mechanisms that 
usually acts upon damaged Pxa1p because Pxa1MUT-mGFP is impaired in function. 
Deletion of UFD4 does not fully inhibit the degradation of Pxa1MUT-mGFP. Similarly, 
Pxa1MUT-mGFP degradation appears only partly reduced in cells lacking the peroxisomal E3 
ligase Pex2p. This could suggest that two pathways target Pxa1MUT-mGFP for degradation, one 
requiring Ufd4p and the other involving Pex2p or perhaps that Pex2p and Ufd4p collaborate to 
facilitate Pxa1MUT-mGFP degradation. Ufd4p can team up with Ubr1p, a RING E3, to facilitate 
the degradation of Mgt1p, a DNA repair demethylase (Hwang et al., 2009). However, the 
impact of peroxisome function on Pxa1MUT-mGFP degradation remains to be determined, 
meaning that further data on the role of Pex2p (and other members of the peroxisomal 
ubiquitination machinery) are required to validate this hypothesis. Nevertheless, a model that 
depicts Pex2p and Ufd4p teaming up to degrade faulty PMPs remains an attractive one. 
Mutations in gene sequences can result in formation of faulty proteins, which could pose 
serious threats to the cell, for two reasons. One reason is the loss of protein activity. However, 
there is also gain-of-toxic function that is unrelated to the protein's function and which has 
become increasingly relevant to human disease (Winklhofer et al., 2008). Faulty proteins often 
expose hydrophobic regions normally buried within the core (Gibson and Ellory, 2002) that 
may take part in unwanted protein-protein interactions, resulting in protein aggregation 
(Dobson, 2004). To minimize such harmful effects, cell employs protein quality control systems 
to remove faulty proteins (Fredrickson and Gardner, 2012). For instance, mutations at position 
F508 in Cystic fibrosis transmembrane conductance regulator (CFTR), which increase the 
tendency of CFTR to aggregate but do not inhibit activity completely (Du et al., 2015; Luciani 
et al., 2010), result in rapid protein degraded (Ward et al., 1995). However, the rapid 
degradation of mutant CFTR leaves cells devoid of CFTR molecules, eventually resulting in 
the severe condition cystic fibrosis (Thomas et al., 1992) and several lines of research have 
focused on blocking CFTR degradation as potential treatment for cystic fibrosis (Zhang et al., 
2012). Similarly, many ALDP mutant proteins that cause ALD are unstable, leading to the 
suggestion that blocking ALDP degradation could represent a novel treatment for ALD (Morita 
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et al., 2019). Indeed, a subset of ALDP mutant proteins in patient cells become stable under 
low-temperature culture conditions and exhibit proper peroxisomal localization (Morita et al., 
2019) while they also display increased residual β-oxidation activity (Zhang et al., 2011). 
Though unstable, a significant proportion of ALDP mutants retain a certain degree of function 
(Morita et al., 2019; Roerig et al., 2001). In line with this, our data demonstrate that Pxa1MUT-
mGFP cells display increased β-oxidation compared to pxa1 cells (Figure 7A), indicating that 
Pxa1MUT-mGFP is partly functional. Furthermore, stabilizing Pxa1MUT-mGFP, through the 
deletion of UFD4, enhances peroxisomal β-oxidation in cells, which would indeed support the 
notion that blocking ALDP mutant degradation might constitute a feasible therapeutic approach 
to treat ALD. However, Yamada et al. indicated that proteasome inhibitors enhance the stability 
of certain ALDP mutants but did not increase peroxisomal β-oxidation in the corresponding 
cells (Yamada et al., 1997). While these results may seem contradictory to those reported here, 
it is important to note that the location where the mutants build up upon stabilization is critical 
in determining whether stabilization will result in enhanced activity. Yamada and co-workers 
did not address this in their study (Yamada et al., 1997) and it is possible that these ALDP 
mutants are stabilized elsewhere in the cell. Hence, further work on the mechanism of ALDP 
degradation is therefore needed to understand at which point blocking ALDP mutant 
degradation could positively affect ALDP activity. Nevertheless, our data demonstrate that 
UFD4 deletion results in a build-up of Pxa1MUT-mGFP at the peroxisomal membrane and 
significantly, a human homolog of Ufd4p, known as TRIP12 (Park et al., 2009), is involved in 
the degradation of a range of different proteins (Hanoun et al., 2014; Kajiro et al., 2011; Larrieu 
et al., 2020). It would therefore be interesting to investigate whether TRIP12 has a role in ALDP 
degradation and if so, whether blocking TRIP12 dependent ALDP mutant degradation 
improves β-oxidation in ALD patients.   
 In summary, we have demonstrated that a faulty peroxisomal fatty acid transporter 
undergoes proteasome-mediated degradation and identify Ufd4p as playing an important role 
in facilitating this degradation. In addition, these results may help to shed new light on the role 
of ALDP degradation in ALD. 
 
Materials and Methods 
Construction of plasmids and S. cerevisiae strains  
S. cerevisiae transformations were performed with the Lithium acetate method, as described 
previously (Knop et al., 1999). S. cerevisiae strains and plasmids used in this study are listed in 
Table 1 and 2 respectively. The primers used in the study are listed in Table S1. Phusion DNA 
polymerase (Thermo Scientific) was used for the amplification of gene fragments.  
The S. cerevisiae WT.Pxa1-mGFP strain was constructed as follows. PCR was 
performed on pHIPZ-mGFP using the Pxa1-mGFP Fw and Pxa1-mGFP Rev primers to amplify 
the C-terminal region of PXA1 together with the Zeocin resistance cassette (bleMX6) and the 
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mGFP coding sequences and the obtained PCR fragment was transformed into the yMaM330 
strain. The plasmid pGW053 was constructed as follows: the genomic region of the PXA1 gene 
was amplified by PCR using Forward primer VIP1080, 485 bp upstream of open reading frame 
and Reverse primer VIP1081, 192 bp downstream of ORF. This was inserted into Ycplac111 
using gap repair between EcoR1 and HindIII sites, resulting in pGW046. This plasmid was used 
as template for site directed mutagenesis to generate Pxa1 G650S/K651R using VIP672 and 
VIP673, producing pGW053. For the construction of S. cerevisiae WT.Pxa1MUT-mGFP, first a 
recombinant plasmid pHIPZ-Pxa1MUT-mGFP was constructed. PCR was performed on 
pGW053 using Pxa1MUT Fw and Pxa1MUT Rev primers to amplify the C-terminal region of 
PXA1 (carrying the two mutations G650S/K651R) and to introduce Pcil and BglII sites. The 
resulting DNA fragment, digested with Pcil and BglII, was cloned into Pcil/ BglII cut pHIPZ-
mGFP to generate pHIPZ-Pxa1MUT-mGFP. PCR was then performed on pHIPZ-Pxa1MUT-
mGFP using Int_Pxa1MUT Fw and Int_Pxa1MUT Rev to amplify the Pxa1MUT-mGFP fragment 
and the obtained PCR product was then transformed into the yMaM330 strain. The obtained 
PCR fragment was also transformed into pdr5, atg12 and ufd4 strains to pdr5.Pxa1MUT-mGFP, 
atg12.Pxa1MUT-mGFP and ufd4.Pxa1MUT-mGFP respectively. The positive transformants of 
WT.Pxa1MUT-mGFP, pdr5.Pxa1MUT-mGFP, atg12.Pxa1MUT-mGFP and ufd4.Pxa1MUT-mGFP 
were checked both by colony PCR and sequencing. In addition, PCR fragment was also 
transformed into nam7, ela1, dsk2, skp2, dma2 and tul1 cells to generate the mutant strains 
expressing Pxa1MUT-mGFP. 
The S. cerevisiae Pxa1-tFT strain was generated as follows. PCR was performed on 
pMaM168 to amplify C-terminal region of PXA1 and tFT tagging module using primers Pxa1-
tFT Fw and Pxa1-tFT Rev. The generated PCR product was then transformed into yMaM330. 
Strains expressing Pex3-mKate2 were constructed as follows. Pex3-mKate2 cassette consisting 
of C-terminal region of PEX3, hygromycin resistance gene (hphMX) and mKate2 coding 
sequences was amplified from pHIPH-Pex14mKate2 using primers Pex3-mKate Fw and Pex3-
mKate Rev. The generated PCR fragment was transformed into WT, WT.Pxa1-mGFP, 
WT.Pxa1MUT-mGFP and ufd4.Pxa1MUT-mGFP. Furthermore, the PCR fragment was also 
transformed into pex2. Pxa1MUT-mGFP, pex4. Pxa1MUT-mGFP and pex5. Pxa1MUT-mGFP 
strains, which were generated as described below 
S. cerevisiae WT.Pxa1MUT-mGFP and ufd4.Pxa1MUT-mGFP strains expressing DsRed-
SKL were constructed as follows. First, the PCR cassette (consisting of TEF promoter and 
DsRed-SKL coding sequences) was digested NotI/SalI and cloned into NotI/SalI cut pHIPX7-
DsRed-SKL to create pHIPH7-DsRed-SKL. The PCR cassette containing TDH3 promoter 
sequence was amplified from pPTDH3-GFP-SKL was digested with NotI/BamHI and cloned into 
NotI/BamHI cut pHIPH7-DsRed-SKL, to create pHIPH8-DsRed-SKL. The resulting plasmid 
after linearization with MunI was transformed into WT.Pxa1MUT-mGFP and ufd4.Pxa1MUT-
mGFP strains to generate WT.Pxa1MUT-mGFP. DsRedSKL and ufd4.Pxa1MUT-mGFP. DsRed-
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SKL respectively. In these strains, the expression of DsRed-SKL was under the control of 
TDH3 promoter.  
S. cerevisiae WT.Pxa1MUT-mGFP+MycUb and WT.Pxa1MUT-mGFP+MycUbK48R 
strains were constructed as follows. First, the Yeast episomal plasmids (YEP) expressing MycUb 
and MycUbK48R from the CUP1 promoter were constructed: the CUP1 promoter coding 
sequence was amplified from pCGCN-FAA4 using primers CUP1_Fw and CUP1_Rev, 
digested with NotI/BamHI and cloned into NotI/BamHI cut pRDV1 (MycUb) or pRDV2 
(MycUbK48R). The resulting vectors were then used to amplify Pcup1-MycUb and Pcup1-
MycUbK48R sequences individually using primers CUP1_Fw and MycUb/UbK48R_Rev and 
these PCR fragments were digested with NotI and SacI and cloned into NotI/ SacI cut pRG226 
(Addgene, 64529). The YEP-PCUP1-MycUbK48R plasmid was transformed into the 
WT.Pxa1MUT-mGFP strain to generate WT.Pxa1MUT-mGFP+MycUbK48R. The YEP-PCUP1-
MycUb plasmid was transformed individually into WT.Pxa1MUT-mGFP, pdr5.Pxa1MUT-mGFP 
and pdr5 strains to generate WT.Pxa1MUT-mGFP+MycUb, pdr5.Pxa1MUT-mGFP + MycUb and 
pdr5 + MycUb respectively. 
 
Construction of S. cerevisiae deletion strains  
The pxa1 deletion strain was constructed by replacing the PXA1 region with the hygromycin 
resistance gene (hphMX). A PCR fragment containing the hygromycin resistance gene and 
PXA1 flanking regions were amplified from pHIPH-Pex14mKate2 using primers DPxa1_Fw 
and DPxa1_Rev. The resulting PXA1 deletion cassette was transformed into yMaM330. For the 
construction of pex5.Pxa1MUT-mGFP, the PEX5 deletion cassette (geneticin resistance gene and 
PEX5 flanking regions) amplified from pFa6AkanMX6 using primers DPex5_Fw and 
DPex5_Rev was transformed in WT.Pxa1MUT-mGFP. 
 S. cerevisiae pex2 and pex4 strains expressing Pxa1MUT-mGFP or Pxa1-tFT were 
constructed as follows. The pex2 and pex4 deletion cassettes consisting of geneticin resistance 
cassette (kanMX) and PEX2 or PEX4 flanking regions were amplified from pFa6AkanMX6 
using DPex2_Fw and DPex2_Rev (for PEX2 deletion cassette) and DPex4_Fw and DPex4_Rev 
(for PEX4 deletion cassette). The obtained deletion cassettes were then transformed 
individually into WT.Pxa1MUT-mGFP and Pxa1-tFT strains to generate pex2. Pxa1MUT-mGFP, 
pex4. Pxa1MUT-mGFP, pex2.Pxa1-tFT and pex4.Pxa1-tFT strains.  
For the construction of atg12.Pxa1-tFT strain, deletion cassette consisting of geneticin 
resistance cassette (kanMX) and ATG12 flanking regions was amplified from pFa6AkanMX6 
using primers DAtg12_Fw and DAtg12_Rev (for ATG12 deletion cassette). The obtained 
deletion cassette was then transformed into Pxa1-tFT to generate atg12.Pxa1-tFT strain. 
All gene integrations were confirmed by colony PCR using Phire Hot Start II DNA 
polymerase (Thermo Fisher Scientific) and gene deletions were checked by colony PCR as well 
as southern blotting analysis of chromosomal DNA, using the ECL Direct Nucleic Acid 
Proteasome dependent quality control of  the peroxisomal membrane protein Pxa1p
129
3
Labelling and Detection system (Thermo Fisher Scientific), according to the protocol provided 
by the manufacturer. 
 
Growth conditions 
The Escherichia coli strain DH5α was used for cloning purposes. E. coli cells were grown in 
LB supplemented with 100 μg/ml Ampicillin at 37 °C. Yeast transformants were selected on 
YPD plates containing 2% agar and 100 μg/ml Zeocin (Invitrogen), 150 μg/ml Geneticin 
(Invitrogen) or 300 μg/ml Hygromycin (Invitrogen) or on YND plates containing 6.7 g/L yeast 
nitrogen base without amino acids (YNB, Difco), 5g/L D- glucose monohydrate (Sigma-
Aldrich), 2% agar and 30 mg/L Leucine, 20 mg/L Histidine and 20 mg/L Methionine or 30 
mg/L Uracil, when required.  
For all the experiments, yeast cells were initially cultured at 30°C on YM2 medium (6.7 
g/L YNB, 1% casein hydrolysate (Sigma-Aldrich), 60 mg/L uracil, 60 mg/L tryptophan) 
containing either 2% or 0.3% (w/v) glucose. To induce peroxisome proliferation, cells grown 
on YM2 medium plus 0.3% glucose were transferred to YNO-glucose medium (6.7 g/L YNB, 
1% casein hydrolysate, 60 mg/L uracil, 60 mg/L tryptophan, 0.05% tween, 0.1% oleate and 
0.1% glucose). For strains expressing Myc tagged ubiquitin: MycUb and MycUbK48R under the 
control of CUP1 promoter and uracil coding gene, URA3 (Table 1), cells were pre-cultured at 
30°C on YM2 medium (lacking uracil) plus 0.3% glucose and then grown on YNO-glucose 
medium (lacking uracil) to an OD600 of 1.5. To inhibit protein synthesis, cells were treated with 
cycloheximide (CHX, Sigma-Aldrich) to a final concentration of 6 mg/ml. To inhibit 
proteasome, cells were treated with 70 μM of MG1232 (Sigma-Aldrich) and 70 μM of 
Bortezomib (Selleckchem).Where indicated, an equal amount of DMSO (control for CHX) was 
added to cells. For spot assays, yeast strains were grown overnight on YM2 medium containing 
2% glucose and shifted to YM2 medium plus 0.3% glucose. After 6h of growth in YM2 plus 
0.3 glucose, yeast cells were spotted onto oleate plates containing 6.7 g/L YNB, 0.1% yeast 
extract, 0.1% oleate, 0.05% Tween, 2% agar and when required uracil (30 mg/L), leucine (60 
mg/L), methionine (20 mg/L) and histidine (20 mg/L) was added. Plates were incubated at 30°C 
for 7 days before imaging. 
 
Preparation of yeast TCA lysates 
Cell extracts of TCA-treated cells were prepared for SDS-PAGE as described previously 
(Baerends et al., 2000). SDS-PAGE and western blotting were performed by established 
methods. Equal volume of samples were loaded per lane and blots were probed with antibodies 
against mGFP (Santa Cruz Biotech, sc-9996), pyruvate carboxylase 1 (Pyc), Pex14p, rabbit 
polyclonal antisera raised against the Myc tag (Santa Cruz Biotech, sc-789) or HA tag (Sigma, 
H6908). Secondary goat anti-rabbit (Thermo Fisher Scientific, 31460) or goat anti-mouse 
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(Thermo Fisher Scientific, 31430) antibodies conjugated to horseradish peroxidase or alkaline 
phosphatase were used for detection. Pyc was used as a loading control.  
 
Quantification of Western blots 
Western blots were scanned using a densitometer (Bio-Rad, GS-710) and protein levels were 
quantified using Image J software (https://imagej.nih.gov/ij/). The intensity of each band 
measured was normalized by dividing by the intensity of the corresponding Pyc band (loading 
control). The normalized Pxa1MUT-mGFP values were compared to Pxa1-mGFP values, which 
was set to 1. The levels of Pxa1MUT-mGFP in mutant cells are displayed relative to Pxa1MUT-
mGFP levels in WT (set to 1). For CHX experiments, the normalized values at time point 0 
(T0) was set to 1.0 and values obtained after CHX addition at indicated time points are displayed 
as a fraction of T0 values. Standard deviations were calculated using Excel. Significance was 
determined using two tailed student’s t-test. * represents P-values < 0.05, ** represents P-values 
< 0.01, and *** represents P-values < 0.001. The data presented are derived from three 
independent experiments.  
 
tFT screening with UPS deletion library 
Tandem fluorescent protein timers (tFT): mCherry and sfGFP were endogenously tagged to 
Pxa1 as described (Khmelinskii et al., 2011). By the use of a pinning robot (Singer Instruments), 
Pxa1-tFT was crossed to UPS deletion library or an array of haploid strains consisting of 
knockout, temperature sensitive (ts) and Decreased Abundance by mRNA perturbation (DAmp) 
alleles of individual components of the Ubiquitin Proteasome System (UPS) (Li et al., 2011; 
Schuldiner et al., 2005; Winzeler et al., 1999). In addition, Pxa1-tFT was crossed to a control 
strain expressing kanMX selection marker from the ura3Δ locus, referred to as wild-type (WT). 
Screens were performed in 1536 format, with four technical replicates of each cross arranged 
next to each other. The selection of diploids, sporulation and the selection of haploids carrying 
Pxa1-tFT and a genetic perturbation, was performed by sequential pinning on appropriate 
selective media as described (Baryshnikova et al., 2010), followed by seamless marker excision 
(Khmelinskii et al., 2011). Using an Infinite M1000 Pro plate reader equipped with automatic 
plate loading stacker (Tecan) and custom temperature control chamber, mCherry intensity 
(587/10 nm excitation, 610/10 nm emission) and sfGFP intensity (488/10nm excitation, 510/10 
nm emission) was measured from colonies grown on a modified YNO-glucose medium 
containing (6.7 g/L YNB, 2g/L amino acid dropout mix (-LEU), 0.05% tween, 0.1% oleate, 
0.1% glucose and 2% agar). First set of measurements were taken after 24 h of growth and 
measurements were taken every 24 h until 72 h (3 days). 
Whole colony fluorescence intensities (mCherry and sfGFP), obtained from UPS mutant 
crossed to Pxa1-tFT, were corrected for auto fluorescence by subtracting the measurements of 
a corresponding mutant crossed to the control strain, yMaM344 (expressing non-fluorescent 
protein). The median value was calculated out of the four technical replicates. The corrected 
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values of mCherry divided by the sfGFP values yielded a ratio, representing the stability of 
Pxa1-tFT in the UPS mutants. Similarly, the mCherry/sfGFP ratio of Pxa1-tFT in WT was 
corrected for auto fluorescence. Using the ratios obtained on day one, two and three a Z- score 
for each day was calculated by the formula. A Z-score indicates how many standard deviations 
a value is from the mean of all values. Z-score can be calculated from the formula: Z= (X - μ) 
/ σ. In the formula, Z is the Z-score, X is the value of the element, μ is the population mean, 
and σ is the standard deviation. A negative Z-score indicates that the value of the element is 
below average while positive Z-score indicates the value is above average. To identify UPS 
mutants which potentially increased the stability of Pxa1-tFT, Z-score (Z) was calculated using 
the formula  
 
Z = mCherry/sfGFP ratio in a UPS mutant (X) – mean mCherry/sfGFP ratio in WT and UPS mutants (μ) 
                      Standard deviation of mCherry/sfGFP ratio in WT and UPS mutants (σ) 
 
A strain (UPS mutant) with a Z-score of 0 indicates that Pxa1-tFT stability is similar to the WT 
as well to the population mean (WT and UPS mutants). While, the mutants with Z-score of 1.0 
and 2.0 indicates that the mCherry/sfGFP ratio in a corresponding mutant is different from the 
WT and population mean by 1.0 and 2.0 standard deviations. Hence, mutant stains displaying 
a Z-score >0 indicate enhanced Pxa1-tFT stability. UPS mutants with an increase in Z-score 
>1.0 on two of the three days tested were considered as potential candidates that significantly 
increased Pxa1-tFT stability. The heat map generated using the Z-scores (obtained from 
mCherry/sfGFP ratio of Pxa1-tFT in UPS mutants and the WT) is presented in Figure 2D. 
 
Fluorescence microscopy 
All images were captured at room temperature using an inverted microscope (Axio Scope A1, 
100×1.30 NA Plan-Neofluar objective, Carl Zeiss), Micro-Manager software and a digital 
camera (CoolSNAP HQ2; Photometrics). For wide field microscopy, GFP fluorescence was 
visualized with a 470/440-nm band pass excitation filter, a 495-nm dichromatic mirror, and 
525/50-nm band pass emission filter. mCherry fluorescence was visualized with a 587/25-nm 
band pass excitation filter, a 605-nm dichromatic mirror, and 647/70-nm band pass emission 
filter. 
 For co-localization analysis, cells were pre-grown on YM2 medium containing glucose, 
transferred to YNO-glucose (low fluorescence) medium and grown until an OD600 of 1.5 after 
which fluorescence microscopy images were captured. For CHX chase analysis, cells grown in 
the same way as indicated above were treated with cycloheximide (CHX) and images were 
taken from cells grown on oleate/glucose at indicated time points (mins) after CHX treatment 
(Figure 2B). The acquired images were processed using Image J software 
(https://imagej.nih.gov/ij/) with optimal settings: mGFP (200, 500), mKate2 (200, 600) and 
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DsRed (200, 500). For co-localization analysis in WT, pex2, pex4 and pex5 cells expressing 
Pxa1MUT-mGFP and Pex3-mKate2 (Figure 5C), images were processed using optimal settings: 
mGFP (200, 800) and mKate2 (200, 600). For quantifying the co-localization of Pxa1-mGFP 
or Pxa1MUT-mGFP in cells expressing peroxisomal markers (Pex3-mKate2 or DsRed-SKL) 
(Figure 1, 2, 6 and S1), a line was drawn along GFP and mKate2/ DsRed-SKL spots using 
ImageJ and the intensity was measured. Using this data, normalized fluorescent intensity of 
green and red spots were calculated and plotted against the distance of the line (from the 
beginning to the end). 
For quantification of the Pex3-mKate2 and Pxa1-mGFP or Pxa1MUT-mGFP fluorescence 
intensities in CHX treated cells (Figure 2C), a rectangular area was drawn using ImageJ to 
envelope the region containing the mGFP/mKate2 spot and pixel intensity inside the area was 
measured. Since the cells expressing Pxa1MUT-mGFP contain very few mGFP positive spots at 
the later time points of CHX treatment, the rectangular area selected contained the peroxisomal 
marker or Pex3-mKate2 spots and the corresponding mGFP intensity was measured. The 
maximum fluorescence intensity of mGFP measured on peroxisomes was corrected for the 
background intensity and a box plot was made using Microsoft Excel. The box represents values 
from the 25 percentile to the 75 percentile; the horizontal line through the box represents the 
median value. Whiskers indicate maximum and minimum values. The mKate2 intensity was 
calculated and displayed in a similar way (Figure 2C). To calculate the mGFP/mKate2 intensity 
ratio, the maximum intensity of Pxa1-mGFP or Pxa1MUT-mGFP, obtained at different time 
points after CHX treatment, was divided by the corresponding maximum intensity of Pex3-
mKate2 in each cell. The dataset was subjected to the two-tail t-test. * represents P-values < 
0.05, ** represents P-values < 0.01 and *** represents P-values < 0.001. 
 
Immunoprecipitation assay 
Immunoprecipitation was performed on cells grown on YNO-glucose medium for 10hrs and 
incubated with proteasome inhibitors (MG132 and Bortezomib) for 90 mins. Around 14 OD 
units of each strain were harvested by centrifugation. Immunoprecipitation using GFP-Trap® 
_M beads was performed according to manufacturer’s protocol (Chromotek) with slight 
modifications. Cells were washed once with 1 mL cold lysis or RIPA buffer (50 mM Tris/Cl 
pH 7.5, 150 mM NaCl, 2 mM EDTA, 0.1% SDS, 1% Triton X-100 and 0.5% Deoxycholate) 
and resuspended in 0.75 mL of lysis buffer containing 2.5 μg/mL leupeptin and 1 mM PMSF 
(added just prior to use). Yeast cells were then lysed using glass beads (~ 30 mins) and samples 
were centrifuged at 8000 rpm at 4°C for 10 mins to remove cellular debris and unbroken cells. 
A fraction of supernatant (Load fraction) was collected and stored for SDS-PAGE analysis. The 
remaining supernatant fractions were then incubated with 30 μl GFP-Trap® _M beads 
(Chromotek) for 2 hrs at 4°C under constant mixing. The beads were magnetically separated 
until the supernatant was clear. The supernatant was discarded and beads were washed five 
times using 500 µl ice cold wash buffer (50 mM Tris/Cl pH 7.5, 150 mM NaCl and 2 mM 
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EDTA). The GFP-Trap® _M beads were then resuspended in 60 µl 4x SDS-Sample buffer and 
boiled for 10 minutes at 95°C. Finally, the beads were separated magnetically and the 
supernatant (Elute fraction) was collected. The load and elute fractions were subjected to SDS-
PAGE and immunoblotting with antibodies against GFP and Myc tagged epitope. 
 
β- Oxidation assay 
Yeast strains were grown on glucose medium containing 5 g/L D glucose, and 6.7 g/L YNB. 
When required; histidine, leucine, uracil, or methionine was added. To induce peroxisome 
proliferation cells were grown for at least 24 hours on 5 g/L glucose medium, and then 
transferred to YPO medium (1.07 g/L oleate, 2.16 g/L Tween-80, 5 g/L peptone, 3 g/L yeast 
extract, 25 mM potassium phosphate buffer (pH=6)). Cells were grown overnight in YPO 
medium to induce β-oxidation. β-Oxidation assay in intact cells were performed as described 
previously by (van Roermund et al., 2008) with slight modifications. The β-oxidation capacity 
was measured in 50 mM MES, pH 6.0 and 9 g/L NaCl supplemented with 10 μM 1-14C-oleate. 
Subsequently, 14C-CO2 was trapped with 2 M NaOH and used to quantify the rate of fatty acid 
oxidation. Results are presented as percentages relative to the rate of oxidation of wild-type 
cells expressing Pxa1-mGFP (set to 100). The data presented are from four independent 
experiments and significance is calculated using two-tailed student’s t test. * represents P-
values < 0.05, ** represents P-values < 0.01, and *** represents P-values < 0.001. 
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Table 1. Yeast strains used in this study 
Strain Description [genotype] Reference 
BY4741  MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 
(Khmelinskii et al., 
2014) (Knop lab) 
BJ1991 MATa, leu2, trp1, ura3-251, prb1-1122, pep4-3, gal2 




MATalpha his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 can1Δ:: 
STE2pr-spHIS5 lyp1Δ::STE3pr-LEU2 
leu2Δ::GAL1pr- I-SCEI-natNT2                              
(Khmelinskii et al., 
2014) (Knop lab) 
WT.Pex3-mKate2 yMaM330, PEX3::mKate2-hphMX This study (Figure 1) 
WT.PXA1-mGFP yMaM330, PXA1::mGFP-bleMX6 
This study (Figure 1, 2, 
4, 7, S1 and S2) 
WT.PXA1MUT-
mGFP 
yMaM330 , PXA1G650S/K651R::mGFP-bleMX6 
This study (Figure 1, 2, 
3, 4, 5, 6, 7, S1 and S2) 
WT. PXA1MUT-
mGFP + PEX3 
mKate2 
yMaM330, WT. PXA1MUT-mGFP + PEX3::mKate2-
hphMX 
This study (Figure 1) 
WT. PXA1-mGFP + 
PEX3 mKate2 
yMaM330, WT. PXA1-mGFP + PEX3::mKate2-hphMX 





yMaM330, WT. PXA1MUT-mGFP + SKL::DsRed-
hphMX 









Knop lab (Figure 4 and 
S1F) 
UPS deletion library BY4741, goi deletions::kanMX 
(Khmelinskii et al., 




(Khmelinskii et al., 
2014) (Knop lab) 
atg12 atg12 deletion strain, BY4741, atg12::kanMX Knop lab 
pex2 pex2 deletion strain, BY4741, pex2::kanMX Knop lab 
pex4 pex4 deletion strain, BY4741, pex4::kanMX Knop lab 
Proteasome dependent quality control of  the peroxisomal membrane protein Pxa1p
135
3
ufd4 ufd4 deletion strain, BY4741, ufd4::kanMX Knop lab 
pdr5 pdr5 deletion strain, BY4741, pdr5::kanMX Knop lab 
nam7 nam7 deletion strain, BY4741, nam7::kanMX Knop lab 
ela1 ela1 deletion strain, BY4741, ela1::kanMX Knop lab 
dsk2 dsk2 deletion strain, BY4741, dsk2::kanMX Knop lab 
skp2 skp2 deletion strain, BY4741, skp2::kanMX Knop lab 
dma2 dma2 deletion strain, BY4741, dma2::kanMX Knop lab 
tul1 tul1 deletion strain, BY4741, tul1::kanMX Knop lab 
atg12.PXA1-tFT  yMaM330, PXA1-tFT + atg12::kanMX This study (Figure 4) 
pex2.PXA1-tFT  yMaM330, PXA1-tFT + pex2::kanMX This study (Figure 4) 
pex4.PXA1-tFT  yMaM330, PXA1-tFT + pex4::kanMX This study (Figure 4) 
pdr5.PXA1MUT-
mGFP 
BY4741, pdr5 + PXA1G650S/K651R:: mGFP-bleMX6 




BY4741, atg12 + PXA1G650S/K651R:: mGFP-bleMX6 
This study (Figure 2, 4, 
S1 and S2) 
pex2.PXA1MUT-
mGFP 
YMaM330, WT. PXA1MUT-mGFP + pex2 deletion 
pex2::kanMX 
This study (Figure 5 and 
S2) 
pex2.PXA1MUT-
mGFP + PEX3 
mKate2 
yMaM330, pex2 PXA1MUT-mGFP + PEX3::mKate2-
hphMX 
This study (Figure 5) 
pex4.PXA1MUT-
mGFP 
YMaM330, WT. PXA1MUT-mGFP + pex4 deletion 
pex4::kanMX 
This study (Figure 5 and 
S2) 
pex4.PXA1MUT-
mGFP + PEX3 
mKate2 
yMaM330, pex4 PXA1MUT-mGFP + PEX3::mKate2-
hphMX 
This study (Figure 5) 
pex5.PXA1MUT-
mGFP 
YMaM330, WT. PXA1MUT-mGFP + pex5 deletion 
pex5::kanMX 
This study (Figure 5 and 
S2) 
pex5.PXA1MUT-
mGFP + PEX3 
mKate2 
yMaM330, pex5 PXA1MUT-mGFP + PEX3::mKate2-
hphMX 
This study (Figure 5) 
ufd4.PXA1MUT-
mGFP 
BY4741, ufd4 + PXA1G650S/K651R::mGFP-bleMX6 
This study (Figure 5, 6, 
7 and S2) 
ufd4.PXA1MUT-
mGFP + PEX3 
mKate2 




Table 2. Plasmids used in this study 
nam7.PXA1MUT-
mGFP 
BY4741, nam7 + PXA1G650S/K651R::mGFP-bleMX6 
This study (Figure 6) 
ela1.PXA1MUT-
mGFP 
BY4741, ela1 + PXA1G650S/K651R::mGFP-bleMX6 
This study (Figure 6) 
dsk2.PXA1MUT-
mGFP 
BY4741, dsk2 + PXA1G650S/K651R::mGFP-bleMX6 
This study (Figure 6) 
skp2.PXA1MUT-
mGFP 
BY4741, skp2 + PXA1G650S/K651R::mGFP-bleMX6 
This study (Figure 6) 
dma2.PXA1MUT-
mGFP 
BY4741, dma2 + PXA1G650S/K651R::mGFP-bleMX6 
This study (Figure 6) 
tul1.PXA1MUT-
mGFP 
BY4741, tul1 + PXA1G650S/K651R::mGFP-bleMX6 




ufd4 PXA1MUT-mGFP + SKL::DsRed-hphMX This study (Figure S1) 
ufd4.PXA1-mGFP BY4741, ufd4 + PXA1::mGFP-bleMX6 
This study (Figure 7 and 
S2) 
fox1 BJ1991, fox1::kanMX 
(van Roermund et al., 
2008).  
pxa1 yMaM330, pxa1 deletion , pxa1::hphMX This study (Figure 7) 
WT.PXA1MUT-
mGFP+MycUbK48R 
yMaM330, WT PXA1MUT-mGFP + PCUP1-MycUbK48R 
[yeast episomal plasmid, YEP-Pcup1-MycUbK48R] 




WT PXA1MUT-mGFP + PCUP1-MycUb [yeast episomal 
plasmid, YEP-Pcup1-MycUb]  
This study (Figure 3 and 
S1) 
pdr5+ MycUb pdr5 +[yeast episomal plasmid, YEP-Pcup1-MycUb] 
This study (Figure 2 and 
S1) 
pdr5.PXA1MUT-
mGFP + MycUb 
pdr5.PXA1MUT-mGFP +[yeast episomal plasmid, YEP-
Pcup1-MycUb] 
This study (Figure 2 and 
S1) 
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Plasmid Description Use Reference 
pGW053 
YCplac111 plasmid 





terminal PXA1 (with 
G650S/K651R)  




pHIPZ containing mGFP; 
bleMX6, AmpR 
1. Vector for cloning  
2. C-terminal mGFP 
tagging to PXA1; genome 
integration 




pHIPZ- mGFP containing 
C-terminal PXA1 with 
two mutations 
G650S/K651R 
[PXA1MUT] ; bleMX6, 
AmpR 
C-terminal mGFP tagging 






mKate2 and C-terminal of 
PEX14 ; hphMX, AmpR 
1. C-terminal mKate2 
tagging to PEX3; genome 
integration (Chen et al., 2018) 
2. Gene disruption (pxa1) 






gene; kanMX, AmpR  
Gene disruption (atg12, 
pex2, pex4 and  pex5) by 
kanMX6 marker  
(Khmelinskii et al., 2014) 
pMaM168 
pFA6a plasmid 




sfGFP) ; URA3, AmpR 
1. C-terminal tFT tagging 
; PXA1-tFT and PEX11-
tFT integration into 
yMaM330 
(Khmelinskii et al., 2014) 
pRG226 
Yeast episomal plasmid 
(YEP) ; URA3, 2μ ori 
Vector for cloning  Addgene, 64529 
pCGCN-
FAA4 
Plasmid containing CUP1 
promoter and mGFP; 
bleMX6, AmpR 
Amplification of CUP1 
promoter; cloning 
(Saraya et al., 2010) 
pRDV1 
Plasmid containing Myc 
tagged ubiquitin (Ub) 
Amplification of MycUb; 
vector for cloning  








under control of DHAS 
promoter; hphMX, AmpR 
pRDV2 
Plasmid containing Myc 
tagged ubiquitin mutant 
(UbK48R) under the 
control of DHAS 
promoter; hphMX, AmpR 
Amplification of 
MycUbK48R; Vector for 
cloning  
(Williams and van der Klei, 2013) 
YEP-PCUP1-
MycUb 
Yeast episomal plasmid 
(YEP) containing 
CUP1promoter and 
MycUb; URA3, AmpR 










Integration into WT and 





DsRed-SKL under the 
control of TEF promoter; 
LEU2, AmpR 




DsRed-SKL under the 
control of TEF promoter; 
hphMX, kanR 




SKL under the control of 
TDH3 promoter; LEU2, 
AmpR 
Amplification of TDH3 
promoter; cloning 




DsRed-SKL under the 
control of TDH3 
promoter, hphMX AmpR 
Integration into WT. 
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Table 3. Primers used in this study 
Primer Sequence Description 
VIP1080
   
ACGACGGCCAGTGAATTCCCCACTCCTGCT
ATCTTACG To amplify PXA1 gene; forward primer 
VIP1081 
CATGATTACGCCAAGCTTGACCAACAACTG




Site directed mutagenesis primer used to 
introduce G650S/K651R mutation into 




Site directed mutagenesis primer used to 
introduce G650S/K651R mutation into 







To amplify Pxa1-mGFP module from 







To amplify Pxa1-mGFP module from 





To amplify Pxa1MUT from pGW053 and 





To amplify Pxa1MUT from pGW053 and 




To amplify Pxa1MUT and mGFP 
sequences from pHIPZ- Pxa1MUT- 






To amplify Pxa1MUT and mGFP 
sequences from pHIPZ- Pxa1MUT- 







To amplify Pex3-mKate cassette from 







To amplify Pex3-mKate cassette from 








To amplify Pxa1-tFT module from 






To amplify Pxa1-tFT module from 






To amplify PEX2 deletion cassette from 






To amplify PEX2 deletion cassette from 






To amplify PEX4 deletion cassette from 






To amplify PEX4 deletion cassette from 






To amplify ATG12 deletion cassette 






To amplify ATG12 deletion cassette 






To amplify PEX5 deletion cassette from 






To amplify PEX5 deletion cassette from 






To amplify PXA1 deletion cassette from 






To amplify PXA1 deletion cassette from 





To amplify CUP1 promoter sequence; 
forward primer 









































To amplify TDH3 sequence with Not-I 







To amplify TDH3 sequence with BamHI 
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Figure S1: Pxa1MUT-mGFP undergoes UPS mediated degradation 
A. Co-localization analysis of Pxa1MUT-mGFP with the peroxisomal marker DsRed-SKL in WT (middle 
panels) and ufd4 (bottom panels) cells. The WT strain lacking fluorescent markers (top panels) was used 
as control. Cells were pre-grown on glucose media and shifted to oleate/glucose media. Fluorescence 
images were taken from cells grown under peroxisome inducing conditions to an OD600 of ~1.5. Blue 
arrows- GFP spots, yellow arrows- DsRed spots and red arrows- background fluorescence. Scale bar: 3 
μm.  
B. Co-localization analysis of Pxa1MUT-mGFP with the peroxisomal marker Pex3-mKate2 in WT (Top 
panels) and ufd4 (bottom panels) cells treated with CHX. These are additional FM images of Figure 6D 
time T=0, showing that circular GFP-positive structures are visible in both in WT and ufd4 cells (see 
Figure 6). Blue arrows- GFP spots, yellow arrows- mKate2 spots and red arrows- background 
fluorescence, scale bar:3 μm. Line profiles were made as described in Figure 1.  
C. Western blots used for the quantification of Pxa1-mGFP and Pxa1MUT-mGFP levels in Figure 1B. 
D. WT cells expressing Pxa1-mGFP were initially grown on glucose, shifted to oleate containing media and 
TCA samples were collected at indicated time points. After lysis, samples were probed by immunoblotting 
with antibodies against mGFP and glucose phosphate dehydrogenase (G6PD; loading control). 
E. CHX chase analysis of Pxa1-mGFP and Pxa1MUT-mGFP, blots used for quantification in Figure 2A.  
F. CHX chase analysis of Pxa1MUT-mGFP in pdr5 cells in the presence or absence of the proteasome 
inhibitors MG132 and Bortezomib. Blots used for quantification presented in Figure 3A. 
G. CHX chase analysis of Pxa1MUT-mGFP in atg12 cells (top panel) and cells expressing Myc-tagged 
ubiquitin (Ub; middle panel) or ubiquitin mutant (UbK48R; bottom panel). Blots used for quantification in 
Figure 3B and 3C,respectively.  
H. CHX chase analysis of Pex11-tFT and Pxa1-tFT, blots used for quantification in Figure 4C. Top bands in 
each panel represent full-length PMP-tFT fusions, *denotes a shorter, mCherry-sfGFP product resulting 
from mCherry hydrolysis during TCA lysate preparation and ** denotes a tFT fragment produced by 







Proteasome dependent quality control of  the peroxisomal membrane protein Pxa1p
145
3
Figure S2: Pxa1MUT-mGFP degradation in peroxisome and non-peroxisome mutant strains 
A. Blots of Pxa1MUT-mGFP levels in cells lacking functional peroxisomes. (Right) WT, pex2 and pex4 
cells and (Middle) WT, atg12 and  pex5 cells, blots used for quantification in Figure 5A. (Left) Blots 
of Pxa1MUT-mGFP levels in mutant strains ufd4, nam7, ela1, dsk2, skp1,tul1 and dma2, blots used for 
quantification in Figure 6A. 
B. CHX chase analysis of Pxa1MUT-mGFP in WT and mutants (pex2, pex4, ufd4 and pex5), blots used 
for quantification in Figure 5B and 6C. 
C. Pex3-mKate2 levels in WT and peroxisome mutant strains expressing Pxa1MUT-mGFP. Bar graph 
(Right) showing Pex3-mKate2 levels in WT, pex2, pex4 and pex5 cells, quantified from western blots 
(Left). Cells were grown as indicated in Figure S1A, lysed and samples were subjected to SDS-PAGE 
and immunoblotting with antibodies against RFP and Pyc. Pex3-mKate2 levels were normalized to 
the loading control Pyc. Protein levels in WT cells were set to 1.Values represent the mean ± SD of 
three independent experiments. Numbers above the columns depict the p-value. 
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Pex13p is a member of docking complex required for the import of peroxisomal matrix proteins. 
We previously demonstrated that Pex13p is rapidly degraded via the ubiquitination proteasome 
system (UPS) in a Pex2p-dependent manner in the yeast Hansenula polymorpha. However, 
whether Pex13p degradation is conserved in other species and which additional factors may be 
involved remains unclear. In this study, we demonstrate that UPS-mediated Pex13p degradation 
occurs in the yeast Saccharomyces cerevisiae and that the mechanisms of Pex13p degradation 
are similar to in H. polymorpha. Additionally, inactivation of Cdc48p, an ATPase involved in 
degrading mitochondrial and ER membrane proteins, does not result in stabilization of Pex13p 
in vivo, indicating that Pex13p degradation likely occurs via a different mechanism than other 
organellar membrane proteins. Furthermore, we utilize a tandem fluorescent protein timer 
approach to identify additional factors involved in Pex13p degradation. Our data demonstrate 
that cytosolic E2 and E3 enzymes play a role in Pex13p degradation. Taken together, our data 
provide further evidence that Pex13p degradation is conserved throughout evolution while they 
also uncover novel components of the UPS that are involved in Pex13p degradation. The 
implications of our findings are discussed.  
 
Keywords: Peroxisome, protein degradation, ubiquitination, PMP, Pex13p 




Peroxisomes are cellular compartments in eukaryotic cells that house metabolic pathways. 
Common functions of peroxisomes include the β-oxidation of fatty acids and the decomposition 
of oxygen reactive species, although many species- and cell-specific peroxisomal functions are 
known (Gabaldon, 2010). Defects in peroxisome function can cause a spectrum of inherited 
developmental brain disorders (Walker et al, 2002). Peroxisome function depends on which 
peroxisomal membrane proteins (PMP) and peroxisomal matrix proteins (MAT) are present in 
the peroxisome. Both PMPs and MATs are post-translationally transported to peroxisomes with 
the aid of receptor proteins. MATs can be targeted to peroxisomes in one of two different ways: 
MATs with a C-terminal peroxisomal targeting signal type-1 (PTS1) sequence can be 
recognized by the cytosolic receptor Pex5p, while MATs containing an N-terminal PTS2 signal 
can be recognized by Pex7p (Braverman et al, 1997; Mukai et al, 2002). PTS2 protein import 
also requires the action of additional co-receptor proteins (Sichting et al, 2003). After 
recognition, the receptor-cargo complex binds to the docking complex on the peroxisomal 
membrane, consisting of Pex14p and Pex13p (Elgersma et al, 1996; Johnson et al, 2001). After 
cargo translocation and release, a process that is poorly understood (Girzalsky et al, 2010), the 
receptor Pex5p is ubiquitinated at the peroxisome by the peroxisomal ubiquitination machinery, 
consisting of the ubiquitin-conjugating enzyme Pex4p and the RING finger ubiquitin ligases 
Pex2p, Pex10p and Pex12p (Platta et al, 2007; Williams et al, 2008), which allows it to be 
recycled back to the cytosol, with the aid of Pex1p and Pex6p, two AAA-ATPases (Platta et al, 
2008). The co-receptor proteins that function with Pex7p in the import of PTS2 proteins can 
also be ubiquitinated in similar way during the import cycle (El Magraoui et al, 2013). 
Previously, we demonstrated that Hansenula polymorpha Pex13p is degraded via the 
ubiquitination proteasome system (UPS), and its degradation requires the peroxisomal 
ubiquitination machinery mentioned above (Chen et al, 2018). The UPS-mediated degradation 
of proteins occurs in a stepwise fashion (Hershko, 1996). Ubiquitin, a globular protein of 
~8kDa, is first activated by a ubiquitin activating enzyme (E1) consuming ATP as energy. The 
activated ubiquitin was then transferred to the Cysteine residue of a ubiquitin conjugating 
enzyme (E2). Ubiquitin can then be either passed on to the active Cysteine of a HECT-class 
ubiquitin ligase (E3) and subsequently transferred to a specific substrate, or be transferred to a 
substrate directly from the E2 with the help of a RING E3 ligase (Scheffner et al, 1995). 
Attachment of ubiquitin to a substrate usually occurs via lysine residues on the substrate 
(Rodriguez, 1996), although ubiquitin attachment to cysteine, serine and threonine residues has 
been reported (Wang et al, 2007; Williams et al, 2007). In yeast, around 11 E2s and more than 
60 E3s are involved in the ubiquitination process (Finley et al, 2012; Ravid & Hochstrasser, 
2007). While ubiquitination serves many functions, UPS-mediated protein degradation often 
requires the attachment of a chain of ubiquitin molecules (referred to as poly-ubiquitination). 
Is this case, ubiquitin itself becomes a substrate for ubiquitination and a common linkage 
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involved in UPS-mediated protein degradation is via Lysine-48 (K48) on ubiquitin (Hershko & 
Ciechanover, 1998). 
In this manuscript, we have investigated the stability of Pex13p in the yeast Saccharomyces 
cerevisiae, to establish how conserved the Pex13p degradation process is across evolution. We 
demonstrate that Pex13p undergoes rapid degradation in wild type S. cerevisiae cells and also 
establish that Pex13p degradation is inhibited when poly-ubiquitin chain formation is blocked. 
Furthermore, Pex13p turnover is inhibited in pex2 and pex4 cells, indicating that the mechanism 
by which H. polymorpha and S. cerevisiae Pex13p is degraded is likely to be conserved. 
Furthermore, we show that the function of Cdc48p, an AAA-ATPase involved in the 
degradation of ER and mitochondrial membrane proteins, is not required for Pex13p 
degradation. Finally, we use a high throughput screening approach, combined with a tandem 
fluorescent timer (tFT) (Khmelinskii et al, 2014; Khmelinskii et al, 2012), to identify additional 
proteins involved in Pex13p degradation. Our tFT and subsequent biochemical analysis 
identifies a role for cytosolic E2 and E3 enzymes in Pex13p degradation, providing a solid 
platform for future studies aimed at understanding the molecular mechanisms and underlying 
functions of Pex13p degradation. 
Results 
The rapid degradation of Pex13p is conserved in S. cerevisiae 
Previously we demonstrated that Pex13p in the yeast H. polymorpha undergoes rapid 
degradation via the UPS (Chen et al, 2018). In addition, UPS-mediated Pex13p degradation 
was reported to occur in plants (Pan et al, 2016), although this degradation event remain 
controversial (Ling et al, 2017; Pan & Hu, 2018). Therefore, we decided to investigate whether 
Pex13p degradation occurs in other organisms and chose the yeast S. cerevisiae for this. We 
utilized Pex13p fused to mGFP, which allowed us to detect the protein on western blot using 
anti-GFP antibodies as well as to follow the subcellular localization of Pex13p using 
fluorescence microscopy. Cells expressing Pex13-mGFP are able to grow on media containing 
oleic acid as sole carbon source (Figure 1A), a condition that requires peroxisome function for 
growth, indicating that Pex13-mGFP is a functional protein.  
To investigate Pex13p turnover, we treated cells expressing Pex13-mGFP with 
cycloheximide (CHX). Treatment of cells with CHX blocks protein production and it is 
commonly used to investigate the kinetics of protein degradation. Cells were grown on oleic 
acid containing media, to stimulate peroxisome proliferation. Pex13-mGFP levels rapidly 
decreased after addition of CHX while Pex14p levels remained largely unaltered (Figure 1B, D 
& E), indicating that Pex13-mGFP undergoes protein degradation, similar to our data in the 
yeast H. polymorpha (Chen et al, 2018). Next, we investigated the role of the UPS in Pex13-
mGFP degradation. To achieve this, we co-expressed the K48R mutant form of ubiquitin (Ub) 
in cells expressing Pex13-mGFP. This Ub-K48R mutant inhibits the formation of poly-
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ubiquitination chain on substrates and therefore inhibits UPS-mediated protein degradation 
(Thrower et al, 2000). Our data demonstrate that Pex13-mGFP turnover is significantly reduced 
in cells expressing Ub-K48R compared to wild-type (P<0.01), indicating that the UPS is 
involved in its degradation (Figure 1C & D). These data demonstrate that, similar to in H. 
polymorpha, Pex13p undergoes rapid, UPS-mediated degradation in S. cerevisiae. 
Figure 1: Rapid degradation of Pex13-mGFP via the UPS occurs in S. cerevisiae.
A   Spot assay to test the growth of cells expressing Pex13-tFT or Pex13-mGFP. S. cerevisiae cells were spotted 
onto oleic acid plates and cultured at 30℃ for 7 days. 
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B    WT cells expressing Pex13-mGFP were grown on oleic acid containing media for 12 hrs and treated with 
DMSO (Ctrl) or Cycloheximide (CHX). TCA samples were taken at the indicated time (hrs) after 
DMSO/CHX addition and probed by SDS-PAGE and immunoblotting with antibodies against mGFP, Pex14p 
and Pyc1p (indicated Pyc). 
C Representative western blots of Ub-K48R cells expressing Pex13-mGFP derived from cells grown and treated 
as in A. Samples were probed with SDS-PAGE and immunoblotting with antibodies against mGFP, Pex14p 
and Pyc1p. 
D    Quantification of Pex13-mGFP levels in WT and Ub-K48R cells expressing Pex13-mGFP. Protein levels were 
normalized to the loading control (Pyc1p) at the corresponding time point and to the protein levels at T0. 
Values represent the mean ± SD of three independent experiments. Asterisks denote statistically significant 
increases in protein levels compared to those in WT samples (*P < 0.05, **P < 0.01). 
E    Quantification of Pex14p levels in WT and Ub-K48R cells expressing Pex13-mGFP. Protein levels were 
normalized to the loading control (Pyc1p) at the corresponding time point and to the protein levels at T0. 
Values represent the mean ± SD of three independent experiments.  
The peroxisomal ubiquitination machinery is required for Pex13p degradation in S. 
cerevisiae  
Previously, we demonstrated that Pex13p in the yeast H. polymorpha was stabilized when 
components of the peroxisomal ubiquitination machinery, such as the E3 ligase Pex2p or the 
E2 Pex4p are absent (Chen et al, 2018). Therefore, we investigated whether the mechanism by 
which Pex13p degradation occurs was also conserved in S. cerevisiae. We introduced Pex13-
mGFP into pex2 or pex4 cells and followed Pex13p-mGFP degradation in CHX-treated cells 
grown on oleic acid containing media (Figure 2). Compared to WT, Pex13-mGFP turnover was 
clearly inhibited in pex2 (Figure 2A & B) and pex4 (Figure 2 D & E) cells (P<0.001), suggesting 
that Pex2p and Pex4p play a role in Pex13p degradation. Next, we investigated the subcellular 
localization of Pex13-mGFP in WT and pex2 cells grown on oleic acid containing media. 
Pex13-mGFP co-localizes with Pex3-mKate (a stable peroxisomal membrane protein, used as 
the peroxisomal membrane marker) on the peroxisomal membrane in pex2 cells (Figure 3A & 
B) and mGFP intensity is significantly increased in pex2 cells (Figure 3A-D). Furthermore, 
Pex13-mGFP levels are significantly elevated in pex2 cells compared to wild-type cells (Figure 
3E & F), again indicating Pex13-mGFP degradation is inhibited in pex2 cells. These data 
strongly suggest that Pex13p degradation in both H. polymorpha and S. cerevisiae proceeds via 
a similar mechanism. 





Figure 2: Pex13-mGFP degradation is inhibited in cells lacking members of the peroxisomal 
ubiquitination machinery 
A Representative western blots of pex2 cells expressing Pex13-mGFP derived from cells grown and treated as 
in (Figure 1B). Samples were probed with SDS-PAGE and immunoblotting with antibodies against mGFP, 
Pex14p and Pyc1p.  
B    Quantification of Pex13-mGFP levels in WT and pex2 cells expressing Pex13-mGFP. Protein levels were 
normalized to the loading control (Pyc1p) at the corresponding time point and to the protein levels at T0. 
Values represent the mean ± SD of three independent experiments. Values of WT were taken from (Figure 
1A). Asterisks denote statistically significant increases in protein levels compared to those in WT samples (*P 
< 0.05, **P < 0.01, ***P < 0.001). 
C   Quantification of Pex14p levels in WT and pex2 cells. Protein levels were normalized to the loading control 
(Pyc1p) at the corresponding time point and to the protein levels at T0. Values represent the mean ± SD of 
three independent experiments. Values of WT were taken from Figure 1B. 
D    Representative western blots of pex4 cells expressing Pex13-mGFP derived from cells grown and treated as 
in (A). Samples were probed with SDS-PAGE and immunoblotting with antibodies against mGFP, Pex14p 
and Pyc1p. 
E    Quantification of Pex13-mGFP levels in WT and pex4 cells expressing Pex13-mGFP. Protein levels were 
normalized to the loading control (Pyc1p) at the corresponding time point and to the protein levels at T0. 
Values represent the mean ± SD of three independent experiments. Values of WT were same as in (Figure 
1B). Asterisks denote statistically significant increases in protein levels compared to those in WT samples (*P 
< 0.05, **P < 0.01, ***P < 0.001). 
F   Quantification of Pex14p levels in WT and pex4 cells. Protein levels were normalized to the loading control 
(Pyc1p) at the corresponding time point and to the protein levels at T0. Values represent the mean ± SD of 
three independent experiments. Values of WT were same as in (Figure 1B). 
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Figure 3: Pex13-mGFP accumulates on peroxisomes in pex2 cells.
A   WT and pex2 cells producing Pex13-mGFP and Pex3-mKate2 were grown on oleic acid containing media to 
an OD600 of 1.0 and fluorescence microscopy images were taken. Images of Pex13-mGFP were processed 
using ImageJ with optimal settings to show signals in WT and pex2. Pex3-mKate2 was used as peroxisomal 
membrane marker. The following settings were used: for WT cells mGFP (290, 650) and mKate2 (225, 600); 
for pex2 cells mGFP (290, 2900) and mKate2 (225, 630). Scale bar: 5μm.
B    Fluorescence images of Pex13-mGFP in WT or pex2 shown in (A) were processed using ImageJ with the same 
settings: mGFP (300, 2000), mKate2 (225, 620). Scale bar: 5μm.
C   Box plot showing quantification of mGFP fluorescence intensity at the peroxisomal membrane in WT and pex2
cells producing Pex13-mGFP. Fluorescence intensities (arbitrary units) were measured using ImageJ. The box 
represents values from the 25 percentile to the 75 percentile; the horizontal line through the box represents the 
median value. Whiskers indicate maximum and minimum values. Pex13-mGFP measurements were taken as 
described in the Materials and Methods section.
D    Average ratio ± SD per cell (n = 40) of mGFP to mKate intensities in WT and pex2 cells. ***P < 0.001.
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E   WT and pex2 cells producing Pex13-mGFP grown on oleic acid media and TCA samples were taken when the 
cultures reached an OD600 of 1.0. Samples were subjected to SDS-PAGE and immunoblotting using antibodies 
against mGFP, Pex14p and Pyc1p. 
F    Quantification of protein levels in WT and pex2 cells, normalized to the loading control Pyc1p. Protein levels 
in WT cells were set to 1. Values represent the mean ± SD of three independent experiments. Asterisks denote 
statistically significant increases in protein levels compared to those in WT samples (**P < 0.01).  
Cdc48p function is not required for Pex13p degradation 
Membrane proteins need to be removed from their native membrane environment before they 
can be degraded by the proteasome and the AAA-ATPase Cdc48p (p97 in humans) is known 
to extract membrane proteins from both the endoplasmic reticulum (ER) and mitochondrial 
membranes and deliver them to the proteasome for degradation (Cao et al, 2003; Wolf & Stolz, 
2012). Therefore, we considered the possibility that Cdc48p could be involved in extracting 
Pex13p out of the peroxisomal membrane and delivering it to the proteasome, for degradation. 
To investigate this, we utilized a temperature sensitive mutant form of Cdc48p (cdc48-3), since 
CDC48 is an essential gene (Dargemont & Ossareh-Nazari, 2012; Wolf & Stolz, 2012; 
Yamanaka et al, 2012). The mutant Cdc48 protein is active when cells are grown at the 
permissive temperature of 23℃ but is inactive when cells are grown at the restrictive 
temperature of 37℃. We used Cdc5p as a control substrate. Cdc5p is a serine/threonine-protein 
kinase required for the cell cycle and its degradation requires Cdc48p (Cao et al, 2003). We 
introduced Pex13-mGFP or Cdc5-HA6 into cdc48-3 cells and followed the degradation of these 
proteins in oleic acid-grown cells treated with CHX, at both 23℃ and 37℃ (Figure 4). Cdc5-
HA6 degradation was observed in cells grown at the permissive temperature while Cdc5-HA6 
turnover was inhibited in cells growing at the restrictive temperature (Figure 4A-C). 
Significantly, Pex13-mGFP was degraded at a similar rate in cells grown at both the permissive 
and the restrictive temperatures (Figure 4D-K), suggesting that Cdc48p function is not required 
for Pex13p degradation. 





Figure 4: Cdc48p function is not required for Pex13p degradation.  
A Representative western blots of cdc48-3 cells expressing Cdc5-HA6 derived from cells grown and treated as 
in (A). Samples were probed with SDS-PAGE and immunoblotting with antibodies against HA and Pyc1p.  
B  Representative western blots of cdc48-3 cells expressing Cdc5-HA6 derived from cells grown and treated as in 
(E). Samples were probed with SDS-PAGE and immunoblotting with antibodies against HA and Pyc1p. 
C  Quantification of Cdc5-HA6 levels in cdc48-3 cells at permissive temperature 23℃ or restrictive temperature 
37℃ expressing. Protein levels were normalized to the loading control (Pyc1p) at the corresponding time point 
and to the protein levels at T0. Values represent the mean ± SD of three independent experiments. (*P < 0.05) 
D  WT cells expressing Pex13-mGFP were grown on oleic acid media at 23℃ for 18 hrs and treated with DMSO 
(Ctrl) or Cycloheximide (CHX). TCA samples were taken at the indicated time (hrs) after DMSO/CHX 
addition and probed by SDS-PAGE and immunoblotting with antibodies against mGFP, Pex14p and Pyc1p. 
E Representative western blots of cdc48-3 cells expressing Pex13-mGFP derived from cells grown and treated 
as in (A). Samples were probed with SDS-PAGE and immunoblotting with antibodies against mGFP, Pex14p 
and Pyc1p.  
F  Quantification of Pex13-mGFP in (A) and (B). Protein levels were normalized to the loading control (Pyc1p) at 
the corresponding time point and to the protein levels at T0. Values represent the mean ± SD of three 
independent experiments. 
G  Quantification of Pex14p levels in WT and cdc48-3 cells expressing Pex13-mGFP. Protein levels were 
normalized to the loading control (Pyc1p) at the corresponding time point and to the protein levels at T0. 
Values represent the mean ± SD of three independent experiments.  




Figure 4 continued 
H  WT cells expressing Pex13-mGFP were grown on oleic acid media at 23℃ for 17 hrs, then shifted to 37℃ for 
1 hr, and treated with DMSO (Ctrl) or Cycloheximide (CHX). TCA samples were taken at the indicated time 
(hrs) after DMSO/CHX addition and probed by SDS-PAGE and immunoblotting with antibodies against 
mGFP, Pex14p and Pyc1p.
I Representative western blots of WT cells expressing Pex13-mGFP derived from cells grown and treated as in 
(E). Samples were probed with SDS-PAGE and immunoblotting with antibodies against mGFP, Pex14p and 
Pyc1p.
J  Quantification of Pex13-mGFP in (E) and (F). Protein levels were normalized to the loading control (Pyc1p) at 
the corresponding time point and to the protein levels at T0. Values represent the mean ± SD of three 
independent experiments.
K  Quantification of Pex14p levels in WT and cdc48-3 cells expressing Pex13-mGFP. Protein levels were 
normalized to the loading control (Pyc1p) at the corresponding time point and to the protein levels at T0. 
Values represent the mean ± SD of three independent experiments. 
Investigating Pex13p degradation with a tandem fluorescent timer
While our data demonstrate a role for the peroxisomal ubiquitination machinery in the 
degradation of S. cerevisiae Pex13p (Figure 2 and 3), we sought to identify which additional 
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factors may regulate Pex13p degradation. To achieve this we utilized a tandem fluorescent timer 
(tFT) approach, which has been previously used to study protein stability in S. cerevisiae cells
(Khmelinskii et al, 2014). The tFT tag consists of mCherry and sfGFP, which have maturation 
half times of around 45 and 5 minutes, respectively (in S. cerevisiae cells grown at 30°C). 
Measuring the red and green fluorescent intensities directly in cells can provide information on 
the relative stability of the tFT-tagged protein in an in vivo setting. A high mCherry/sfGFP 
intensity ratio indicates that the tagged protein is stable while a low mCherry/sfGFP ratio 
indicates an unstable protein (Khmelinskii et al, 2012). Cells expressing Pex13-tFT only (and 
hence not the WT version of the protein) can grow on oleic acid (Figure 1A), suggesting that 
the Pex13-tFT protein is functional. Furthermore, Pex13-tFT was rapidly degraded in cells 
treated with CHX (Figure 5), demonstrating that Pex13-tFT can be used to study Pex13p 
degradation.  
                 
Figure 5: Pex13-tFT is rapidly degraded in S. cerevisiae cells treated with CHX.
A   Representative western blots of samples derived from cells expressing Pex13-tFT or Pex11-tFT grown for 12 
hrs on oleic acid media. Blots were probed with antibodies directed against mGFP and Pyc1p. * Denotes a 
hydrolysed product of mature mCherry during SDS-sample preparation due to chemical breakage of the 
fluorophore. This cuts mCherry into two pieces, at around position 69 of mCherry, thereby generating a 
fragment containing the C-term mCherry and sfGFP of approximately 45 kDa. # Denotes an incomplete 
degradation product of sfGFP due to its rigid fold. This 33 kDa band often appears as a doublet. The presence 
of this band is a strong signature that the tFT tagged protein is degraded by the proteasome (Khmelinskii et 
al, 2016). 
B   Quantification of Pex13-tFT and Pex11-tFT levels of blots in the left. Protein levels were normalized to the 
loading control (Pyc1p) at the corresponding time point and to the protein levels at T0. Values represent the 
mean ± SD of three independent experiments.
Investigating Pex13p degradation in the yeast Saccharomyces cerevisiae
165
4
Next, we created a library of 152 strains made by synthetic genetic array (SGA) expressing 
Pex13-tFT that either lacked a gene involved in protein degradation or which contained a 
mutant version of a protein involved in protein degradation (in case the deletion was lethal) 
(Tong & Boone, 2006). Gene deletion and gene tagging were validated by PCR (data not 
shown). Mutant cells expressing Pex13-tFT were grown on synthetic complete media plates 
containing 0.1% oleic acid and 0.1% glucose for seven days at 30°C. Colonies (four technical 
replicates for each mutant strain plus controls) were imaged every day to determine mCherry 
and GFP fluorescence intensities and the average ratio of mCherry to sfGFP intensities was 
determined for each strain on each day. These ratios were normalized to the ratio measured in 
WT cells expressing Pex13-tFT and the Z-score, the deviation of the ratio for a particular mutant 
strain compared to the average ratio across all strains, was calculated for each strain (Figure 6). 
Further details on how the images were taken and the data were processed can be found in the 
Materials and Methods section.  
We considered mutant strains that displayed an increase in Z-score of more than 1.0 on 
each of the seven days potentially interesting. These strains, which include cells deleted for 
PEX4, PEX2, PEX10, PEX12 and UBI4 (which depletes the amount of ubiquitin available in 
the cell, but does not result in an absence of ubiquitin completely because of the presence of 
additional copies of the UBI gene), display an increase in Pex13-tFT stability on each of the 
seven days (Figure 6). A role for these factors in Pex13p degradation was already shown (Figure 
1, 2 & 3), validating our tFT approach. In addition, cells deleted for UBR2, UFD4, RCY1, 
YUH1, UBP6 and UBC4 all displayed increased Pex13-tFT stability on each of the seven days 
(Figure 6). Ufd4p is a cytosolic HECT E3 ligase which regulates the degradation of misfolded 
proteins (Theodoraki et al, 2012). Interestingly, Ufd4p is also involved in the degradation of 
Pxa1p (Devarajan et al, in preparation), a peroxisomal membrane protein involved in the import 
of activated long-chain fatty acids from the cytosol to the peroxisomal matrix (Shani et al, 
1995). Ubc4p is a ubiquitin-conjugating enzyme (E2) involved in the degradation of abnormal 
or excess proteins while it also mediates the ubiquitination of Pex5p (Seufert & Jentsch, 1990; 
Williams et al, 2007). Ubc4p is known to work with Ufd4p in the ubiquitination of certain 
substrates (Bao, 2015). Ubr2p is a cytosolic RING E3 ligase which like Ufd4p, is involved in 
the degradation of misfolded proteins (Nillegoda et al, 2010). S. cerevisiae cells depleted of 
Ubr2p cannot grow on oleic acid containing media (Lockshon et al, 2007; Saleem et al, 2010), 
although the underlying peroxisomal defect in these cells is unknown. Ubp6p is a de-
ubiquitinating enzyme that associates with the proteasome and can negatively regulate 
proteasomal activity (Hanna et al, 2006) and it is also involved in Pxa1p degradation (Devarajan 
et al, in preparation). Rcy1p is involved in recycling plasma membrane proteins internalized by 
endocytosis (Wiederkehr et al, 2000) and is required for recycling of the v-SNARE Snc1p 
(Galan et al, 2001). Yuh1p is a de-ubiquitinating enzyme that regulates cellular ubiquitin levels 
(Miller et al, 1989). Taken together, our tFT analysis identifies additional factors potentially 
involved in Pex13p degradation. 
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Figure 6: tFT analysis identifies additional factors involved in Pex13p degradation.
Heat-map indicating relative Pex13-tFT stability in different mutant yeast strains. Strains expressing Pex13-tFT 
were grown for seven days at 30℃ on oleic acid plates with 0.1% glucose (w/v). The mCherry and sfGFP 
fluorescence intensities were measured for colonies from each strain on each day and the mCherry/sfGFP ratio 
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was calculated and used to determine the Z-score, the deviation of the ratio for a particular strain on a particular 
day compared to the average ratio across all strains on that day. Increases in Z-score are colour coded, ranging 
from 1.0 or less (green) to 5.0 (red). The data for each square in the heat map are derived from four technical 
replicates.
Ufd4p, Ubc4p and Ubr2p facilitate the targeted degradation of Pex13p  
Our tFT data identified six additional candidates that could play a role in Pex13p degradation 
and we chose to investigate the role of three of these candidates in Pex13p turnover. These were 
the cytosolic E2 Ubc4p and the cytosolic E3 ligases Ufd4p and Ubr2p. As negative control we 
chose atg12 cells, since no increase in Pex13-tFT stability was observed in these cells (Figure 
6). We introduced Pex13-mGFP into ufd4, ubc4, ubr2 and atg12 cells and investigated Pex13-
mGFP steady state levels in cells grown on oleic acid containing media, establishing that Pex13-
mGFP levels are significantly elevated ufd4, ubr2 and ubc4 cells (Figure 7). In addition, 
degradation of Pex13-mGFP proceeded at a significantly lower rate in CHX treated ufd4
(Figure 8), ubc4 (Figure 9) and ubr2 (Figure 10) cells, supporting our data on the steady state 
levels of Pex13-mGFP in these mutant strains (Figure 7A,B). Taken together, these data provide 
further evidence for a role for Ufd4p, Ubc4p and Ubr2p in Pex13-mGFP degradation.
Figure 7: Pex13-mGFP levels are increased in ufd4, ubr2 and ubc4 cells.
A   Representative western blots of samples derived from WT and mutant cells grown for 12 hrs on oleic acid 
media. The atg12 strain was used as a negative control. Blots were probed with antibodies directed against 
mGFP, Pex14p and Pyc1p.
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B    Quantification of protein levels in WT and mutant cells, normalized to the loading control Pyc1p. Protein 
levels in WT cells were set to 1. Values represent the mean ± SD of three independent experiments. Asterisks 
denote statistically significant increases in protein levels compared to those in WT samples (*P < 0.05, **P < 
0.01). 
Figure 8: Cells lacking the cytosolic E3 Ufd4p display enhanced Pex13-mGFP stability.
A   The ufd4 cells expressing Pex13-mGFP were grown on oleic acid media for 12 hrs and treated with DMSO 
(Ctrl) or Cycloheximide (CHX). TCA samples were taken at the indicated time (hrs) after DMSO/CHX 
addition and probed by SDS-PAGE and immunoblotting with antibodies against mGFP, Pex14p and Pyc1p.
B  Quantification of Pex13-mGFP level in ufd4 cells expressing Pex13-mGFP. Protein levels were normalized to 
the loading control (Pyc1p) at the corresponding time point and to the protein levels at T0. Values represent 
the mean ± SD of three independent experiments. Values of WT were same as in (Figure 1B). Asterisks denote 
statistically significant increases in protein levels compared to those in WT samples (*P < 0.05).
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C   Quantification of Pex14p level in ufd4 cells expressing Pex13-mGFP. Protein levels were normalized to the 
loading control (Pyc1p) at the corresponding time point and to the protein levels at T0. Values represent the 
mean ± SD of three independent experiments. Values of WT were same as in (Figure 1B).
Figure 9: The cytosolic E2 Ubc4 is involved in Pex13-mGFP degradation.
A   The ubc4 cells expressing Pex13-mGFP were grown on oleic acid media for 12 hrs and treated with DMSO 
(Ctrl) or Cycloheximide (CHX). TCA samples were taken at the indicated time (hrs) after DMSO/CHX 
addition and probed by SDS-PAGE and immunoblotting with antibodies against mGFP, Pex14p and Pyc1p.
B  Quantification of Pex13-mGFP level in ubc4 cells expressing Pex13-mGFP. Protein levels were normalized to 
the loading control (Pyc1p) at the corresponding time point and to the protein levels at T0. Values represent 
the mean ± SD of three independent experiments. Values of WT were same as in (Figure 1B). Asterisks denote 
statistically significant increases in protein levels compared to those in WT samples (*P < 0.05).
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C   Quantification of Pex14p level in ubc4 cells expressing Pex13-mGFP. Protein levels were normalized to the 
loading control (Pyc1p) at the corresponding time point and to the protein levels at T0. Values represent the 
mean ± SD of three independent experiments. Values of WT were same as in (Figure 1B).
Figure 10: Deletion of UBR2, which encodes for a cytosolic RING E3 ligase, impacts on Pex13-
mGFP degradation.
A   The ubr2 cells expressing Pex13-mGFP were grown on oleic acid media for 12 hrs and treated with DMSO 
(Ctrl) or Cycloheximide (CHX). TCA samples were taken at the indicated time (hrs) after DMSO/CHX 
addition and probed by SDS-PAGE and immunoblotting with antibodies against mGFP, Pex14p and Pyc1p.
B    Quantification of Pex13-mGFP levels in WT and ubr2 cells expressing Pex13-mGFP. Protein levels were 
normalized to the loading control (Pyc1p) at the corresponding time point and to the protein levels at T0. 
Values represent the mean ± SD of three independent experiments. Values of WT were same as in (Figure 
1B). Asterisks denote statistically significant increases in protein levels compared to those in WT samples (*P 
< 0.05, **P < 0.01).
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C   Quantification of Pex14p levels in WT and ubr2 cells expressing Pex13-mGFP. Protein levels were normalized 
to the loading control (Pyc1p) at the corresponding time point and to the protein levels at T0. Values represent 
the mean ± SD of three independent experiments. Values of WT were same as in (Figure 1B).  
Discussion 
Pex13p is a PMP and member of the peroxisomal docking complex which is required for MAT 
import, although its actual role in the import process is still unclear. Pex13p has a relatively 
short half-life in the yeast H. polymorpha and it is degraded via the UPS in a Pex2p-dependent 
manner (Chen et al, 2018) In addition Arabidopsis Pex13p can be degraded by the UPS, in a 
process involving the RING E3 Ligase SP1 (Pan et al, 2016). Together, these reports suggest 
that UPS-mediated Pex13p degradation is a conserved process, which led us to investigate 
Pex13p degradation in the yeast S. cerevisiae. Our data clearly establish that Pex13p is degraded 
in S. cerevisiae while additionally demonstrating that Pex13p degradation likely proceeds via a 
similar UPS-mediated mechanism to that in H. polymorpha. Although the function of Pex13p 
degradation remains unclear (see Chapter 3 of this thesis), the fact that it has been shown to 
occur in three different organisms strongly suggests that Pex13p degradation is fundamental to 
peroxisomes. This poses the question as to whether Pex13p degradation also occurs in humans 
and if so, what would be the impact of blocking Pex13p degradation on human health? 
Mutations in Pex2p, Pex10p or Pex12p have been reported in patients suffering from 
peroxisome biogenesis disorders (Gootjes et al, 2004a; Gootjes et al, 2004b; Warren et al, 
2000). In many cases the RING E3 complex members displayed reduced activity or loss of 
function, which resulted in defects in peroxisomal MAT import (Krause et al, 2006). It is 
probable that many of the defects exhibited by these patients are caused by inhibitions to Pex5p 
recycling. Nevertheless, because the peroxisomal E3 ligases are clearly involved in Pex13p 
degradation, it is feasible that some of the effects displayed by patients with reduced 
peroxisomal E3 ligase activity may stem from blocking Pex13p degradation. 
Cdc48p is an AAA-ATPase involved in protein degradation and it is able to extract 
ubiquitinated substrates from the ER and mitochondrial membranes and target them to the 
proteasome for degradation (Wolf & Stolz, 2012). However, since our data establish that 
Cdc48p function is not required for Pex13p degradation, it remains unknown how ubiquitinated 
Pex13p may target to the proteasome. One possibility is that another AAA-ATPase regulates 
the transport of Pex13p towards the proteasome. Pex1p and Pex6p are two such ATPases that 
form a complex and can extract ubiquitinated Pex5p from the peroxisomal membrane (Platta et 
al, 2008), although Pex3p degradation in H. polymorpha did not require Pex1p (Williams & 
van der Klei, 2013). This may argue against a role for the Pex1p/Pex6p complex in Pex13p 
degradation. Similarly the membrane bound AAA-ATPase Msp1p, which was reported to 
extract tail anchored proteins out of the peroxisomal membrane for degradation (Weir et al, 
2017), is also a potential candidate to fulfil this function. Another possibility is that the cytosolic 
proteasome approaches ubiquitinated Pex13p while still at the peroxisomal membrane. The 
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proteasome can associate with the ER membrane (Lipson et al, 2008; Mayer et al, 1998), which 
led Mayer et al. to propose that dislocation and degradation are coupled (Mayer et al, 1998). 
They further proposed that Cdc48p and Rpt4p (a subunit of 19S regulatory particle of the 
proteasome) might work in parallel, due to their structural (both are hexameric AAA-ATPases) 
and functional (both can bind ubiquitin conjugates) similarities (Dai & Li, 2001; Elsasser & 
Finley, 2005; Lam et al, 2002). In such a model, the proteasome may not require the action of 
an additional AAA-ATPase to facilitate Pex13p degradation. Clearly further work is needed to 
investigate how ubiquitinated Pex13p is extracted from the peroxisomal membrane. 
Using a tandem fluorescent timer (tFT) and high throughput screening approach, we 
observed that, in addition to in cells lacking members of the peroxisomal ubiquitination 
machinery, Pex13-tFT stability was also increased in cells lacking Ufd4p, Ubc4p or Ubr2p. 
Furthermore the steady state levels of Pex13-mGFP was increased while Pex13-mGFP 
degradation was reduced in each of these deletion strains. Together these data strongly suggest 
that Ufd4p, Ubr2p and Ubc4p play a role in Pex13-mGFP degradation. This raises the question 
what is the relationship between the different E2s and E3s that play a role in Pex13p 
degradation? One possibility is that several pathways act in parallel on Pex13p. One pathway 
may rely on the peroxisomal ubiquitination machinery while another may require Ubc4p as E2 
and Ufd4p or Ubr2p as E3. Ubc4p is known to act as E2 for Ufd4p (Bao, 2015). However, 
another option is that all these factors act together in ubiquitinating Pex13p. Ufd4p can associate 
with the RING E3 ligase Ubr1p, which allows the rapid formation of poly-ubiquitin chains on 
substrates (Hwang et al, 2010). Perhaps this is also the case for Pex13p, with Ufd4p, Ubr2p and 
Ubc4p “joining forces” with Pex4p and the peroxisomal E3 ligases to promote the rapid 
formation of poly-ubiquitinated Pex13p, to facilitate its degradation. Nevertheless, deletion of 
PEX2 or PEX4 has a dramatic effect on Pex13-mGFP degradation (Figure 2) whereas deletion 
of UFD4, UBR2 or UBC4 has a smaller impact on Pex13-mGFP degradation (Figure 7-10). 
These data could suggest that the peroxisomal ubiquitination machinery is the major player in 
Pex13p degradation, while the cytosolic factors Ufd4p, Ubc4p and Ubr2p play a more minor 
role (Figure 11). However, further investigations are required, including the potential roles of 
the other factors identified in our tFT analysis in Pex13p degradation. 
In summary, our results demonstrate that Pex13p degradation is a general process 
conserved across different organisms yet occurring likely via similar mechanisms while they 
also identify roles for additional, cytosolic E2s and E3s in Pex13p degradation. However, 
further study is required before the mechanisms that underlie Pex13p degradation become clear. 
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                                                Figure 11. A schematic model of Pex13p degradation. 
The ubiquitination machinery at the peroxisomal membrane, including Pex4p (E2) and RING complex 
Pex2p/ Pex10p/ Pex12p (E3), plays a major role in Pex13p ubiquitination. The cytosolic factors Ufd4p, 
Ubc4p and Ubr2p play a more minor role, possibly involved in a later step of poly-ubiquitination chain 
formation.  
Materials and Methods  
Molecular techniques and construction of S. cerevisiae strains 
S. cerevisiae strains used in this study are listed in Table 1. Strains used in tFT analysis were 
constructed as described previously (Khmelinskii et al, 2014). The plasmids and primers used 
in this study are listed in Table 2 and 3 respectively. Phusion DNA polymerase (Thermo 
Scientific) was used to produce gene fragments. 
Competent cells of S. cerevisiae were prepared as follows: Cells were inoculated in 20 mL 
YPD liquid media and incubated with shaking of 200 rpm overnight at 30℃. The OD 600 of 
the overnight culture was measured and cells were diluted to 0.25 in 50 mL YPD. The cells 
were harvested at 5000 rpm for 5 min when the OD 600 reached 0.8~ 1.0. Cells were washed 
twice with sterile water, once with 5 mL of 1 M Sorbitol, and suspended in 300 μL of 1 M 
Sorbitol. The competent cells were aliquoted into 50 μL and frozen at -80℃.  
For S. cerevisiae transformation, 15 μL of PCR product, 40 μL of denatured salmon sperm 
DNA (100℃ for 10 min, and immediately cooled on ice-water) and 300 μL of PEG/ LiAc/ TE 
solution (0.8 mL 50% PEG-3350, 0.1 mL 100 mM Tris-HCl pH7.5 with 10 mM EDTA, 0.1 
mL 1M Lithium acetate) were mixed with 50 μL of cells and shaken for 30 min at 30℃. Cells 
were mixed with 40 μL DMSO and heat shocked for 15 min at 42℃. Cells were cooled on ice 
for 1 min and washed once with 1mL YPD. Cells were finally resuspended in 5 mL YPD, 
shaken for 2~ 3 hr at 30℃ and plated on either YPD plates containing appropriate antibiotics 
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or, for cells expressing Ub-K48R, on YND plates without Uracil. Plates were grown at 30℃ for 
2 to 3 days. 
The Pex13-mGFP fragment was prepared as follows: The plasmid pHIPZ-Pex13-mGFP 
containing H. polymorpha Pex13-mGFP and Zeocin resistance gene was used as the template. 
The Zeocin fragment together with its promoter and terminator was obtained by PCR using the 
primers ScPex13-mGFP-F and Tcyc1-dnScP13-R, resulting in a product of 2240 bp with 
homologous region of upstream and downstream to PEX13 at both ends. This PCR-based 
fragment was used for transformation to obtain strains expressing Pex13-mGFP. 
To produce the Pex3-mKate fragment, the plasmid pHIPH-Pex14-mKate2 containing H. 
polymorpha Pex14-mKate2 and Hygromycin resistance gene was used as template. The 
Hygromycin fragment, together with its promoter and terminator, was obtained by PCR using 
the primers ScPex3-mKate-F_SRI and ScPex3-mKate-R_SRI, resulting in a product of 2858 
bp with homologous region of upstream and downstream to PEX3. This fragment was 
transformed into yeast, to obtains strains expressing Pex3-mKate. 
The Cdc5-HA6 fragment was prepared as follows: A HA6 fragment and Hygromycin 
cassette, together with its promoter and terminator sequences, was obtained by PCR using the 
primers ScCdc5-HA6-F and HYG-dnCdc5-R and the plasmid pHIPH-AID-HA6 as template. 
The resulting 1724 bp product, containing sequences homologous to the upstream and 
downstream regions of S. cerevisiae CDC5, was used for transformation, to obtain a cdc48-3 
strain expressing Cdc5-HA6. 
The episomal plasmid Yep-Pcup1-myc-Ub-K48R has myc-Ub-K48R cassette under 
control of Copper promoter (Pcup1-overexpression promoter), with URA3 marker for selection 
in yeast. Yeast episomal plasmids, unlike genome integration, are high copy plasmids and 
remain free in the cell. PCR of CUP1 promoter was performed on the plasmid pCGCN-FAA4-
mGFP using primers NotI-CUP1-F and CUP1-BamHI-R, resulting a fragment of 347 bp. The 
fragment was further digested with NotI and BamHI, and cloned into NotI/ BamHI digested 
pRDV2 vector, generating pHIPH-Pcup1-myc-Ub-K48R. PCR was performed on the plasmid 
pHIPH-Pcup1-myc-Ub-K48R with primers NotI-CUP1-F and UbKR-SacI-R, resulting a 632 
bp fragment which was digested with NotI and SacI and cloned into NotI/ SacI digested pRG226 
(ADDGENE), producing a plasmid of 5979 bp, termed as Yep-Pcup1-myc-Ub-K48R. 
PEX11 and PEX13 were endogenously and seamlessly tagged by PCR targeting with tFT 
as  previously described (Khmelinskii et al, 2014; Khmelinskii et al, 2011).   
Strains and growth conditions 
The S. cerevisiae strains used in this study are derivatives of BY4742 or CB199 and are listed 
in Table S1. All integrations were confirmed by colony PCR using Phire Hot Start II (Thermo 
Scientific). Strains containing Pex13-mGFP were further checked by fluorescence microscopy 
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and Western blotting and strains containing Pex3-mKate were further checked by fluorescence 
microscopy. 
Yeast transformants were selected on YPD plates containing 2% agar and 100 μg/ml 
Zeocin (Invitrogen) or 300 μg/ml Hygromycin (Invitrogen) or on YND plates (6.7g/L Yeast 
Nitrogen base w/o Amino acids (DIFCO), 5g/L Glucose (BOOM B.V.)) containing 2% agar, 
for the Ub-K48R strain. The E. coli strain DH5α was used for cloning purposes. E. coli cells 
were grown in LB supplemented with 100 μg/ml Ampicillin at 37 °C. For selection of 
auxotrophic transformants, selective minimal medium was supplemented with 2% glucose and 
the required amino acids mixture. Cycloheximide (CHX) when used, was added to a final 
concentration of 6 mg/ml. 
All S. cerevisiae liquid cultures were gown while shaking at 200 rpm. S. cerevisiae cells 
for TCA lysates, CHX assays and fluorescence microscopy were grown on YM2 media (6.7g/L 
Yeast Nitrogen base w/o Amino acids (DIFCO), 10g/L Casein hydrolysate (Sigma), 0.06g/L 
Uracil (Sigma) and 0.06g/L L-Tryptophan (Sigma)). Cells were first grown on YM2 
supplemented with 2% glucose at 30℃ overnight, then transfer to YM2 plus 0.3% glucose at 
2pm on day-2 and grown at 30℃ for 8 hr. Finally cells were transferred to YM2 plus 0.1% oleic 
acid (Sigma), 0.1% glucose and 0.05% Tween-80 (YM2O) and grown at 30℃ till an OD600 of 
around 1.0 (~10-12hr), after which cells were either harvested for TCA lysates or 
CHX/fluorescence microscopy experiments were performed.  
For experiments using the Cdc48 temperature sensitive strain cdc48-3, cells expressing 
Pex13-mGFP were grown on YM2 plus 2% glucose at 23℃ overnight, then at 10am on day-2 
cells were transferred to YM2 plus 0.3% glucose and grown at 23℃ for 12hr. Finally, cells were 
transferred to YM2O media and grown further at 23℃. After 17hrs of growth, cells were split 
into two groups, those for CHX treatment at the permissive (23℃) temperature and those for 
CHX treatment at the restrictive (37℃) temperature. For permissive-temperature growth, cells 
were grown on YM2O media for a further 1hr at 23℃ and treated with DMSO or CHX. For 
restrictive temperature growth, cells were shifted to 37℃ for 1 hr, treated with DMSO or CHX 
and grown further at 37℃.  
Preparation of yeasts TCA lysates 
Cell extracts of TCA-treated cells were prepared for SDS-PAGE as detailed previously 
(Baerends et al, 2000). Three OD600 units of cells from each culture (at each time point) were 
taken for TCA lysis so that the amount of cells is constant, and after TCA lysis, equal volume 
(10μL) of each sample was loaded per lane and blots were probed with rabbit polyclonal 
antisera raised against the Myc tag (Santa Cruz Biotech, sc-789), Pex14p (Bottger et al, 2000), 
or pyruvate carboxylase 1 (Pyc1p) (Fahimi et al, 1993) or mouse monoclonal antisera raised 
against HA tag (Sigma, H3663) or mGFP (Santa Cruz Biotech, sc-9996). Secondary goat anti-
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rabbit (31460) or goat anti-mouse (31430) antibodies conjugated to horseradish peroxidase 
(Thermo Fisher Scientific) were used for detection. Pyc1p was used as a loading control. 
 
Quantification of Western blots 
Blots were scanned by using a densitometer (GS-710; Bio-Rad Laboratories) and protein levels 
were quantified using Image Studio Lite Ver5.2 software (LI-COR Biosciences). In the case of 
Pex14p blots, both the phosphorylated and unphosphorylated forms were included in the 
calculation if both forms were visible. The value obtained for each band was normalized by 
dividing it by the value of the corresponding Pyc1p band (loading control). For comparison of 
absolute protein levels (Figures 2 and 4), normalized values obtained for Pex13p and Pex14p 
levels in WT cells were set to 1 and the levels of these proteins in mutant cells are displayed 
relative to WT. For CHX experiments (Figures 1, 5, 6 and 7), the normalized values of T0 
samples were set to 1.0 and values obtained from the T1-T3 samples are displayed as a fraction 
of T0 values. Standard deviations were calculated using Excel. * represents P-values < 0.05, ** 
represents P-values < 0.01 and *** represents P-values < 0.001. The data presented are derived 
from three independent experiments.  
Fluorescence Microscopy 
All fluorescence microscopy images were acquired using a 100×1.30 NA Plan-Neofluar 
objective (Carl Zeiss). Wide-field microscopy images were captured by an inverted microscope 
(Axio Scope A1, Carl Zeiss) using Micro-Manager software and a digital camera (CoolSNAP 
HQ2; Photometrics). GFP signal was visualized with a 470/440-nm band pass excitation filter, 
a 495-nm dichromatic mirror, and a 525/550-nm band pass emission filter. mKate signal was 
visualized with a 587/525-nm band pass excitation filter, a 605-nm dichromatic mirror, and a 
647/670-nm band-pass emission filter. 
For images taken of Pex13-mGFP in WT grown on oleic acid containing medium, the optimal 
settings were mGFP (290, 650) and mKate2 (225, 600), and in pex2, the optimal settings mGFP 
(290, 2900) and mKate2 (225, 630) were applied for processing. The general settings used to 
compare the signal of Pex13-mGFP in WT and pex2, mGFP (300, 2000) and mKate2 (225, 
620) were applied for processing. 
For quantification of the Pex13-mGFP signal in WT or pex2 cells, a rectangular area was 
drawn using the “rectangular tool” from ImageJ (Abramoff et al, 2004) to envelope the region 
containing the Pex13-mGFP spot and pixel intensity inside the area was measured. The 
measured maximum fluorescence intensity of GFP on peroxisomes was corrected for the 
background intensity and a box plot was made using Microsoft Excel. The box represents values 
from the 25 percentile to the 75 percentile; the horizontal line through the box represents the 
median value. Whiskers indicate maximum and minimum values.  
 




Yeast strains were grown overnight at 30 °C on YM2 medium containing 2% glucose and 
shifted to YM2 medium plus 0.3% glucose. After 6h of growth in YM2 plus 0.3% glucose, cells 
were diluted to 0.1 OD and ten-fold serial dilutions were made up to 0.0001 OD. From every 
dilution, 3 μL yeast cells were spotted onto oleate plates containing 6.7 g/L YNB, 1 g/L SCSM–
LEU dropout mix (Hopkins mixture, FOR MEDIUM), 180 mg/L leucine, 0.1% oleate, 0.05% 
Tween and 2% agar was added. Plates were incubated at 30°C for 7 before imaging. 
Tandem fluorescent timer (tFT) analysis 
The tFT analysis in this study is mainly based on previous established tFT technique, and the 
following procedure is adapted from the detailed protocols already published (Khmelinskii et 
al, 2014; Khmelinskii et al, 2012). Chromosomal gene tagging and gene deletion were 
performed using standard procedures based on PCR targeting as previously described (Janke et 
al, 2004). Gene deletion and gene tagging were validated by PCR. Expression of Pex13p fused 
to tFT tag which consists of two fluorescent proteins mCherry and sfGFP was validated using 
immunoblotting and confirmed with fluorescence microscopy.  
Pex13-tFT was crossed using the synthetic genetic array method (Tong & Boone, 2006) 
with a yeast strain library which consisted of 152 strains that either lacked a gene involved in 
protein degradation or which contained a mutant version of a protein involved in protein 
degradation (in case the deletion was lethal), resulting in a library expressing Pex13-tFT in each 
mutant. All the colonies used for imaging were prepared fresh every time. WT and mutant 
strains expressing Pex13-tFT were first grown on YPD plates with 2% agar at 30 °C. From agar 
plates, they were pinned together (Singer Instruments) on a single plate for mating and diploid 
selection. Colonies were then plated on sporulation plates (Potassium Acetate (Sigma) 20g/L, 
agar 2%). After sporulation, yeast strains expressing Pex13-tFT fusions were grown at 30 °C 
in synthetic complete medium (yeast nitrogen base with amino acid supplements, Sigma) 
(Khmelinskii et al, 2012) with 0.1% glucose, 0.1% oleic acid, 0.5% tween and 2% agar.  
The tFT library used in this study consists of one WT strain without Pex13-tFT (used to 
correct the background signal), one WT with Pex13-tFT fluorescent fusion protein (used as 
negative control), and 152 mutants in each of which a gene from UPS system is disrupted either 
by deletion for non-essential genes or by mutations for essential genes. Each plate had 1536 
colonies, including Pex13-tFT crossed with UPS mutants, non-functional fluorescent protein 
crossed with UPS mutants used for background correction, and Pex13-tFT crossed with WT as 
control, with four technical replicates for each strain. Strains were grown for 7 days, and images 
were taken every day. The plates were imaged with an M1000 Pro plate reader equipped with 
automatic plate loading stackers (Tecan) and custom temperature control chambers. 
Measurements were taken with 10 flashes each for sfGFP (488/10nm excitation, 510/10 nm 
emission) and mCherry (587/10 nm excitation, 610/10 nm emission).  
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The mCherry/ sfGFP ratio of each mutant was the average of four colonies of the same 
strain. For the further calculation of Z-score (see below), ratios of fluorescent intensities were 
normalized to the WT expressing Pex13-tFT on the same plate on the same day, and the ratio 
in WT expressing Pex13-tFT was set to 1. 
A Z-score, also known as a standard score, indicates how many standard deviations an 
element is from the mean. A Z-score can be calculated from the formula: Z= (X - μ) / σ. In the 
formula, Z is the Z-score, X is the value of the element (the average of four mCherry/ sfGFP 
intensity ratios of one strain on the plate on the same day), μ is the population mean (the average 
of all ratios on the same plate on the same day), and σ is the standard deviation (the standard 
deviation of all ratios on the same plate on the same day). The mCherry and sfGFP fluorescence 
intensities were measured for colonies from each strain on each day and the mCherry/sfGFP 
ratio was calculated and used to determine the Z-score, the deviation of the ratio for a particular 
strain on a particular day compared to the average ratio across all strains on that day. Increases 
in Z-score are colour coded, ranging from 1.0 or less (green) to 5.0 (red). The data for each 
square in the heat map are derived from four technical replicates. We applied a cut-off of 1 to 
screen out most of the background. As for the interpretation of Z-scores, a Z-score less than 0 
represents an element less than the mean and a Z-score greater than 0 represents an element 
greater than the mean. A Z-score equal to 1 represents an element that is one standard deviation 
greater than the mean while -1 represents one standard deviation less than the mean. 
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Table 1. S. cerevisiae strains used in this study 
 
Strain Description Reference 
WT The SGA entry strain Y8205 (MATα 
can1Δ::STE2pr-SpHIS5 lyp1Δ::STE3pr-LEU2 
his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) with the genetic 
elements (natR) required for seamless protein tagging, 
generating the library background strain yMaM330. 
(Khmelinskii et 
al, 2014) (Knop 
lab) 
Pex11-tFT yMaM330, PEX11::mCherry-I-SceIsite- 
SpCYC1term-ScURA3-I-SceIsite-mCherryΔN-sfGFP 
Knop lab  
Pex13-tFT yMaM330, PEX13::mCherry-I-SceIsite- 
SpCYC1term-ScURA3-I-SceIsite-mCherryΔN-sfGFP 
Knop lab 
WT Pex13-mGFP Sc WT with Pex13-mGFP (zeoR) This study 
WT Pex13-mGFP+ 
Pex3-mKate 





Sc WT with myc tagged Ub-K8R (URA) and Pex13-
mGFP (zeoR) 
This study 
BY4741  MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 (Khmelinskii et 
al, 2014) (Knop 
lab) 
UPS deletion library BY4741, goi deletions::kanMX (Khmelinskii et 
al, 2014) (Knop 
lab) 
pex2 Sc WT cell deleted PEX2 (BY4741, pex2::kanMX) Knop lab 
pex2+ Pex13-mGFP pex2 with Pex13-mGFP (zeoR) This study 
pex2+ Pex13-mGFP+ 
Pex3-mKate 
pex2 with Pex13-mGFP (zeoR) and Pex3-mKate 
(hygR) 
This study 
pex4 Sc WT cell deleted PEX4 (BY4741, pex4::kanMX) Knop lab 
pex4+ Pex13-mGFP pex4 with Pex13-mGFP (zeoR) This study 
ufd4 Sc WT cell deleted UFD4 (BY4741, ufd4::kanMX) Knop lab 
ufd4+ Pex13-mGFP ufd4 with Pex13-mGFP (zeoR) This study 
ubc4 Sc WT cell deleted UBC4 (BY4741, ubc4::kanMX) Knop lab 
ubc4+ Pex13-mGFP ubc4 with Pex13-mGFP (zeoR) This study 
atg12 Sc WT cell deleted ATG12 (BY4741,atg12::kanMX) Knop lab 
atg12+ Pex13-mGFP atg12 with Pex13-mGFP (zeoR) This study 
ubr2 Sc WT cell deleted UBR2 (BY4741, ubr2::kanMX) Knop lab 
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ubr2+ Pex13-mGFP ubr2 with Pex13-mGFP (zeoR) This study 
cdc48-3 Temperature sensitive (ts) mutant cdc48-3 contains a 
heat-sensitive allele of CDC48, with permissive 
(23℃) or the restrictive temperature (37℃) 
(Cao et al, 
2003) 
cdc48-3+ Pex13-mGFP cdc48-3 with Pex13-mGFP (zeoR) This study 




Table 2. Plasmids used in this study 
 
Plasmid Description Reference 
pHIPZ-Pex13-mGFP C-terminal part of Pex13 fused with 
mGFP, zeoR ; ampR 
(Knoops et al, 2014) 
pHIPH-Pex14-mKate2 Plasmid containing the C-terminal 
region of H. polymorpha PEX14 fused 
to mKate2; hygR ; ampR 
(Chen et al, 2018) 
Yep Pcup1-myc-Ub-K48R Yeast episomal plasmid (URA) 
containing Ub-K48R fused to myc tag 
on its N-terminus, under control of 
Copper ion inducible promoter 
This study 
pCGCN-FAA4-mGFP Plasmid for S. cerevisiae containing 
Pcup1, FAA4, mGFP, natR, ampR 
(Saraya et al, 2010) 
pRDV2 Myc tagged ubiquitin mutate (Ub-
K48R) under control of DHAS 
promoter, zeoR ; ampR 




Plasmid containing myc tagged Ub-
K48R under control of CUP1 promoter, 
hygR ; ampR 
This study 
pRG226 The episomal E. coli/ S. cerevisiae 
shuttle vector (empty backbone), URA ; 
ampR 
(Gnügge et al, 2016) 
pHIPH-AID-HA6 Plasmid containing Auxin Inducible 
Degron (AID) with 6xHA tag at its C-
terminus, hygR ; ampR 
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Table 3. Primers used in this study 
 






To clone a fragment of 2858 bp 
containing 3’end of S. cerevisiae PEX3 
fused to mKate with Hygromycin 
resistance, forward primer, used to 






To clone a fragment of 2858 bp 
containing 3’end of S. cerevisiae PEX3 
fused to mKate Hygromycin resistance, 
reverse primer, used to make strain 
Pex3-mKate 
Pex3mKate-cPCR-F1 GGCAGCGTGAACGAATAC To check the positive colonies 
containing Pex3-mKate in the colony 
PCR, forward primer 
Pex3mKate-cPCR-R1 CTAGCCACTGCCACTTCG To check the positive colonies 
containing Pex3-mKate in the colony 





To clone a fragment of 2240 bp 
containing 3’end of S. cerevisiae 
PEX13 fused to mGFP with Zeocin 
resistance, forward primer, used to 






To clone a fragment of 2240 bp 
containing 3’end of S. cerevisiae 
PEX13 fused to mGFP with Zeocin 
resistance, reverse primer, used to 
make strain Pex13-mGFP 
ScPex13-F TACGGTGCAGGAGCG To check the positive colonies 
containing Pex13-mGFP in the colony 
PCR, forward primer 
mGFP-reverse_SRI AAGTCGTGCTGCTTCATGT
G 
To check the positive colonies 
containing Pex13-mGFP in the colony 
PCR, reverse primer 
NotI-CUP1-F GCATGCGGCCGCCCCTTTA
TTTCAGGCTGAT 








To clone a 632 bp fragment containing 









To clone a fragment of 1724 bp 
containing 3’end of S. cerevisiae CDC5 
fused to HA6 tag with Hygromycin 
resistance, forward primer, used to 





To clone a fragment of 1724 bp 
containing 3’end of S. cerevisiae CDC5 
fused to HA6 tag with Hygromycin 
resistance, forward primer, used to 
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Peroxisomes are single membrane bound organelles that are present in nearly all eukaryotic 
cells. Common peroxisome functions include β-oxidation of fatty acids and detoxification of 
hydrogen peroxide however, they are also involved in a wide variety of metabolic process that 
vary depending on the organism, cell type and developmental stage. The functions of 
peroxisomes are largely determined by peroxisomal matrix proteins that are involved in 
peroxisomal metabolism and peroxisomal membrane proteins (PMPs), which are involved in 
peroxisome formation, fission and transport of proteins and small molecules into peroxisomes. 
Thus, peroxisomal proteins need to be tightly controlled through regulation of protein synthesis, 
targeting as well as protein degradation. Peroxisomal proteins may undergo degradation either 
because they are damaged/unfolded by various stress factors or because they are no longer 
needed. Generally, protein degradation needs to be tightly controlled in order to prevent the 
accumulation of unwanted proteins or occurrence of unwanted protein degradation events. 
While many efforts have been placed on studying the post-translational targeting of PMPs to 
peroxisomes, little is known about PMP degradation. Investigating how and why PMPs are 
degraded will allow us to better understand the role of PMP degradation in a cellular context. 
Damaged and redundant membrane proteins from other organelles such as the ER and 
mitochondria are generally degraded by the Ubiquitin Proteasome System (UPS), which 
involves poly-ubiquitination of the substrate protein by a cascade of enzymes (E1, E2 and E3) 
followed by the degradation in the proteasome. Peroxisomes possess an E2 (Pex4p) and several 
E3 ligases (Pex2p, Pex10p and Pex12p), which are known to ubiquitinate the cycling receptor 
proteins Pex5p and Pex20p family members. Recently, this peroxisomal ubiquitination 
machinery was reported to be involved in the degradation of the PMPs Pex3p and Pex13p in H. 
polymorpha. In spite of these recent reports, questions remain, including which other PMPs 
undergo UPS mediated degradation, what are the functions of PMP degradation and whether 
all PMP degradation events share a common mechanism?   
The research presented in this thesis provides insights into PMP degradation in S. 
cerevisiae. Chapter 1 summarizes the current knowledge on how membrane proteins from the 
ER and mitochondria are recognized, extracted from the membrane and targeted for degradation 
by the ubiquitin proteasome system. Furthermore, we discuss what is currently known about 
PMP degradation, including possible functions of PMP turnover and how PMP degradation 
may be facilitated.  
In Chapter 2 we present our investigations into PMP stability in the yeast S. cerevisiae 
using the tandem fluorescent protein timer (tFT) approach. A tFT tag consists of two fluorescent 
proteins, in this case mCherry and sfGFP, which are fused to the protein of interest. The ratio 
of the fluorescent intensity of the two fluorescent proteins serves as an indicator for protein 
stability. We observed that the tFT approach can report on the stability of individual PMP-tFT 
fusions in cells, which varied from unstable (Pex13-tFT and Pxa1-tFT) to stable (Pex11-tFT). 
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The tFT tagged versions of Pex13p, Pxa1p and Pex11p were induced on oleate containing 
media and displayed peroxisomal-like localization. Furthermore, growth assays demonstrated 
that the functionality of Pex13p was not compromised by fusion to a tFT tag, whereas the 
functionality of Pxa1p was impaired by the tFT tag. Together, these data demonstrate that the 
tFT approach is valid to study PMP stability. The fact that the tFT tag impaired Pxa1p function 
demonstrates that attaching a tFT tag to a PMP may be used to deliberately destabilize PMPs, 
to investigate quality control events associated with that particular PMP. On the other hand 
Pex13-tFT, which retained its functionality, is rapidly degraded, indicating that tFT tags can 
also be effectively used for studying the targeted downregulation of PMPs. Either way, a strong 
point of the tFT approach is that it can be used to investigate PMP stability under different 
growth conditions (as was the case in this chapter) as well as to screen against mutant libraries, 
to identify factors that are involved in PMP degradation, as we have done in Chapters three and 
four.  
Chapter 3 reports on quality control of the PMP Pxa1p in S. cerevisiae. Pxa1p is a yeast 
homolog of human adrenoleukodystrophy protein (ALDP) and mutations in ALDP, which often 
lead to protein instability, can result in the severe genetic disorder adrenoleukodystrophy 
(ALD). We selected two ALD causing mutations and generated the corresponding mutations in 
yeast Pxa1p (Pxa1MUT), tagged to mGFP. We observed that Pxa1MUT-mGFP is rapidly degraded 
while Pxa1-mGFP remained stable, establishing a role for quality control in Pxa1MUT-mGFP 
turnover. Significantly, Pxa1MUT-mGFP degradation was reduced upon proteasome inhibitor 
treatment, demonstrating that the proteasome is involved and further suggesting a role for 
ubiquitination in Pxa1MUT-mGFP turnover. Our attempts to detect ubiquitinated forms of 
Pxa1MUT-mGFP were unsuccessful, possibly because ubiquitinated Pxa1MUT-mGFP is present 
at a low level or that ubiquitination of another protein and not Pxa1MUT-mGFP may be required 
for Pxa1MUT-mGFP degradation. Using the tFT approach, we observed that the cytosolic E3 
ligase Ufd4p plays a major role in Pxa1MUT-mGFP degradation. The observation that Pxa1MUT-
mGFP is stabilized on peroxisomes in ufd4 cells suggest that Ufd4p dependent quality control 
of Pxa1MUT-mGFP occurs at peroxisomes. Like Ufd4p, loss of the peroxisomal E3 ligase Pex2p 
also inhibited Pxa1MUT-mGFP degradation. There could be two reasons to explain why multiple 
E3s are involved in Pxa1MUT-mGFP degradation; 1) two parallel pathways target Pxa1MUT-
mGFP for degradation, one requiring Ufd4p and other involving Pex2p or alternatively 2) the 
loss of peroxisomal ubiquitination machinery factors impacts on peroxisome function, which 
in turn inhibits Pxa1MUT-mGFP degradation. The absence of the cycling receptor protein Pex5p 
also inhibits Pxa1MUT-mGFP turnover. Hence, the loss of Pex2p or Pex4p could indirectly 
inhibit Pxa1MUT-mGFP degradation. Finally, we show that Pxa1MUT-mGFP retained a certain 
degree of activity and this was increased by inhibiting Pxa1MUT-mGFP degradation through the 
deletion of UFD4. Details on the mechanisms of how Ufd4p regulates Pxa1MUT-mGFP turnover 
will enable us to better understand how cytosolic UPS factors can regulate the turnover of PMPs 
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and can hence impact on peroxisome function. Furthermore, the fact that inhibiting Pxa1MUT-
mGFP degradation can enhance Pxa1p cellular activity demonstrates that blocking ALDP 
mutant degradation may represent an effective way to treat ALD.  
In Chapter 4 we present our research on S. cerevisiae Pex13p. Similar to H. 
polymorpha, we observed that Pex13p fused to mGFP (Pex13-mGFP) in S. cerevisiae 
undergoes rapid degradation in cells grown on peroxisome inducing conditions, establishing 
that Pex13p turnover is a conserved event. By employing the tFT approach, we demonstrate 
that the peroxisomal ubiquitination machinery plays a major role in Pex13-mGFP degradation, 
while the additional cytosolic UPS factors Ufd4p, Ubc4p and Ubr2p play minor roles, possibly 
through the formation of poly-Ub chains on Pex13-mGFP. The fact that multiple E2s and E3s 
appear to be involved in Pex13-mGFP turnover suggests that either several pathways act in 
parallel to facilitate Pex13-mGFP degradation or that all these factors act together in 
ubiquitinating Pex13-mGFP, to target the protein for proteasomal degradation. Our data also 
demonstrate that the function of Cdc48p is not required for Pex13-mGFP degradation. Since 
Cdc48p is involved in the degradation of ER and mitochondrial membrane proteins, this 
observation sets the degradation of PMPs apart from that of other organellar membrane proteins 
and establishes that different mechanisms exist to facilitate these degradation processes. One 
possibility is that the AAA-ATPase Msp1p, which was reported to extract tail anchored proteins 
such as Pex15p from the peroxisomal membrane for degradation could target Pex13p to the 
proteasome. Alternatively, the AAA-ATPases Pex1p and Pex6p, which are involved in the 
extracting ubiquitinated Pex5p from the peroxisomal membrane could also be seen as an 
interesting candidate for further study. However, recent reports indicate that proteasomes can 
be recruited directly to membranes, to facilitate the degradation of membrane proteins. Perhaps 
such a mechanism could also control the degradation of Pex13p. Clearly further work is needed 
to investigate how ubiquitinated Pex13p is extracted from the peroxisomal membrane and why 
Pex13p is targeted for degradation. 
PMPs play a crucial role in regulating many peroxisomal functions and therefore are 
important for peroxisome homeostasis and cellular metabolism. Investigating the degradation 
of PMPs would help us understand how PMP homeostasis is controlled, to what extent PMP 
degradation is involved in regulating peroxisomal functions and how PMP degradation relates 
to other protein degradation systems in the cell. In this thesis we have investigated the 
degradation of PMPs in S. cerevisiae. Our data clearly show that Pxa1-tFT and Pxa1MUT-mGFP, 
which are both inhibited in function, undergo rapid degradation. The fact that only faulty 
versions of Pxa1p, but not the wild-type version, undergo degradation demonstrates the 
existence of a quality control pathway at the peroxisomal membrane that targets faulty PMPs 
for degradation. The strong link between ER and mitochondrial membrane protein quality 
control and disease tells us that future studies should be aimed at investigating this PMP quality 
control pathway. Furthermore, the involvement of Ufd4p in the degradation of Pxa1MUT-mGFP, 
Pxa1-tFT and (potentially) Pex13-mGFP indicates both that common mechanisms may exist 
that target PMPs for degradation and that cytosolic proteins can regulate PMP degradation and 
hence the peroxisome function. Future studies that aim to identify and characterise additional 
cytosolic UPS factors involved in PMP degradation will provide valuable insights into the role 






































































Peroxisomen zijn organellen met een enkel membraan die in bijna alle eukaryote cellen 
voorkomen. Veel voorkomende peroxisoomfuncties zijn onder meer β-oxidatie van vetzuren 
en detoxificatie van waterstofperoxide, maar ze zijn ook betrokken bij een breed scala aan 
metabolische processen die variëren afhankelijk van het organisme, celtype en 
ontwikkelingsstadium. De functies van peroxisomen worden grotendeels bepaald door 
peroxisomale matrixeiwitten die betrokken zijn bij het peroxisomale metabolisme en 
peroxisomale membraaneiwitten (PMP's), die betrokken zijn bij de peroxisoomvorming, 
splitsing en transport van eiwitten en kleine moleculen naar peroxisomen. Het is belangrijk dat 
peroxisomale eiwitten strak worden gecontroleerd door regulering van eiwitsynthese, targeting 
en eiwitafbraak. Peroxisomale eiwitten kunnen worden afgebroken omdat ze zijnbeschadigd / 
ontvouwen door verschillende stressfactoren of omdat ze niet langer nodig zijn. Over het 
algemeen moet de afbraak van eiwitten streng worden gecontroleerd om de ophoping van 
ongewenste eiwitten of het optreden van ongewenste eiwitafbraak te voorkomen. Hoewel er 
veel inspanningen zijn geleverd om de post-translationele targeting van PMP's op peroxisomen 
te bestuderen, is er weinig bekend over PMP-afbraak. Door te onderzoeken hoe en waarom 
PMP's worden afgebroken, zullen we de rol van PMP-afbraak in een cellulaire context beter 
kunnen begrijpen. 
Beschadigde en overtollige membraaneiwitten van andere organellen zoals het 
endoplasmatisch reticulum (ER) en mitochondriën worden in het algemeen afgebroken door 
het Ubiquitin Proteasoom Systeem (UPS), dat poly-ubiquitinering van het substraateiwit 
teweeg brengt door een cascade van enzymen (E1, E2 en E3) gevolgd door de afbraak in het 
proteasoom. Peroxisomen hebben één E2 (Pex4p) en verschillende E3-ligasen (Pex2p, Pex10p 
en Pex12p), waarvan bekend is dat ze de cyclische receptoreiwitten Pex5p en Pex20p 
familieleden ubiquitineren. Onlangs werd gemeld dat deze peroxisomale ubiquitinatie machine 
betrokken is bij de afbraak van de PMP's Pex3p en Pex13p in H. polymorpha. Ondanks deze 
recente rapporten blijven er vragen liggen, waaronder welke andere PMP's UPS-gemedieerde 
afbraak ondergaan, wat zijn de functies van PMP-afbraak en of alle PMP-afbraakgebeurtenissen 
een gemeenschappelijk mechanisme delen? 
Het onderzoek in dit proefschrift geeft inzicht in PMP-afbraak in S. cerevisiae. 
Hoofdstuk 1 vat de huidige kennis samen over hoe membraaneiwitten uit het ER en 
mitochondriën worden herkend, uit het membraan worden gehaald en voor afbraak worden 
getarget door het ubiquitine-proteasoom systeem. Verder wordt besproken wat er momenteel 
bekend is over PMP-afbraak, inclusief mogelijke functies van PMP-verloop en hoe PMP-
afbraak kan worden gefaciliteerd. 
In Hoofdstuk 2 presenteren we ons onderzoek naar PMP-stabiliteit in de gist S. 
cerevisiae met behulp van de tandem fluorescent proteïne timer (tFT) benadering. Een tFT-tag 
bestaat uit twee fluorescerende eiwitten, in dit geval mCherry en sfGFP, die zijn gefuseerd met 
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het betreffende eiwit. De verhouding van de fluorescentie-intensiteit van de twee fluorescerende 
eiwitten dient als indicator voor eiwitstabiliteit. We hebben waargenomen dat de tFT-
benadering de stabiliteit van individuele PMP-tFT-fusies in cellen kan weergeven, dit varieerde 
van onstabiel (Pex13-tFT en Pxa1-tFT) tot stabiel (Pex11-tFT). De tFT-gelabelde versies van 
Pex13p, Pxa1p en Pex11p werden geïnduceerd op oleaat bevattende media en vertoonden 
peroxisomaal-achtige lokalisatie. Bovendien toonden groei-experimenten aan dat de 
functionaliteit van Pex13p niet werd aangetast door fusie met een tFT-tag, terwijl de 
functionaliteit van Pxa1p wel werd aangetast door de tFT-tag. Samen tonen deze resultaten aan 
dat de tFT-benadering een goede manier is om PMP-stabiliteit te bestuderen. Het feit dat de 
functie tFT-tag Pxa1p verminderde, toont aan dat het bevestigen van een tFT-tag aan een PMP 
kan worden gebruikt om PMP's opzettelijk te destabiliseren.Dit kan gebruikt worden om 
kwaliteitscontrolegebeurtenissen te onderzoeken die verband houden met die specifieke PMP. 
Aan de andere kant wordt Pex13-tFT, dat zijn functionaliteit behield, snel afgebroken, wat 
aangeeft dat tFT-tags ook effectief kunnen worden gebruikt voor het bestuderen van de gerichte 
downregulatie van PMP's. Een sterk punt van de tFT-benadering is dat het kan worden gebruikt 
om PMP-stabiliteit onder verschillende groeiomstandigheden te onderzoeken (zoals het geval 
was in dit hoofdstuk) en om te screenen tegen mutante bibliotheken, om factoren te identificeren 
die betrokken zijn bij PMP degradatie, zoals we hebben gedaan in de hoofdstukken drie en vier. 
Hoofdstuk 3 beschrijft de kwaliteitscontrole van de PMP Pxa1p in S. cerevisiae. Pxa1p 
is een gisthomoloog van humaan adrenoleukodystrofie-eiwit (ALDP) en mutaties in ALDP, die 
vaak tot eiwitinstabiliteit leiden, kunnen leiden tot de ernstige genetische aandoening 
adrenoleukodystrofie (ALD). We selecteerden twee ALD-veroorzakende mutaties en 
genereerden de overeenkomstige mutaties in gist Pxa1p (Pxa1MUT), getagd aan mGFP. We 
hebben waargenomen dat Pxa1MUT-mGFP snel wordt afgebroken, terwijl Pxa1-mGFP stabiel 
blijft, wat aangeeft dat kwaliteitscontrole een rol speelt in het Pxa1MUT-mGFP -verloop. De 
afbraak van Pxa1MUT-mGFP werd significant verminderd na behandeling met 
proteasoomremmers, wat aantoont dat het proteasoom hierbij betrokken is en verder een rol 
suggereert voor ubiquitinatie in het Pxa1MUT-mGFP -verloop. Onze pogingen om 
ubiquitinevormen van Pxa1MUT-mGFP te detecteren, waren niet succesvol, mogelijk omdat 
geubiquitineerde Pxa1MUT-mGFP weinig aanwezig is of omdat ubiquitinering van een ander 
eiwit en niet Pxa1MUT-mGFP nodig is voor Pxa1MUT-mGFP -afbraak. Met behulp van de tFT-
benadering hebben we waargenomen dat het cytosolische E3-ligase Ufd4p een belangrijke rol 
speelt bij de afbraak van Pxa1MUT-mGFP. De waarneming dat Pxa1MUT-mGFP is gestabiliseerd 
op peroxisomen in ufd4-cellen suggereert dat Ufd4p-afhankelijke kwaliteitscontrole van 
Pxa1MUT-mGFP plaatsvindt bij peroxisomen. Net als Ufd4p remt het verlies van de 
peroxisomale E3-ligase Pex2p ook de afbraak van Pxa1MUT-mGFP. Er kunnen twee redenen 
zijn om uit te leggen waarom meerdere E3's betrokken zijn bij Pxa1MUT-mGFP -afbraak; 1) 
twee parallelle routes richten zich op Pxa1MUT-mGFP voor afbraak, één vereist Ufd4p waarbij 
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de andere Pex2p betrokken is, of alternatief 2) het verlies van factoren van het peroxisomale 
ubiquitineringsysteem beïnvloedt de peroxisoomfunctie, wat op zijn beurt de afbraak van 
Pxa1MUT-mGFP remt. De afwezigheid van het cyclische receptoreiwit Pex5p kan ook het 
Pxa1MUT-mGFP -verloop remmen. Dit wijst erop dat het verlies van Pex2p of Pex4p indirect 
de afbraak van Pxa1MUT-mGFP kan remmen. Ten slotte laten we zien dat Pxa1MUT-mGFP een 
bepaalde mate van activiteit behoud en dat dit wordt verhoogd door Pxa1MUT-mGFP -afbraak 
te remmen door de verwijdering van UFD4. Details over de mechanismen van hoe Ufd4p het 
Pxa1MUT-mGFP -verloop reguleert, zullen ons in staat stellen om beter te begrijpen hoe 
cytosolische UPS-factoren het verloopvan PMP's kunnen reguleren en dus van invloed kunnen 
zijn op de peroxisoomfunctie. Bovendien toont het feit dat het remmen van de afbraak van 
Pxa1MUT-mGFP de cellulaire activiteit van Pxa1p kan versterken aan dat het blokkeren van 
ALDP-mutantafbraak een effectieve manier kan zijn om ALD te behandelen. 
In hoofdstuk 4 presenteren we ons onderzoek naar S. cerevisiae Pex13p. Net als bij H. 
polymorpha, hebben we waargenomen dat Pex13p gefuseerd met mGFP (Pex13-mGFP) in S. 
cerevisiae een snelle afbraak ondergaat in cellen die zijn gegroeid onder peroxisoom-
inducerende omstandigheden, wat aantoont dat het Pex13p-verloop een geconserveerde 
gebeurtenis is. Door de tFT-benadering toe te passen, laten we zien dat de peroxisomale 
ubiquitinatiemachines een belangrijke rol spelen bij de afbraak van Pex13-mGFP, terwijl de 
aanvullende cytosolische UPS-factoren Ufd4p, Ubc4p en Ubr2p een ondergeschikte rol spelen, 
mogelijk door de vorming van poly-Ub-ketens op Pex13- mGFP. Het feit dat meerdere E2's en 
E3's betrokken lijken te zijn bij het Pex13-mGFP-verloop, suggereert dat verschillende routes 
parallel werken om de afbraak van Pex13-mGFP te faciliteren of dat al deze factoren 
samenwerken bij het ubiquitineren van Pex13-mGFP, om het eiwit te targeten voor 
proteasomale afbraak. Onze resultaten tonen ook aan dat de functie van Cdc48p niet vereist is 
voor Pex13-mGFP-afbraak. Aangezien Cdc48p betrokken is bij de afbraak van ER- en 
mitochondriale membraaneiwitten, onderscheidt deze waarneming de afbraak van PMP's van 
die van andere organellaire membraaneiwitten en bewijst dat er verschillende mechanismen 
bestaan om deze afbraakprocessen te faciliteren. Eén mogelijkheid is dat het AAA-ATPase 
Msp1p, waarvan werd gerapporteerd dat het staartverankerde eiwitten zoals Pex15p uit het 
peroxisomale membraan haalt voor afbraak, Pex13p zou kunnen targeten om naar het 
proteasoom getransporteerd te worden. Als alternatief zouden de AAA-ATPases Pex1p en 
Pex6p, die betrokken zijn bij het extraheren van geubiquitineerd Pex5p uit het peroxisomale 
membraan, ook kunnen worden beschouwd als een interessante kandidaat voor verder 
onderzoek. Recente rapporten geven echter aan dat proteasomen rechtstreeks op membranen 
kunnen worden gerekruteerd om de afbraak van membraaneiwitten te faciliteren. Misschien 
zou een dergelijk mechanisme ook de afbraak van Pex13p kunnen reguleren. Er is nog meer 
onderzoek nodig om duidelijk te krijgen hoe geubiquitineerd Pex13p wordt geëxtraheerd uit 
het peroxisomale membraan en waarom Pex13p het doelwit is voor afbraak. 
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PMP's spelen een cruciale rol bij het reguleren van veel peroxisomale functies en zijn 
daarom belangrijk voor de peroxisoomhomeostase en het celmetabolisme. Onderzoek naar de 
afbraak van PMP's zou ons helpen te begrijpen hoe PMP-homeostase wordt gereguleerd, in 
welke mate PMP-afbraak betrokken is bij het reguleren van peroxisomale functies en hoe PMP-
afbraak zich verhoudt tot andere eiwitafbraaksystemen in de cel. In dit proefschrift is de afbraak 
van PMP's in S. cerevisiae onderzocht. De resultaten laten duidelijk zien dat Pxa1-tFT en 
Pxa1MUT-mGFP, welke beide minder goed functioneren, snel worden afgebroken. Het feit dat 
alleen defecte versies van Pxa1p, maar niet de wildtype-versie, degradatie ondergaan, toont het 
bestaan aan van een kwaliteitscontroleroute op het peroxisomale membraan dat gericht is op 
defecte PMP's voor degradatie. De sterke link tussen ER en mitochondriale 
membraaneiwitkwaliteitscontrole en ziekte geeft aan dat toekomstige studies gericht moeten 
zijn op het onderzoeken van deze PMP-kwaliteitscontroleroute. Bovendien geeft de 
betrokkenheid van Ufd4p bij de afbraak van Pxa1MUT-mGFP, Pxa1-tFT en (mogelijk) Pex13-
mGFP aan dat er gemeenschappelijke mechanismen kunnen bestaan die PMP's voor afbraak 
targeten, en dat cytosolische eiwitten de PMP-afbraak en daarmee de peroxisoomfunctie 
kunnen reguleren. Toekomstige studies die gericht zijn op het identificeren en karakteriseren 
van aanvullende cytosolische UPS-factoren die betrokken zijn bij PMP-afbraak, zullen 
waardevolle inzichten verschaffen in de rol van PMP-verloop bij gezondheid en ziekte. 
 
 
 
 
 

